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ABSTRACT 
 
THE ROLE OF B-TYPE PHOSPHOLIPASES IN S. CEREVISIAE: FUNCTION, 
REGULATION, AND PHYSIOLOGICAL RELEVANCE IN LIPID HOMEOSTASIS 
 
 
 
By 
Beth A. Surlow 
August 2014 
 
Dissertation supervised by Dr. Jana Patton-Vogt. 
Membrane phospholipid synthesis and turnover is a continual process during normal cell 
growth. The turnover of the glycerophospholipids by B-type phospholipases (PLBs) in 
Saccharomyces cerevisiae results in the formation glycerophosphodiesters through a deacylation 
reaction. Here, I address several aspects of the glycerophospholipid deacylation, transport, and 
reutilization pathway in S. cerevisiae. First, I show the RAS GTPase-activating proteins, Ira1 and 
Ira2, are required for utilization of the glycerophosphodiester – glycerophosphoinositol (GroPIns) 
– as a phosphate source. Second, I demonstrate loss of the cell surface associated PLBs, Plb1-3, 
and/or utilization of GroPIns causes actin cytoskeleton defects and an increased cell size. For the 
third and major part of my dissertation, I identified a novel interaction between Ypk1 and Plb1.  
Ypk1, the yeast homolog of the human serum- and glucocorticoid-induced kinase (Sgk1), 
affects diverse cellular activities, including sphingolipid homeostasis. Here, I report that Ypk1 also 
  v 
impacts the turnover of the major phospholipid, phosphatidylcholine (PC). Pulse-chase 
radiolabeling reveals that a ypk1∆ mutant exhibits increased Plb1-mediated PC deacylation and 
glycerophosphocholine (GroPCho) production compared to wild type. Consistent with a link 
between Ypk1 and Plb1, the levels of both Plb1 protein and PLB1 message are elevated in a ypk1∆ 
strain compared to WT yeast. Furthermore, I discovered that an increase in PLB1 expression also 
occurs upon disruption to sphingolipid synthesis and is mediated by the Crz1 transcription factor. 
Taken together, these findings suggest that sphingolipid synthesis is coordinated with PC turnover 
to maintain optimal lipid homeostasis. 
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Chapter 1 Introduction 
1.1   Saccharomyces cerevisiae as a model organism 
Saccharomyces cerevisiae (S. cerevisiae) the common budding yeast, is a well-studied 
model eukaryote. Yeast was first used as an experimental organism in the early twentieth century 
and has proven to be an asset in studying basic cellular processes (1). S. cerevisiae is a unicellular 
fungus in the phylum Ascomycota that can exist stably in culture as a haploid or diploid. The 
genome of S. cerevisiae has approximately 6,000 ORFs contained on 16 chromosomes. Several 
characteristics of yeast have made it ideal to use in research. For example, the environmental 
conditions can be controlled by using defined media, and altering the composition as needed. The 
generation time for yeast is about 90 minutes, which allows for quick mass production. 
Additionally, many yeast strains containing drug resistance, auxotrophic markers, and specific 
mutations are readily available for use, including the yeast deletion set (2). A variety of other tools 
are available for yeast researchers, including those associated with the Saccharomyces Genome 
Database (SGD), where there is catalogued information on each gene (http://yeastgenome.org/). 
Many cellular functions of yeast, including many aspects of lipid metabolism, are conserved 
among higher eukaryotes, which make yeast a valuable model organism for studies of humans, 
animals, and plants. 
1.2  Major lipid classes in the S. cerevisiae plasma membrane 
The primary structural components of the S. cerevisiae cell membrane include 
glycerophospholipids, sphingolipids, and sterols, which are regulated by a variety of mechanisms 
in order to maintain optimal lipid homeostasis (3). A structural illustration of an example from 
each class of lipids is shown in Figure 1-1. The plasma membrane of the cell not only acts as a 
boundary, but also mediates transport of molecules and acts as a platform for signaling pathways 
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(4,5). In response to cellular stress, the regulatory networks of these lipids must coordinately adapt 
to maintain cell viability. Cells need to maintain the most favorable ratios of lipids in the plasma 
membrane, as well as in the membranes of the different organelles (6). The mechanisms for lipid 
trafficking between organelles, establishing and maintaining precise lipid compositions of specific 
compartments, and changing of lipid environments in response to environmental signals are not 
completely elucidated.  
 
Figure 1-1. Structures of the major lipid classes in the S. cerevisiae plasma membrane.   
Representative examples showing the basic structure of glycerophospholipids, sphingolipids, and sterols. 
The head groups are circled in red, with choline and inositol for the glycerophospholipid and sphingolipid 
respectively. Both the glycerophospholipid and sphingolipid have a phosphate group attached to the head 
group, and the respective backbone, glycerol and ceramide. Structures were generated using the LIPID 
MAPS structure database (7,8).  
 
The major glycerolipids include the glycerophospholipids, – phosphatidylcholine (PC), 
phosphatidylethanolamine (PE), phosphatidylserine (PS), phosphatidylinositol (PI) – 
phosphatidylglycerol (PG), and cardiolipin (CL). Other phospholipid intermediates found in the 
cell include phosphatidic acid (PA), diacylglycerol (DAG), triacylglycerol (TAG), CDP-
Glycerophospholipid
(Phosphatidylcholine, PC)
Sphingolipid
(Inositol phosphoceramide, IPC)
Sterol
(Ergosterol)
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diacylglycerol (CDP-DAG), phosphatidylmonoethanloamine (PMME), 
phosphatidyldiethanloamine (PDME), phosphorylated phosphoinositides (PIPs), and 
lysophospholipids (LysoPL) (9). Structurally the glycerophospholipids are composed of a glycerol 
backbone with two fatty acids attached by ester linkages, a phosphate group, and various head 
groups. The primary fatty acids found in the glycerophospholipids are oleic, palmitoleic, palmitic 
and stearic acids (5,9). The fatty acid and head groups both affect lipid packing in the membrane, 
therefore influencing membrane fluidity. Significant progress has been made, and extensively 
reviewed, in elucidating the aspects of glycerophospholipid metabolism, including gene-enzyme 
relationships in biosynthetic pathways, localization of these processes, and regulation of synthesis 
and turnover (9).  The glycerophospholipids are the primary focus of this dissertation.  
The classification of sphingolipids includes sphingosines, ceramides, sphingomyelin, and 
phosphorylated or glycosylated derivatives of these metabolites (10,11). Sphingolipids have a 
basic structure containing a ceramide moiety attached to a fatty acid by an amide linkage. The 
three complex sphingolipids in S. cerevisiae are inositol phosphate ceramide (IPC), mannosyl-
inositolphosphate-ceramide (MIPC), and mannosyl-diinositolphosphate-ceramide (M[IP]2C). 
Greater than 90% of the cell’s complex sphingolipids are found in the plasma membrane (12). The 
regulation of sphingolipid synthesis has largely been uncharacterized until very recently. The Orm 
family of proteins were characterized and found to negatively regulate serine palmitoyl transferase, 
the enzyme catalyzing the rate limiting step in sphingolipid biosynthesis (13) (Figure 4-5). 
Understanding of sphingolipid metabolism will be important in Chapter 4 of this dissertation. 
In S. cerevisiae, ergosterol is the most abundant sterol in the plasma membrane, which 
serves a similar purpose to cholesterol, the main sterol lipid in higher eukaryotes. The sterols are 
necessary to maintain membrane fluidity, protein function, and organelle differentiation (14). The 
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research described here examined a potential connection to ergosterol metabolism, but was not 
pursued in detail.  
Together with membrane proteins, these lipids – glycerophospholipids, sphingolipids, and 
ergosterol – make up the membranes of all cellular organelles, and the outer plasma membrane 
boundary of the cell, which is greatly enriched in the complex sphingolipids and ergosterol.  Lipid 
asymmetry contributes to the physical properties of the membrane, with PE, PI, and PS enriched 
in the intracellular leaflet, and with PC and sphingolipids primarily present in the extracellular 
leaflet (5,15). Furthermore, enrichment of certain lipids and proteins into microdomains in the 
membrane confers regulated functionality of the membrane as a platform for signaling cascades 
(4,16). Considering the lipid ratios determine the functional characteristics of the membrane, it is 
likely that crossover in regulation of lipid metabolism exists. Understanding the biosynthesis and 
turnover of the glycerophospholipids and sphingolipids, in particular, will be essential for the 
research described here.  
1.3 Glycerophospholipid metabolism in yeast  
S. cerevisiae has proven to be a powerful eukaryotic model for phospholipid metabolism 
since many synthesis pathways are similar to those in mammalian cells (9,17-19). Phospholipids 
are not only vital components of biological membranes, but many also act as signaling molecules 
or precursors of signaling molecules that impinge upon a variety of cellular processes such as cell 
growth and metabolism. Glycerophospholipids consist of two fatty acid chains bound via acyl 
bonds to the SN1 and SN2 hydroxyl groups of a glycerol backbone. The primary 
glycerophospholipids found in S. cerevisiae include phosphatidylcholine (PC), 
phosphatidylethanolamine (PE), phosphatidylinositol (PI), and phosphatidylserine (PS), all are 
shown in Figure 1-2 (9,17). All of these major glycerophospholipids are derived from phosphatidic 
acid (PA) and can be synthesized via the CDP-DAG pathway (20). Alternatively, PC and PE can 
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be synthesized via the Kennedy pathway, primarily when choline and ethanolamine are 
supplemented in the media, although both pathways occur regardless of choline and ethanolamine 
availability (9,17). The basic biochemical pathways for the synthesis of the major phospholipids 
are summarized in Figure 1-3.  
 
Figure 1-2. Structures of the major plasma membrane glycerophospholipids. 
The structure shown at the top displays a generic glycerophospholipid with stearic and palmitic acid acyl 
chains. The “X” can represent any of the head groups shown in the diagram to produce the corresponding 
glycerophospholipid.  
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Figure 1-3. Synthesis pathways for the major phospholipids found in yeast.  
The basic pathways for phospholipid synthesis and the gene products catalyzing the reactions are shown. 
The major lipid species are shown in red boxes with yellow text. The glycerophosphodiesters are shown in 
red boxes with blue text. The phosphorylated phosphoinositdes are shown in red boxes with black text. 
Gene names shown in red are regulated by inositol and contain the UASINO element in their promoters. Other 
gene products not regulated by inositol are shown in black. Metabolic intermediates are shown in black at 
the end of arrows. Dotted line indicates several steps in the pathway were omitted. Gluc-6-P, glucose-6-
phosphate; Ins-1-P, inositol-1-phosphate; Gro-3-P, glycerol-3-phosphate; lyso-PA, lysophosphatidic acid; 
PA, phosphatidic acid; CDP, cytidine diphosphate; DAG, diacylglycerol; PI, phosphatidylinositol; PS, 
phosphatidylserine; PE, phosphatidylethanolamine; PMME, phosphatidylmonomethylethanolamine; 
PMDE, phosphatidyldimethylethanolamine; PC, phosphatidylcholine; Cho, choline; Cho-P, choline 
phosphate; Etn, ethanolamine; Etn-P, ethanolamine phosphate; PIP, phosphorylated phosphatidylinositol 
phospholipids; GroPCho, glycerophosphocholine; GroPIns, glycerophosphoinositol.  
 
The synthesis of these phospholipids is regulated by genetic and biochemical factors at the 
transcriptional level, by mRNA stability, and post-translationally (9,17,20,21). Enzymatic activity 
is additionally regulated by lipids, phospholipid precursors and products, and by covalent 
modifications (20). Phospholipid biosynthetic genes are regulated by factors including nutrient 
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availability, growth stage, pH, temperature, and by message stability (9,17). The promoters of 
several genes in the CDP-DAG and Kennedy pathways contain the UASINO element (inositol 
response upstream activating sequence), which is regulated by the transcription factors Ino2, Ino4, 
and Opi1(20). The UASINO element, also known as the inositol/choline response element (ICRE), 
contains a consensus binding site, 5’CATGTGAAT3’ (22),  for the Ino2/Ino4 heterodimer 
complex, which activates transcription of several genes involved in glycerophospholipid synthesis 
(9). Repression of transcription occurs via Opi1 binding to Ino2, hence preventing the Ino2/Ino4 
complex from binding to the UASINO elements. (23,24).  
These transcription factors are regulated by a series of mechanisms including the presence 
or absence of inositol and choline (9). Several observations have supported the hypothesis 
proposed by Carman and Henry that the mechanism by which the cells sense inositol, choline, and 
other phospholipid precursors is through their effects on phospholipid synthesis (9). Furthermore, 
evidence shows PA is the signaling lipid controlling the UASINO co-regulated genes. PA co-
regulates these genes by a mechanism in which Opi1 binds PA and Scs2, an integral ER membrane 
protein, at the ER/nuclear membrane thereby preventing Opi1 translocation into the nucleus (25). 
The binding affinity of Opi1 to PA is strongly affected by cellular pH, and in turn the ionization 
state of PA, instead of the absolute abundance of PA (26). However, when PA levels are depressed, 
such as when inositol is added to the medium, Opi1 can enter the nucleus and interact with Ino2 
to prevent transcription (17,23).  
PA content and UASINO containing genes are controlled, in part, by inositol (27) and zinc 
(17). Inositol availability causes an increase in PI synthesis due to excess substrate availability, 
which then results in depletion of the PA pool for synthesis of other phospholipids. Lower levels 
of PA allow Opi1 repression of UASINO containing genes encoding enzymes in the CDP-DAG and 
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Kennedy pathways causing an increase in PI and a decrease in PA, PS, and PC levels (20). 
Depletion of zinc activates PI synthase resulting in decreased PA levels and repression of UASINO 
containing genes involved in PE synthesis (21). As regulators of phospholipid synthesis, inositol 
and zinc both regulate through PA levels. Briefly, PA levels are also regulated by the PA 
phosphatase encoded by PAH1 and by DAG kinase encoded by DGK1 (28). The activity of several 
phospholipid synthesis genes are additionally regulated by phosphorylation by PKA, PKC, and 
casein kinase II (23). While PA has an important role in regulating glycerophospholipid synthesis 
in S. cerevisiae, it is also implicated in multiple physiological processes in plant and animal cells, 
with PA formation occurring in response to stress, such as pathogen infection or drought. 
One UASINO containing gene commonly evaluated to assess overall misregulation of the 
UASINO containing genes is INO1 (24). INO1 encodes inositol-3-phosphate synthase, which 
converts glucose-6-phosphate to inositol-3-phosphate (29). INO1 is regulated by inositol and 
choline at the transcriptional level. In the absence of inositol and choline, Ino2/Ino4 activates 
transcription of INO1 through the UASINO element (24). Inositol auxotrophy and excess inositol 
excretion can indicate misregulation of INO1 and other UASINO containing genes (23). For 
example, ino2∆ and ino4∆ mutants are inositol auxotrophs, while opi1∆ mutants excrete excessive 
inositol into the media. Testing for inositol auxotrophy and excess inositol secretion is commonly 
employed to check for proper regulation of the phospholipid biosynthetic genes.  
Synthesis of the primary glycerophospholipids mentioned thus far is clearly regulated at 
various levels. These glycerophospholipids have biological importance as is, but are also available 
for subsequent metabolism and modification. Multiple phosphorylated PI species (PIPs), 
highlighted in Figure 1-4, are also present in S. cerevisiae. These PIPs are generated by the action 
of kinases and/or phosphatases, which covalently modify three of the hydroxyl groups of the 
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inositol ring on PI. There are seven major PIPs derived from PI, each with a unique function and 
localization: phosphatidylinositol-4-phosphate (PtdIns[4]P), phosphatidylinositol-4,5-bis-
phosphate (PtdIns[4,5]P2), phosphatidylinositol-5-phosphate (PtdIns[5]P), phosphatidylinositol-3-
phosphate (PtdIns[3]P), phosphatidylinositol-3,4-bis-phosphate (PtdIns[3,4]P2), 
phosphatidylinositol-3,5-bis-phosphate (PtdIns[3,5]P2), and phosphatidylinositol-3,4,5-
triphosphate (PtdIns[3,4,5]P3) (30). The PIPs found specifically in S. cerevisiae include, 
PtdIns[3]P, PtdIns[4]P, PtdIns[3,5]P2, and PtdIns[4,5]P2  (31). Additionally, PtdIns[3,4,5]P3 has 
been detected in the fission yeast Schizosaccharomyces pombe, but not in S. cerevisiae (31). The 
PIPs each have distinct functions. The catabolism of PI and PC by the B-type phospholipase will 
be the major focus of the study, but great interest lies in further examination of potential PIP 
catabolism by the PLBs.  
 
Figure 1-4. Phosphorylation sites of phosphatidylinositol.  
Phosphatidylinositol can be phosphorylated at three of the hydroxyl groups on the inositol ring to produce 
the phosphorylated phosphoinositides (PIPs). The hydrophilic inositol head group protrudes from biological 
membranes making the hydroxyls in positions 3, 4, and 5 accessible to kinases and phosphatases found at 
the membrane or in the cytosol.  
 
1.4 Role and classification of phospholipases 
 During the course of normal cell growth, phospholipids are continually synthesized and 
degraded in a regulated fashion. The catabolic reactions occur through the action of 
phospholipases. Phospholipases are the enzymes that hydrolyze phospholipids to produce a variety 
of metabolites, some of which have signaling functions, and some of which are shuttled back into 
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phospholipid synthesis or other metabolic pathways. Phospholipases, which have been identified 
in both prokaryotes (32,33) and eukaryotes (34), are involved in a diverse range of processes 
including membrane homeostasis, nutrient acquisition, interaction with host cells, and signaling 
molecule production (35). In some organisms, phospholipases have a key role in virulence (36,37), 
and are found in venoms (38,39).  
Phospholipases are generally classified as types A (1 or 2), B, C, or D, depending on where 
they cleave the phospholipids (Figure 1-5). The phospholipases A1 and A2 hydrolyze the SN1 and 
SN2 fatty acid chains, respectively, producing a free fatty acid and a lysophospholipids 
(phospholipids with only a single fatty acid). The B-type phospholipases (PLBs) have both A1 and 
A2 activity meaning they can deacylate both the SN1 and SN2 acyl groups of glycerophospholipids 
with minimal accumulation of lysophospholipids. Phospholipase C cleaves just before the 
phosphate group producing diacylglycerol (DAG) and phosphate monoester (eg. inositol-
phosphate). Phospholipase D activity produces a free head group (eg. choline) and phosphatidic 
acid. Lysophospholipase and transacylase enzymes also assist in catabolism and modification of 
glycerophospholipids. Some fungal PLBs can have all three functions: phospholipase A1/A2 
activity, lysophospholipase activity, and transacylase activity (35). Lysophospholipases deacylate 
lysophospholipids, while transacylases act by transferring the acyl group from one 
lysophospholipid to another. There are currently sixteen S. cerevisiae genes listed in the NCBI 
Gene database with observed or putative phospholipase activity or domains (Appendix A 1). 
PLA2 enzymes were the first phospholipases discovered and the superfamily has greatly 
expanded the classification into six types, that each consist of one or more groups and subgroups: 
1) secreted PLA2 (sPLA2) including Groups I, II, III, V, IX, X, XI, XII, XIII, and XIV each having 
a His/Asp catalytic dyad, 2) cytoplasmic PLA2 (cPLA2) Group IV with a conserved catalytic 
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Ser/Asp and critical Arg in proximity of the catalytic center, 3) calcium independent PLA2 (iPLA2) 
Group VI also having a Ser/Asp catalytic site, 4) platelet activating factor acetylhydrolyase (PAF-
AH) Groups VII and VIII which have a conserved catalytic Ser/His/Asp, 5) lysosomal PLA2 
(LPLA2) Group XV with a Ser/His/Asp catalytic site, and 6) adipose PLA2 (AdPLA2) Group XVI 
containing a His/Cys catalytic site (40).  The older classification system by the “Type” designation 
has become more ambiguous with the continual discovery of new PLA2 enzymes, and with new 
information obtained about the already identified PLA2s, such as the finding that most of the types 
are all found in the cytoplasm, and several of the groups outside of the iPLA2 Type are also 
independent of calcium. The group designations alone, which are based on the organism and 
sequence homology, more accurately classify the differences between the PLA2s (41,42). Various 
PLA2 enzymes exist in bacteria, fungi, and mammalian cells, which are all included as part of the 
aforementioned classification system (35).  
 
Figure 1-5. Phospholipase cleavage sites.  
Generic phospholipid shown with the cleavage sites for the different phospholipases. Only phospholipase 
B has the ability to hydrolyze both of the acyl groups.  
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Many fungi have multiple PLB genes – S. cerevisiae has four known PLB genes and C. 
albicans has five (35). In S. cerevisiae, the four genes encoding enzymes with phospholipase B 
activity are PLB1, PLB2, PLB3, and NTE1 (43). PLB1, PLB2, and PLB3 have >60% identity at 
the DNA level (44) and share a predicted catalytic center with conserved Arg/Ser/Asp (45). In 
yeast, phospholipases help regulate many processes, including, but not limited to, growth, 
nutritional/stress response, meiosis/mitosis cell cycle, and secretion (46).  
1.5 Glycerophosphodiester production and transport in S. cerevisiae and higher eukaryotes 
 In S. cerevisiae, the deacylation of the glycerophospholipids via phospholipases of the B-
type produce glycerophosphodiesters (GPXs) and free fatty acids (43). The B-type phospholipases 
(PLBs) in S. cerevisiae are most similar to the mammalian cPLA2 Group IV phospholipases (47-
49). The deacylation of phosphatidylinositol (PI) and phosphatidylcholine (PC) in yeast produces 
the intracellular and extracellular glycerophosphodiesters, glycerophosphoinositol (GroPIns) and 
glycerophosphocholine (GroPCho), respectively (Figure 1-6). In mammalian cells, PLA1/2 activity 
followed by lysophospholipase activity will release arachadonic acid, lysophosphatidylinositol 
(LysoPI), and the glycerophosphoinositols (49-51). Bacteria (52,53), mammals including humans 
(54-57), and fungi (35,36) all possess enzymes with PLB activity. A human homologue of PLB 
was first identified in the epidermis, suggesting a function involving hydrolysis of lipids for use 
as components of the epidermal barrier (49). A PLB precursor has also been identified in human 
neutrophils, which has the ability to deacylate PC, PI, PE, and their lysophospholipids, suggesting 
a role in defense against microbes or involvement in inflammation (49,58).  
Glycerophosphodiesters can also be formed by catabolism of the phosphorylated 
phosphoinositols (PIPs) to produce the collectively termed, glycerophosphoinositol 
glycerophosphodiesters (GroPIPs). The GroPIPs are water-soluble metabolites initially thought to 
be byproducts of PIP metabolism. However, evidence suggests these metabolites have their own 
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functions and metabolism (49,51). In mammalian cells, PLA2IVα produces GroPIns and 
GroPI[4]P via its dual phospholipase and lysophospholipase activity on PI and PtdIns[4]P 
respectively (49). PLA2IVα activity is suggested to be regulated by calcium, phosphorylation, 
PtdIns[4,5]P2 binding, and hormonal stimulation (40,49). Production of GroPIns and GroPI[4]P 
have been reported in many cell types upon different types of stimulation, such as by calcium or 
hormones (50). A few examples include GroPIns production upon stimulation of platelets, 
macrophages, neutrophils, thyroid cells, kidney slices, and brain slices. GroPI[4]P production has 
been observed in cell types such as fibroblasts, thyroid cells, and hepatocytes.  
 
Figure 1-6. Deacylation Reaction.   
The glycerophospholipid, phosphatidylcholine (PC), is deacylated via the action of a B-type phospholipase 
enzyme to produce the glycerophosphodiester, glycerophosphocholine (GroPCho) and two free fatty acids.  
 
The deacylation of the PIPs in yeast is also a regulated process that is influenced by several 
conditions. In S. cerevisiae, GroPIns, GroPI[4]P and GroPI[4,5]P2 release has been observed upon 
stimulation by glucose (59). Importantly, no studies have addressed the role of Plb1-3 in GroPI[4]P 
and GroPI[4,5]P2 release, although published literature states the PLBs also act on the PIPs to 
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produce GroPIPs (44,45). This extracellular release of the GroPIPs occurs in both yeast and 
mammalian cells (49,60). Upon release in mammalian cells, the GroPIPs may be further 
metabolized by extracellular phosphodiesterases, act as paracrine or autocrine signals, or can be 
transported back into the cell (49).  
The glycerophosphodiesters are hydrophilic and cannot enter the cell without the action of 
a transporter. The glycerophosphodiester transporter, Git1, was first discovered in yeast when 
GroPIns was observed to be secreted and taken back up (61). The human protein with the highest 
identity to Git1 was later identified as Glut2 (62). Glut2 mediates uptake of GroPIns and is 
primarily expressed in cells of the liver, kidney, and small intestine (49). GroPIns is able to get 
into cells not expressing Glut2, indicating there are likely other unidentified GroPIns transporters 
in mammalian cells (49).  
In S. cerevisiae, both GroPIns and GroPCho can be transported into the cell via the 
permease encoded by GIT1. Once inside the cell, GroPIns and GroPCho are metabolized. In fact, 
exogenous GroPIns and GroPCho can individually be provided as the sole phosphate source for 
the cells (63,64). GroPCho is broken down into choline and glycerol-3-phosphate via the 
glycerophosphodiester phosphodiesterase, Gde1 (65,66). The enzyme facilitating the catabolism 
of GroPIns and the subsequent products is currently unknown. The biochemical pathways specific 
to GroPIns and GroPCho in S. cerevisiae are shown in Figure 1-7. The deacylated 
glycerophosphoinositide (GroPIPs) derivatives exit and enter mammalian cells as well (50,67,68).   
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Figure 1-7. Metabolic pathways for GroPIns and GroPCho in S. cerevisiae.  
GroPIns and GroPCho metabolism and transport are shown with the corresponding genes that encode the 
enzymes required for the reactions to take place. Git1 transports GroPIns and GroPCho into the cell. 
 
1.6 The B-type Phospholipases in S. cerevisiae  
 Some information about substrate preferences and factors affecting each of the PLB gene 
products is available through gene deletion and overexpression studies. Plb1 primarily deacylates 
PC producing GroPCho, and less robustly produces GroPEtn from PE (69). Plb2 is responsible for 
exogenous phospholipid hydrolysis (45). Plb3, which only uses PtdIns and PtdSer as substrates, is 
thought to be mainly responsible for extracellular GroPIns production with Plb1 having some 
additional influence (45). Plb1, Plb2, and Plb3 have phospholipase B, lysophospholipase, and 
lysophospholipid acyltransferase (LPAT) activities (45,46,69). The other enzyme with 
phospholipase B activity in S. cerevisiae, Nte1, controls internal GroPCho production and has been 
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suggested to be localized to the endoplasmic reticulum (70). At a lower efficiency Plb1 and Plb2 
can hydrolyze PA and PtdIns[4,5]P2 (44).  
Biochemical studies have predicted Plb1 and Plb3 localization at the plasma membrane 
and periplasmic space in stationary phase S. cerevisiae cells (43,45,69). In addition to localization 
in the plasma membrane and periplasmic space, Plb2 is predicted to be found in the supernatant 
(43,45). However, large-scale microscopic datasets employing fluorescent tags fused to the C-
terminal end and expressed under control of their endogenous promoters, YPL+ (71,72) and 
YeastGFP (73-75), and a study utilizing C-terminal fusions to an epitope tag with the target genes 
expressed under control of the GAL promoter, Organelle DB (76), contain no data or inconclusive 
data for Plb1, Plb2, and Plb3 localization, as reported on SGD. In addition, a localization screen 
of proteins involved in lipid metabolism, in which Plb1 was C-terminally tagged and expressed 
under the TEF promoter, showed ER and vesicle localization, but no PM localization, and the 
medium was not analyzed (77). Furthermore, Plb1 and Plb3 have predicted 
glycosylphosphatidylinositol (GPI) – anchor attachment sites (78). Interestingly, recent evidence 
in addition to the data presented in Chapter 4, suggests Plb1 may have an intracellular role.  
Analysis of the enzyme kinetics for the B-type phospholipases, and all phospholipases, is 
complex given that the enzymes act on individual lipids that are aggregated together to form 
micelles, vesicles, and membrane bilayers at the lipid-water interface (40). Frequently, a “surface 
dilution kinetic model” is employed to study many enzymes in lipid metabolism in vitro, in which 
activity is measured in the presence of cell-free mixed micelles containing lipids and a detergent 
(79). The affinity for different substrates of the B-type phospholipases in vivo mentioned above is 
different from the primary substrates observed in vitro (44). Furthermore, in vitro experiments 
have shown pH, and the presence or absence of various cations, Ca+2, Mg+2, Fe+3, and Al+3, affect 
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the activity of Plb1, Plb2, and Plb3 (44). Of particular interest, at pH = 2.5 the presence of any of 
the listed cations caused decreased activity of Plb1, but at pH = 5.5 Plb1 activity was increased by 
the presence of the cations. In vivo Plb1-mediated GroPCho production increased with increasing 
pH from 3.5 to 7.5, contrary to the in vitro observations that increasing pH resulted in decreased 
Plb1 activity (44). Importantly, Plb1 activity can clearly be affected by pH and cations.  
1.7 Glycerophosphodiesterase hydrolysis of the glycerophosphodiesters 
A number of glycerophosphodiesterases (GDEs) that catalyze the breakdown of the 
glycerophosphodiesters have been characterized in bacteria, fungi, plants, and animals (51). In S. 
cerevisiae, the glycerophosphodiesterase Gde1 hydrolyzes GroPCho to choline and glycerol-3-
phosphate, but the enzyme facilitating breakdown of GroPIns is unknown (65,66). In mammalian 
cells, seven different GDEs (GDE1 – 7) have been identified each with specific substrate 
specificity, cellular localization, and tissue specificity (51). The mammalian GDE enzymes are 
relatively newly characterized proteins, and unlike bacterial GDE enzymes, can hydrolyze 
substrates other than the glycerophosphodiesters, including GPI anchors (51). Both mammalian 
Gde1 and Gde3 prefer GroPIns over GroPCho, but they hydrolyze different bonds. Gde1 activity 
produces inositol and glycerol phosphate, while Gde3 acts like a PLC, producing glycerol and 
inositol-1-P (49,51). All but one of the mammalian GDEs are predicted to be membrane bound, so 
the GPXs would need to reach the plasma membrane for further catabolism (49) supporting the 
role of PLB or PLA activity at the plasma membrane.  
1.8 Summary of Background and Significance 
 The PLBs deacylate phospholipids, thereby changing the phospholipid composition of the 
cell membrane. Several studies have shown that certain signaling pathways, protein activities, and 
cytoskeletal elements require specific membrane phospholipid composition for proper functioning. 
In addition, the PLB products, the glycerophosphodiesters, have been shown to elicit physiological 
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effects in mammalian cells, including those involved in cytoskeletal function and cell morphology. 
A more thorough examination of PLB function and regulation in the yeast S. cerevisiae, as 
described here, provides novel evidence for how phospholipase B activity impacts cellular 
physiology.  
 The overall goal of my project was to further elucidate the physiological functions and 
regulation of the B-type phospholipases (PLBs). My central hypothesis was that the PLBs are 
important for membrane homeostasis and cellular functions under certain environmental 
conditions. The specific objectives of my work as detailed in the following three chapters were as 
follows: 1) Determine how alterations in the RAS/cAMP signal transduction pathway affect PLB1, 
PLB2, and PLB3 gene response, 2) Examine phenotypes associated with deletion of one or more 
of the PLB genes and identify potential genetic interactions that could contribute to the elucidation 
of the PLB function, and 3) Elucidate the mechanism by which Ypk1 regulates Plb1 activity. 
Objectives 1 and 2 were initiated for the intended completion of the M.S. degree, but instead led 
into my transition to the Ph.D. program, at which time I began the major project for my Ph.D. 
work, Objective 3. Each of these objectives will be discussed individually in Chapters 2, 3, and 4 
respectively, with Chapter 4 serving as the majority of my Ph.D. work. Together, the data provided 
here furthers our understanding of the role and regulation of the PLBs. 
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Chapter 2 Neurofibromin Homologs Ira1 and 
Ira2 affect glycerophosphoinositol Production 
and Transport in Saccharomyces cerevisiae 
 
Running Title: Glycerophosphoinositol metabolism 
Reprinted from Eukaryotic Cell, Vol. 8 No. 12, pages 1808-1811.  
Bishop, A. C.*, Surlow, B.A.*, Anand, P., Hofer, K., Henkel, M., Patton-Vogt, J. 
"Neurofibromin homologs Ira1 and Ira2 affect glycerophosphoinositol production and transport 
in Saccharomyces cerevisiae." Copyright (2009) with permission from the American Society of 
Microbiology.  
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the PLB genes in the IRA mutant strains (data not shown in publication). Additional experiments 
I completed pertaining to this project, but excluded from final submission of the publication are 
included in the Supplement to Chapter 2.  
 
Andrew Bishop, a graduate student in the Patton Vogt lab, completed the GroPIns transport and 
production experiments shown in Figure 2.  
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yeast knockout collection to identify strains bearing compromised growth when given GroPIns 
as the sole phosphate source.  
 
Katherine Hofer, an undergraduate in the Patton Vogt lab performed anion exchange 
chromatography for separation of inositol containing compounds in Figure 2.  
 
Abstract 
Saccharomyces cerevisiae produces extracellular glycerophosphoinositol through 
phospholipase-mediated turnover of phosphatidylinositol and transports glycerophosphoinositol 
into the cell upon nutrient limitation. A screening identified the RAS GTPase-activating proteins 
Ira1 and Ira2 as required for utilization of glycerophosphoinositol as the sole phosphate source, 
but the RAS/cyclic AMP pathway does not appear to be involved in the growth phenotype. Ira1 
and Ira2 affect both the production and transport of glycerophosphoinositol. 
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2.1 Introduction 
Membrane phospholipids are continually synthesized and degraded as cells grow and 
respond to environmental conditions. A major pathway of phosphatidylinositol (PI) turnover in 
Saccharomyces cerevisiae is its deacylation to produce extracellular glycerophosphoinositol 
(GroPIns) (60). Plb3, an enzyme with phospholipase B (PLB)/lysophospholipase activity, is 
thought to be primarily responsible for the production of extracellular GroPIns, with Plb1 playing 
a lesser role (44,45,69). GroPIns is transported into the cell by the Git1 permease (61). GIT1 
expression is upregulated by phosphate limitation and inositol limitation. In fact, GroPIns can act 
as the cell’s sole source of both inositol (61) and phosphate (63).  
A screening for gene products involved in the process by which GroPIns enters the cellular 
metabolism identified Ira1 and Ira2, yeast homologs of the mammalian protein neurofibromin. 
Alterations in NF1, the gene encoding neurofibromin, are associated with the pathogenesis of 
neurofibromatosis type 1, an autosomal dominant genetic disease (80-82). Ira1 and Ira2 and 
neurofibromin function as RAS GTPase-activating proteins (RAS GAPs). S. cerevisiae Ras1 and 
Ras2 activate adenylate cyclase to modulate cyclic AMP (cAMP) levels. The binding of cAMP to 
the regulatory subunits of protein kinase A (Bcy1) results in dissociation and activation of the 
catalytic subunits (Tpk1 to Tpk3). Ira1 and Ira2 inactivate RAS and thereby downregulate the 
pathway (83,84). Hydrolysis of cAMP by the phosphodiesterases encoded by PDE1 and PDE2 
also downregulates the pathway (85-87). The RAS/cAMP pathway responds to nutrient signals to 
modulate fundamental cellular processes, including stress resistance, metabolism, and cell 
proliferation (85,87,88). 
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2.2 Results and Discussion 
2.2.1 Identification of IRA genes as affecting GroPIns metabolism.  
To identify genes involved in the metabolic process by which GroPIns is used as a 
phosphate source, we screened the MATα viable yeast knockout collection (Research Genetics) for 
strains displaying compromised growth when GroPIns rather than low Pi was supplied as the 
phosphate source. Synthetic complete medium, high-Pi (10 mM KH2PO4) medium, low-Pi (0.2 
mM KH2PO4) medium, and GroPIns+ (70 µM) medium were made as described previously (64). 
Mutants were transferred by hand pinner from a master plate to a 96-well plate containing low-Pi 
medium and allowed to grow at 30°C for 3 days. From low-Pi medium, cell inocula were 
transferred to plates containing GroPIns+ medium. Growth was monitored at 595 nm after 4 days 
of incubation at 30°C. The ratio of absorbance in low-Pi medium to absorbance in GroPIns+ 
medium was determined. This screening was performed twice. Mutants with a value of 3 or greater 
for the ratio of absorbance in low-Pi medium to absorbance in GroPIns+ medium were subjected 
to a second screening by the monitoring of their growth in test tubes. As expected, the GIT1 gene 
was required for growth, and no other mutant displayed a complete growth abatement phenotype 
(Figure 2-1 A). In particular, we did not identify a gene likely to encode a 
glycerophosphodiesterase responsible for GroPIns catabolism. A likely explanation for this result 
is that multiple gene products are involved in the mechanism(s) by which GroPIns enters cellular 
metabolism. However, a number of strains exhibited a slow-growth phenotype, one of which was 
the ira2∆ mutant (Figure 2-1 A). To confirm the validity of this result, we analyzed growth on 
GroPIns in strains of the unrelated ∑1278b background (gifts from M. Cardenas, Duke 
University), and found that not only the ira2∆ mutant but also the ira1∆ mutant and the ira1∆ira2∆ 
double mutant (Table 1) exhibited greatly reduced growth on GroPIns (Figure 2-1 B). The ira1∆ 
mutant was not present in the deletion set screened initially.  
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Table 2.1 S. cerevisiae strains used in this study (Chapter 2) 
 
To probe the role of the RAS/cAMP in GroPIns metabolism, we analyzed other strains 
bearing alterations in the pathway. Interestingly, a pde2∆ mutant that, like the ira2∆ mutant, 
exhibits increased cAMP levels (89) was not defective for growth on GroPIns. Similarly, a strain 
bearing a plasmid-borne hyperactive allele of RAS2, RAS2-V19 (a gift from P. Herman, Ohio State 
University) (90-92), was not defective for growth on GroPIns (Figure 2-1 A). Thus, upregulation 
of the RAS/cAMP pathway may not be the primary reason for the growth defect seen in the 
absence of Ira1 or Ira2. Not surprisingly, ras1∆ and ras2∆ mutants, expected to downregulate the 
RAS/cAMP pathway, were not defective for growth on GroPIns (data not shown). 
A trivial explanation for the inability of strains bearing mutations in the IRA genes to utilize 
GroPIns as a phosphate source is that the cells are less robust than WT cells and die before they 
are able to induce the metabolism required to utilize GroPIns. To test this, we compared the 
survival of the WT and an ira1∆ira2∆ mutant upon phosphate starvation and found no difference 
between the two strains (data not shown). 
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Figure 2-1. Ira1 and Ira2 are required for optimal growth of cells using GroPIns as a 
phosphate source.  
Strains in the BY4742 (A) or ∑1278b (B) background were grown overnight in low-Pi medium. Cells were 
transferred to low-Pi or GroPIns+ medium (A600 ≈ 0.005). Absorbance was recorded after 48 h of growth at 
30°C. WT cells transformed with empty vector pRS415 (vector) or plasmid pPHY453, containing the 
hyperactive RAS2 allele, RAS2-Val19 (RAS2V19), were also assayed (A). Readings are means ± standard 
errors of the means of results of at least two independent experiments. 
 
2.2.2An ira1∆ira2∆ mutant exhibits altered GroPIns transport activity. 
To determine the cause of the defect in GroPIns utilization that occurs upon deletion of 
IRA1 or IRA2, we measured GroPIns transport activity (63) under low-Pi conditions. In cells 
harboring single-deletion mutations, GroPIns transport was similar to that of the WT strain or only 
slightly reduced (Figure 2-2 A). However, the simultaneous deletion of IRA1 and IRA2 resulted in 
a clear reduction in activity. These results do not explain the growth defects seen in the single-
deletion mutants, but they do indicate a role for Ira1 or Ira2 in regulating Git1. A complete 
understanding of the nature of the regulation of GroPIns transport by Ira1 or Ira2 will be the focus 
of future studies. 
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Figure 2-2. Ira1 and Ira2 affect GroPIns transport activity and GroPIns production.  
(A) Cells grown to log phase in low-Pi medium were assayed for GroPIns transport activity. Data represent 
means ± standard errors of the means of results of two independent experiments performed in duplicate. 
(B) Cells pre-labeled with [3H]-inositol were re-inoculated into fresh high-Pi medium, and the amount of 
extracellular GroPIns was determined following 22 h of growth. Data are means ± standard errors of the 
means of results of at least three independent experiments and are reported as the percentage of total [3H]-
inositol label found as extracellular GroPIns normalized for culture density. 
 
2.2.3 Deletion of IRA1 or IRA2 increases the extracellular accumulation of GroPIns. 
We next monitored the effect of Ira1 or Ira2 upon extracellular production of GroPIns via 
PI deacylation. Cells were grown overnight in medium containing 3 µCi/ml of [2-3H]-inositol. 
Cells were harvested, washed, and reinoculated to an A600 of 0.2 in high-Pi medium, the condition 
under which extracellular GroPIns accumulates (61). At various times, aliquots of the cultures 
were centrifuged, and the inositol compounds in the supernatant were separated (93). The ira1∆, 
ira2∆, and ira1∆ira2∆ mutants accumulated roughly twice as much extracellular GroPIns as the 
WT strain (Figure 2-2 B) upon entrance to stationary phase. The lack of an additive effect upon 
GroPIns formation in the double mutant compared to formation in the single mutants may be 
explained by substrate availability. In other words, there may be a limited amount of plasma 
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membrane-associated PI available for PLB-mediated turnover. Whereas an ira1∆ira2∆ double 
mutant exhibits an increase in PLB1 and PLB3 transcript levels as measured by real-time reverse 
transcriptase PCR (data not shown, Supplemental Figure 2-3 S), no such increase was detectable 
in the ira1∆ or ira2∆ mutant. Thus, Ira1 or Ira2 regulation of the PLB activity leading to GroPIns 
formation likely occurs at multiple levels and will be the focus of future studies. Another 
explanation is that yet another, uncharacterized, phospholipase exists for the formation of GroPIns 
in the absence of Ira1 or Ira2. Importantly, GroPIns transport does not occur under the growth 
conditions of the experiment (high Pi), so diminished transport cannot explain the increased 
accumulation of GroPIns in the absence of Ira1 or Ira2.  
In summary, this study indicates a role for Ira1 and Ira2 in regulation of both the production 
of extracellular GroPIns and its transport into the cell. In addition, we show that Ira1 and Ira2 are 
required for the utilization of GroPIns as a phosphate source under conditions in which transport 
of GroPIns into the cell is normal. However, we were unable to show a linkage between 
hyperactivation of the RAS/cAMP pathway, which occurs upon deletion of IRA1 or IRA2, and the 
growth phenotype. Future studies will focus on determining the mechanism(s) for the growth 
disturbance, including whether it involves the RAS/cAMP pathway or other, less defined functions 
of Ira and Ira2. Growth is a multifactorial process, and a combination of disturbances, some 
involving heightened signaling through the RAS/cAMP pathway and some not, may contribute to 
alterations in the cell’s ability to utilize GroPIns as a phosphate source. Ira1 and Ira2 are large 
proteins, each over 3,000 amino acids. The RAS GAP-related domain of each protein is contained 
within a few hundred amino acids, and C-terminal regions of approximately 200 amino acids bind 
to Gpb1 or Gpb2 and are important for protein stability (94). In addition, yeast Ira1 and Ira2 
proteins and the human neurofibromin type 1 protein all contain bipartite phospholipid binding 
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modules consisting of a Sec14 homologous segment and a pleckstrin homology-like domain (95). 
Both in vitro phospholipid binding and lipid exchange activity have been documented for 
neurofibromin (96), suggesting that Ira1 and Ira2 may have similar activities. Indeed, Ira1 appears 
to play a membrane-anchoring role for adenylate cyclase in addition to its role as a RAS GAP (97). 
It is tempting to speculate that Ira1 or Ira2 might also play a role in the membrane association or 
activation of an enzyme or enzymes responsible for the metabolism of internalized GroPIns. A test 
of that hypothesis awaits the identification of the gene products involved in the process by which 
GroPIns enters cellular metabolism.  
This work was supported by National Institutes of Health grant GM59817 to J.P.-V. We 
thank M. Cardenas for the gift of strains and P. Herman for the gift of plasmids. We thank Lindsay 
Chromiak and David Ekpin for technical assistance. 
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2.3 Supplement to Chapter 2  
The experiments described here were completed as part of the project described in the 
Chapter 2 manuscript, but were excluded from the publication. The purpose of these supplemental 
studies was to examine PLB1-3 and INO1 transcriptional expression in response to alterations in 
the Ras/cAMP pathway 
2.3.1 Experimental Procedures 
Strains, plasmids, and growth conditions. The S. cerevisiae strains used in this study are 
shown in Table 2.1.  Strains were grown aerobically with shaking at 30ºC.  Turbidity was 
monitored by measuring the optical density at 600nm (A600) on a BioMate 3 Thermo Spectronic 
spectrophotometer. Media used for this study included rich yeast extract peptone dextrose (YEPD) 
media, or synthetic complete yeast nitrogen base (YNB) media made as described previously, but 
containing 2% glucose (93). To control media phosphate concentration, KH2PO4 (1 g/L) was 
excluded from the synthetic mix and replaced with KCl (1 g/L). KH2PO4 was added back at a 
concentration of 10 mM (high) or 200 µM (low) as indicated. YNB containing 75 µM inositol (I+) 
or lacking inositol (I-) was used as noted.  
The plasmids pRS416 (JVE288) and pJR1040-RASVal19 (JVE290) were kindly provided by 
Paul Herman (90) (The Ohio State University). Plasmids pBH315-GIT1-lacZ (JVE294) and 
pJH359-INO1/CYC1/lacZ (98) were available or made previously in the lab. Transformation of 
plasmids into yeast strains was performed using standard lithium acetate chemical transformation.  
β-galactosidase assays. Gene promoter activity was measured as a function of β-galactosidase 
(β-gal) activity using either the Pierce β-galactosidase kit per the manufacturer’s instructions or 
using the lab β-gal protocol. Cells were grown to late log phase in YNB medium lacking the 
specified amino acid for selection, harvested, and an aliquot was assayed for β-gal activity. Briefly, 
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using the Pierce kit, 350 µL of working solution (50:50, 2X β-gal assay buffer: Y-PER) was added 
to 350 µL of culture to start the assay and incubated at room temperature for 6.5 minutes. β-gal 
stop solution (300 µL) was added, solution agitated with a Vortex mixer, and centrifuged for 30s 
at 13,000 x g. Supernatant absorbance was measured at 420 nm and used to calculate β-gal activity 
([1000 x A420nm]/[time in minutes x Volume in mL x OD600 at harvest]). For the lab procedure, 10 
ODUs (optical density units) of cells were harvested and resuspended by Vortex agitation in 150 
µL of Z buffer, 50 µL chloroform, and 20 µL of 0.1% SDS. 0.7 mL of ONPG (1.2 mg/mL) was 
added to start the reaction and incubated at room temperature for 10 minutes. The reaction was 
stopped with 0.5 mL of 1M Na2CO3 and centrifuged for 2 minutes. The absorbance of the 
supernatant was measured at 420 nm and used to calculate β-gal activity (A420nm x 1000 x (1/time 
in minutes)).  
RNA Extraction and real time qRT-PCR gene expression analysis. Cultures were grown in 
YNB medium containing 75 µM inositol under the conditions specified in the text. RNA was 
extracted using a hot phenol-chloroform extraction (99). A 7 µg sample of RNA was DNase treated 
with 2 units of DNase at 37ºC for 30 minutes using the TURBO DNA-free™ Kit (Applied 
Biosystems) per the manufacturer. Message abundance was quantified by quantitative reverse 
transcriptase PCR (qRT-PCR) using the Verso™ SYBR® Green 1-Step QRT-PCR ROX Kit 
(Thermo Scientific) on the Applied Biosystems StepOnePlus Real Time PCR System. The 
primers used are shown in Table 3.2. Standard curves for each primer pair were optimized to 
determine acceptable primer concentration (70-100 nM) and template concentrations (15-25 ng/25 
µL reaction). Reverse transcription was carried out at 50C for 15 min followed by 95C for 15 
min for RT inactivation and polymerase activation. Amplification parameters were 40 cycles at 
95C 15s, 54.5C 30s, and 72C 40s. Primer specificity was verified by melt curve analysis and 
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visualization of amplicons by gel electrophoresis. Primer sets did not produce amplicons when 
RNA from the respective deletion strains was used as template. No template control (NTC) and 
minus reverse transcriptase (-RT) reactions were performed to verify there was no genomic DNA 
contamination in the RNA samples and/or the reagents. RNA from at least three independent 
cultures of all strains was analyzed in triplicate reactions per primer set. Data was normalized to 
the endogenous control gene, SNR17, and analyzed using the comparative ∆CT approach 
(100,101).  
2.3.2 Results and Discussion 
An ira1∆ira2∆ mutant exhibits altered PLB1-3 transcript levels.  
The B-type phospholipase encoded by PLB3 is primarily responsible for the production of 
GroPIns via PI deacylation, with Plb1 having some contribution (44). To determine if 
transcriptional regulation of the PLB genes is responsible for the increase in GroPIns production 
observed upon deletion of IRA1 and IRA2, real-time qRT-PCR was performed.  The transcript 
level of PLB2 was also monitored.  Deletion of both IRA1 and IRA2 resulted in an increase in 
PLB1 and PLB3 message (Figure 2-3 S). However, deletion of IRA1 or IRA2 individually had little 
or no effect on PLB1 transcript levels and actually decreased PLB3 transcript levels. Hence, these 
results do not support a model for increased PLB gene expression causing the increased GroPIns 
production occurring upon deletion of IRA2 (Figure 2-2 B), but do indicate that deletion of both 
IRA1 and IRA2 affects PLB1 and PLB3 message levels. With regard to PLB2, there was a clear 
decrease in transcript levels in the ira1∆, ira2∆, and ira1∆ ira2∆ mutants (Figure 2-3 S).  
INO1 expression is altered in the IRA1 and IRA2 mutants. 
During the course of the transport experiments, we discovered that ira1∆ira2∆ mutants are 
inositol auxotrophs. Inositol auxotrophy is typically the result of misregulation of INO1, the gene 
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encoding inositol-3-phosphate synthase (Figure 1-3), which is the rate-limiting step in inositol 
biosynthesis (29). In a WT strain, INO1 is derepressed in cells grown in inositol-free medium, and 
repressed in cells grown in inositol containing medium. We hypothesized the inositol auxotrophy 
in the IRA mutants is due to misregulation of the INO1 gene. INO1 expression was monitored in 
response to phosphate and inositol concentrations by transforming strains with a reporter construct, 
in which the INO1 promoter is fused to lacZ (98). Because the ira1∆ira2∆ mutant cannot grow in 
the absence of inositol, INO1 expression was monitored in the presence of 10M inositol, a 
concentration that supports growth and only partially represses INO1 expression in a WT strain. 
Deletion of either IRA1 or IRA2 reduces INO1 expression, and the deletion of both simultaneously 
increases the effect (Figure 2-4 S). Also noteworthy is that INO1 expression, in general, is reduced 
under low phosphate conditions. Importantly, the reduced INO1 expression of the ira1∆, ira2∆ 
and ira1∆ira2∆ double mutants cannot explain the growth defect observed when GroPIns was 
supplied as a phosphate source, as the growth experiments shown in Figure 2-1 were performed in 
the presence of inositol. 
Upregulation of the Ras/cAMP pathway with the RasV19 allele results in inositol auxotrophy 
Because prior experiments in the lab showed ira1,2∆ is an inositol auxotroph, and ira1∆, 
ira2∆, and ira1,2∆ have defective growth on GroPIns we hypothesized that upregulation of the 
Ras/cAMP pathway by introduction of a constitutively active form of RAS, RasVal19, may have a 
similar affect (90). A strain bearing a hyperactive allele of RAS2, RAS2V19 (91) exhibited moderate 
inositol auxotrophy (Figure 2-5 S), suggesting that upregulation of the RAS/cAMP pathway is 
involved in mediating the inositol auxotrophy phenotype. 
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Figure 2-3 S. PLB1 and PLB3 message levels are elevated in the ira1ira2 double mutant 
but not in the single deletion strains.  
Relative message abundance of PLB1, PLB2, and PLB3 in WT (JPV 569), ira1∆ (JPV 573), ira2∆ (JPV 
574), and ira1∆ira2∆ (JPV 575) (∑1278b background) grown in YNB highPi medium to log phase (OD600 
≈ 0.7) at 30ºC. Total RNA was extracted from cells and transcript levels were analyzed by real-time qRT-
PCR using the comparative ∆CT method. Data were normalized to the amount of the endogenous control 
mRNA, SNR17, and expressed relative to the value in WT cells. Values represent the mean ± S.E. of at 
least 3 individual cultures each assayed in triplicate. 
 
 
Figure 2-4 S. Deletion of IRA1 or IRA2 decreases INO1 promoter-driven ß-galactosidase 
activity.  
WT (JPV 467), ira1 (JPV 573), ira2 (JPV 574), and ira1,2 (JPV 575) were transformed with the 
plasmid pJH359-INO1/CYC1/lacZ (JVE3) and grown to late log phase (OD600 ≈ 0.8-1.0) in YNB –URA 
media with the indicated phosphate and inositol concentrations. Cells were harvested and assayed using the 
Pierce β-gal assay kit. Data represent the mean ± S.E. of three individual transformants in each strain 
assayed in duplicate.  
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Figure 2-5 S. Expression of the hyperactive RAS2V19 allele results in inositol auxotrophy.  
WT (JPV 569) transformed with empty vector (pRS416 empty, JVE289) or plasmid pJR1040 containing a 
hyperactive RAS2 allele (RAS2V19) (JVE291) were spotted onto YNB – URA synthetic medium containing 
(I+) or lacking (I-) inositol. 5 l of cells normalized to A600=0.5 were spotted in a series of four 10-fold 
dilutions. 
 
Lack of inositol increases GIT1 expression in the WT and ira1 strains  
Clearly Ira1 and Ira2 affect inositol biosynthesis and GroPIns transport. Since GIT1 
expression is upregulated by phosphate starvation (102) and by inositol limitation in a WT strain 
(Figure 2-6 S), GIT1 expression upon inositol limitation in the IRA mutants was monitored using 
a plasmid with β–gal activity driven by the GIT1 promoter. Lack of inositol increases GIT1 
expression similar to WT in the ira1 strain, while GIT1 expression in the ira2 strain is 
unchanged by presence or absence of inositol (Figure 2-6 S). Although there is increased GroPIns 
accumulation in the IRA mutants as compared to the WT (Figure 2-2), this cannot be explained by 
the potential lack of GroPIns transport due to a decrease in GIT1 expression because in I+ 
conditions the mutants and WT have similar GIT1 expression. Furthermore, the transport 
experiments were performed in abundant phosphate conditions in which Git1 activity is turned off 
(102). 
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Figure 2-6 S. GIT1 expression is decreased in WT and ira1∆ in media containing inositol.  
WT (JPV 569), ira1∆ (JPV 573), and ira2∆ (JPV 574) were transformed with GIT1-lacZ containing plasmid 
(JVE 294). At least three individual transformants were grown to late log phase at 30°C in -URA 200µM 
phosphate +/- inositol media and assayed for β-gal activity using the lab protocol.  Data are means ± S.E. 
 
2.3.3 Conclusions 
A relationship between Ira1/2 and inositol biosynthesis was uncovered by the finding that 
the ira1∆ira2∆ mutant is an inositol auxotroph. Misregulation of INO1, which is normally 
derepressed in the absence of inositol, is typically the cause of inositol auxotrophy. Indeed, INO1-
driven -galactosidase activity was decreased upon deletion of IRA1 or IRA2. The fact that a 
hyperactive RAS2 allele exhibited moderate inositol auxotrophy suggests that this phenotype, 
unlike the growth phenotype, is attributable to hyperactivation of the RAS/cAMP pathway.  
 In addition to affecting GroPIns transport and inositol biosynthesis, our results indicate that 
Ira1/2 affect GroPIns formation, which occurs via PLB-mediated turnover of PI. Although an 
increase in GroPIns formation is seen in the ira1 and ira2 mutants, an increase in PLB1 or PLB3 
transcript only occurs in the double mutant (Figure 2-3 S). Thus, Ira1/2 regulation of the PLB 
activity leading to GroPIns formation likely occurs at multiple levels. Potential post-transcriptional 
mechanisms of regulation include localization or phosphorylation status. An alternate explanation 
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is that yet another, uncharacterized, phospholipase exists for the formation of GroPIns in the 
absence of Ira1/2. Importantly, the increased extracellular accumulation of GroPIns seen in the 
absence of Ira1/2 cannot be explained by a decrease in its transport into the cell, as under the 
growth conditions of the experiment (I+, high Pi), GIT1 is not expressed (102) (data not shown).  
 In total, this study indicates a role for IRA1/2 in the ability of cells to use GroPIns as a 
phosphate source, in both GroPIns formation and transport, and in inositol biosynthesis. Future 
studies could focus on determining the mechanisms for those disturbances, including whether they 
involve the RAS/cAMP pathway or other, less defined, functions of Ira1/2. Further study of PLB 
expression and activity in response to alterations in the Ras/cAMP pathway could help elucidate a 
link between GroPIns metabolism and this pathway. However, the Ras/cAMP pathway was not 
addressed further in this dissertation. 
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Chapter 3 Examination of the roles and 
regulation of the PLBs and Git1, including 
examination of phenotypes associated with 
altered dosage of these genes  
 
Note: The work described in this Chapter was pursued as exploratory work to initially finish the 
intended M.S. degree. In completing this probing work, and finding an interesting connection 
between Ypk1 and Plb1, the project was extended into the basis for my Ph.D. dissertation work. 
Therefore, many of the described experiments were not investigated in detail.  None of the findings 
in Chapter 3 are published and upon transition from the M.S. to Ph.D. requirements my project 
was further defined. However, some of the cursory findings presented here helped lead us to the 
Ypk1-Plb1 interaction thoroughly examined in Chapter 4 as the major project for my dissertation.     
3.1 Introduction 
The phospholipids of the plasma membrane are continually being synthesized and 
degraded in response to environmental conditions. One aspect of this metabolism is carried out 
through a recycling process consisting of i) deacylation of glycerophospholipids via the B-type 
phospholipases (45,69,103), ii) the resultant production of intracellular and extracellular 
glycerophosphodiesters (GPXs), iii) transport of the GPXs back into the cell via the transporter, 
Git1 (64,93,102), and iv) the catabolism of and reutilization of the GPXs in cellular metabolism 
(43,66). This recycling pathway will be referred to as the glycerophospholipid deacylation, 
transport, and reutilization (GDTR) pathway.  In this chapter, I report on preliminary studies on 
the GDTR pathway that were initiated, but were not pursued to the level of publication. The topics 
are as follows:  i) morphological assessment of cells upon loss of Git1, loss of PLB1-3, and in cells 
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utilizing of GroPIns as a sole phosphate source, ii) potential reacylation of GroPIns, and iii) genetic 
interactions with the PLBs, one of which was pursued for completion of my Ph.D.  
3.1.1 The Git1 glycerophosphodiester transporter  
The Git1 permease of S. cerevisiae is a H+ symporter and a member of the major facilitator 
superfamily (MFS) of proteins responsible for transporting GroPIns, and at a lower affinity 
GroPCho, into the cell (104,105). Four homologues to S. cerevisiae GIT1 have been characterized 
in the pathogenic yeast, C. albicans, named CaGIT1–4, each with varied affinity for particular 
GPXs (104,106). In mammalian cells, Glut2 is the only GPX transporter characterized to date, but 
others likely exist (67). GPX transporters are not essential proteins, but in phosphate limiting 
conditions or  in circumstances when GPXs are available, either in the growth medium or in the 
human body, the ability to transport and utilize the GPXs can be advantageous, and even contribute 
to virulence of an organism (106).  
3.1.2 The S. cerevisiae B-type phospholipases 
The three cell surface PLBs, Plb1, Plb2, and Plb3 deacylate the glycerophospholipids at 
the plasma membrane to produce the GPXs that can then be transported into the cell by Git1 
(45,61,69). The other PLB, Nte1, produces intracellular GroPCho at the ER membrane (103). 
Published information about these enzymes in S. cerevisiae is reviewed in Chapter 1. Limited 
studies have focused on characterizing the PLBs so there are many gaps in our knowledge of their 
roles, specifically in how they affect cellular physiology. Moreover, the purpose of the production 
and recycling of the glycerophosphodiesters is largely unknown. 
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Figure 3-1. Activities of the PLBs and hypothetical GroPIns acyltransferase activity. 
PLB enzymes are known to hydrolyze PI to lysophosphatidylinositol (LysoPI), which can be hydrolyzed 
again by the lysophospholipase activity of the PLB to produce GroPIns. PLBs are also able to add a fatty 
acid to LysoPI in the presence of a fatty acid source, typically another phospholipid, via transacylase 
activity. The existence of a PLB activity reacylating GroPIns has not been characterized.  GPI AT, GroPIns 
acyltransferase.  
 
3.1.3 Potential ability of the PLBs to reacylate GPXs to produce lysoglycerophospholipids or 
glycerophospholipids  
The fate of the glycerophosphodiesters produced by PLB activity is only partially 
understood. While Gde1 hydrolyzes GroPCho to produce glycerol-3-phosphate and choline (66), 
no enzyme catalyzing the catabolism of GroPIns has been identified in yeast, although human 
glycerophosphodiesterases have activity on GroPIns (51). One hypothesis is that the 
glycerophosphodiesters, GroPCho and GroPIns, can be reacylated to produce LysoPC or LysoPI, 
followed by additional acylation to produce the full lipids, PC and PI. This GroPCho 
acyltransferase (GPC AT) activity has been observed in yeast and mammalian cells, but has 
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remained controversial since enzymes catalyzing this activity remain elusive (107). Many putative 
acyltransferase enzymes in yeast have been examined, but none were found to possess GPC AT 
activity. The PLBs possess phospholipase, transacylase, and lysophospholipase activity, but 
acyltransferase activity with a GPX as the substrate has not been attributed to the PLBs (Figure 
3-1).  
Importantly, PI is required for cell viability and is synthesized by the action of PI synthase, 
encoded by PIS1 (Figure 1-3) (108). In the absence of Pis1, cells cannot make PI and will die. 
However, if supplied with GroPIns and reacylation of GroPIns occurs, cells with non-functional 
Pis1 hypothetically would survive. I explored this possibility in Section 3.3.7.  
3.1.4 Morphology and cytoskeletal structure of S. cerevisiae cells 
All cells must maintain an optimal architecture for survival. This includes a diverse range 
of properties such as aggregation, gross morphology, and cytoskeleton structure. Yeast cells can 
vary in shape and size depending on genetic background, but generally diploids are larger and 
ellipsoidal, and haploids are smaller and more spherical (109). Screens of the yeast deletion set 
have yielded morphological classifications of mutants into categories including WT, elongate, 
round, football, clumpy, and other (110) and classified mutants as large (uge) or small (whi) 
(111,112). These morphological classifications are based on cell size, shape, and aggregation 
compared to WT cells. Cell size regulation through a balance of growth and proliferation is a 
tightly controlled process in all eukaryotic cells.   
Eukaryotic cells have the ability to aggregate together, resulting in formation of tissues and 
organs in higher eukaryotes, or forming flocs, biofilms, and psuedohyphae in the single celled 
yeast (113). These non-sexual aggregates in yeast can serve various purposes from protection of 
the innermost cells, response to nutrient starvation, or a change in membrane properties causing 
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sticking (114,115). This clumping, or flocculation, occurs due to interactions between the surface 
glycoproteins encoded by the flocculation (FLO) genes, but recent data indicates involvement of 
additional genes (113).  
The yeast cytoskeleton, composed of actin filaments, microtubules, and septins, functions 
in multiple processes in the cell including regulation of cell polarity, endocytosis, cell division, 
maintenance of cell morphology, and intracellular vesicular transport (116,117). Contrary to 
mammalian cells, yeast actin only forms three primary structures in the cell, actin patches, actin 
cables, and the actinomyosin ring. Actin patches are dense networks of actin filaments localized 
to the polarized growth zone and at sites of clathrin-mediated endocytosis, while actin cables are 
bundles of actin filaments extending the long axis of the cell. The actinomyosin ring forms during 
cytokinesis at the division site (reviewed in (116)).  
Here, I will examine these structural properties – aggregation, morphology, and actin 
cytoskeleton structure – upon disruption to the GDTR pathway. 
3.1.5 Potential functional interactions between the PLB genes and other genes implicated in 
the maintenance of cellular morphology 
To better understand the roles of the PLBs in physiology, I proceeded to identify potential 
functional interactions between the PLBs and other genes. The resources on the Saccharomyces 
Genome Database, including the BioGRID interaction database, were used to narrow down a list 
of interesting interactions from the total genetic and physical interactions identified for each of the 
PLB genes (yeastgenome.org). Based on results that will be described in this chapter, interactions 
that were potentially involved with cell morphology or actin cytoskeleton maintenance were of 
primary interest, namely the genetic interactions between Ypk1 – Plb1 and Lge1 – Plb3. The 
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interaction between Plb1 and Ypk1 proved to be the most interesting and was therefore pursued in 
great detail in Chapter 4.  
Because the glycerophospholipids are a significant structural component of the cell, I 
hypothesized that alterations in various aspects of the GDTR pathway, might contribute to gross 
morphological features of the cell. This hypothesis led me to ask, is gross morphology altered in 
yeast cells upon loss of various genes in the GDTR pathway, specifically GIT1 and PLB1-3, and 
furthermore, what particular cellular processes are impacted by PLB activity? Here, I investigated 
several aspects of the GDTR pathway and how defects in the genes mediating this pathway can 
affect cell physiology. This chapter will focus on four major areas: i) cellular morphology upon 
loss of Git1 and upon utilization of GroPIns as a phosphate source in WT cells, ii) cellular 
morphology and utilization of GroPIns upon loss of the PLBs and factors regulating the PLBs, iii) 
ability of the cell to reacylate GroPIns to produce PI through activity of the PLBs, and iv) 
functional interactions of the PLBs with other proteins affecting cell morphology and the actin 
cytoskeleton.                                                                                                      
3.2 Experimental Procedures  
Strains and Media. The S. cerevisiae strains used in this study are shown in Table 3.1. 
Strains were grown aerobically with shaking at 30ºC or 37ºC, as noted.  Turbidity was monitored 
by measuring the optical density at 600nm (A600) on a BioMate 3 Thermo Spectronic 
spectrophotometer. The cells were grown in various media as indicated. Yeast peptone dextrose 
(YPD) was purchased from Fisher Scientific. Synthetic defined medium of yeast nitrogen base 
(YNB) was made as described previously, but containing 2% glucose (93). YNB medium was 
supplemented with either 200 µM KH2PO4 defined as low phosphate (LoPi) or 10 mM KH2PO4 
defined as high phosphate (HiPi), or contained 6.8 mM phosphate if not specified. When indicated, 
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YNB medium was supplemented with 75 µM inositol (I+) or did not contain inositol (I-). Plates 
were prepared by adding 2% agar.  
Yeast Transformation. Plasmid DNA and PCR products were transformed into yeast by 
high efficiency lithium acetate chemical transformation procedure (118-120). Yeast cells were 
grown to log phase, made competent with lithium acetate treatment, transformed with the desired 
DNA, and transformants were selected on medium appropriate for the specific selectable markers. 
When transforming cells with a drug resistance marker, as opposed to a nutritional marker, cells 
were grown in non-selective rich medium for several hours prior to plating on selective medium. 
PCR-mediated gene deletion. Gene deletions were performed by replacing all or part of the 
targeted gene with a selectable marker (121). Primers were designed with approximately 60 base 
pairs of homology to the target genomic sequence to be replaced and 20 base pairs homology to 
the sequences of the selectable marker. The PCR products were purified, verified for correct size 
by agarose gel electrophoresis, and extracted from the gel. The purified DNA fragments were 
transformed into the desired yeast strains. Transformants were identified on selective medium. 
Genomic DNA was isolated from potential deletion strains using a phenol-choloroform extraction, 
and the gene deletion was verified by PCR. Verification of deletions was performed using two 
primer sets, with both primers outside of the targeted deletion area, and the other set containing 
one primer outside of the targeted deletion and one primer binding inside the inserted selectable 
marker. Primers are listed in Table 3.2. 
Calcofluor Staining. Cells were grown to an OD600 = 0.5. Calcofluor was added at a final 
concentration of 0.2 mg/mL to an aliquot of culture. Suspension was mixed by vortex agitation 
and incubated at room temperature for 5 minutes. Cells were pelleted and washed three times with 
water. An aliquot of resuspended cells was examined by fluorescent microscopy.  
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Table 3.1 S. cerevisiae strains used in this study (Chapter 3) 
Strain  Genotype Source 
JPV 13 WT EG123; leu2-3, 112 ura3-52 trp1-1 his4 can1R derived from EG123, D. Levin 
JPV 140 leu2-3, 112 ura3-52 trp1-1 his4 can1R plb1∆plb2∆ EG123, Susan Henry 
JPV 201 a/alpha  his3/his3 leu2/leu2 met15/MET15 LYS2/lys2 
ura3/ura3  git1∆/GIT1 
BY4743 heterozygous diploid 
JPV 203 WT BY4741; his3∆1 leu2∆0 met15∆0 ura3∆0 Research Genetics 
JPV 212 his3 leu2 lys2 ura3 git1::KanMX Research Genetics 
JPV 381 a/alpha his3/his3 leu2/leu2 ura3/ura3 MET15/met15 LYS2/lys2 Research Genetics 
 JPV 399 WT BY4742; his3∆1 leu2∆0 lys2∆0 ura3∆0 Research Genetics 
JPV 467  E1278b; ura3-52 Heitman lab at Duke University 
JPV 469  E1278b; ura3-52 git1∆::KanMX our lab, Claudia Almaguer 
JPV 477 leu2-3, 112 ura3-52 trp1-1 his4 can1R plb1∆ EG123, SH1082, Susan Henry 
JPV 478 leu2-3, 112 ura3-52 trp1-1 his4 can1R, plb2∆ EG123, SH1083, Susan Henry 
JPV 479 leu2-3, 112 ura3-52 trp1-1 his4 can1R plb3∆ EG123, SH1084, Susan Henry 
JPV 480 leu2-3, 112 ura3-52 trp1-1 his4 can1R plb1∆, plb2∆, plb3∆ EG123, SH1085, Susan Henry 
JPV 569  WT ∑1278b; ura3-52 M. Cardenas  
JPV 573 ∑1278b; ura3-52 ira1::LoxP-nat M. Cardenas  
JPV 574  ∑1278b; ura3-52 ira2::LoxP-nat M. Cardenas  
JPV 575 ∑1278b; ura3-52 ira1::LoxP-nat ira2::LoxP-nat M. Cardenas  
 JPV 617 BY4741;  plb1::hph our lab, Beth Surlow 
  JPV 618 BY4741;  plb2::KanMX our lab, Beth Surlow 
 JPV 619 BY4741;  plb3::nat1 our lab, Beth Surlow 
 JPV 620 BY4741; plb1::hph, plb2::KanMX our lab, Beth Surlow 
 JPV 621 BY4741; plb1::hph, plb3::nat1 our lab, Beth Surlow 
 JPV 622 BY4741; plb2::KanMX, plb3::nat1 our lab, Beth Surlow 
 JPV 623 BY4741; plb1::hph, plb2::KanMX, plb3::nat1 our lab, Beth Surlow 
 JPV 624 ∑1278b; ura3-52, plb1::hph our lab, Beth Surlow 
 JPV 625 ∑1278b; ura3-52, plb2::KanMX our lab, Beth Surlow 
 JPV 626 ∑1278b; ura3-52, plb3::nat1 our lab, Beth Surlow 
 JPV 627 ∑1278b; ura3-52, plb1::hph, plb2::KanMX our lab, Beth Surlow 
 JPV 628 ∑1278b; ura3-52, plb1::hph, plb3::nat our lab, Beth Surlow 
 JPV 629 ∑1278b; ura3-52, plb2::KanMX, plb3::nat our lab, Beth Surlow 
 JPV 630 ∑1278b; ura3-52, plb1::hph, plb2::KanMX, plb3::nat our lab, Beth Surlow 
 JPV 636 BY4742;  ypk1::KanMX  Research Genetics 
 JPV 645 BY4742; lge1::KanMX, plb3::nat our lab, Beth Surlow 
 JPV 668 BY4742; plb1::hph  our lab, Beth Surlow 
 JPV 669 BY4742; ypk1::KanMX plb1::hph  our lab, Beth Surlow 
 JPV 679 BY4742; nte1::ble1   our lab, Beth Surlow 
 JPV 680 BY4742; plb1::hph, plb2::KanMX, plb3::nat, nte1::ble1 our lab, Beth Surlow 
 JPV 691 BY4742; ypk1::KanMX, nte1::ble1 our lab, Beth Surlow 
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Table 3.2 Nucleotide sequences of primers used in this study (Chapter 3) 
Name Sequence Notes 
snr17 rev 5' CGG TTT CTC ACT CTG GGG TAC - 3' RT-PCR primer for SNR17 
snr17 for 5' TTG ACT CTT CAA AAG AGC CAC TGA - 3' RT-PCR primer for SNR17 
PLB1 For.  5' - GCA TAC ACC AAG GAG GCT TTG - 3' RT-PCR primer for PLB1 
PLB1 Rev.  5' - GAG TGG ATA GCA AGG AAG TGT CAC - 3' RT-PCR primer for PLB1 
PLB3 For.  5' - CCT GAC TTG GTC TTC CAT TAG GGA T - 3' RT-PCR primer for PLB3 
PLB3 Rev.  5' - GAT ACC TAC CGT CCG CAA - 3' RT-PCR primer for PLB3 
plb2 ForB 5' - ATC TCT GAG GCT ACT GAC GGT - 3' RT-PCR primer for PLB2 
plb2 RevB 5' - CGA AGA GTT TGA GTT AGA AGT GAC A  - 3' RT-PCR primer for PLB2  
Plb1/Hph F 5’ CAA AAC CAT GAA GTT GCA GAG TTT GTT GGT 
TTC TGC TGC AGT TTT GAC TTC TCT AAC CAG 
CTG AAG CTT CGT ACG C ‘3 
Primer used for PLB1 deletion  
Plb1/Hph R 5’ AGA GCC TAA ATT AGA CCG AAG ACG GCA 
CTA ATG ACA CTT AAG ACA CCA ATA AAA GGC 
ATA GGC CAC TAG TGG ATC TG ‘3 
Primer used for PLB1 deletion  
Plb2/KanMX 
F 
5’ CTT ACG CAG ATG CAA TTA CGG AAC ATA TTA 
CAG GCT AGC TCG CTA ATT TCT GGA CTT TCG 
CTC ATT TAG CCC ATA CAT CC ‘3 
Primer used for PLB2 deletion  
Plb2/KanMX 
R 
5’ CAG AAG GGC TTC TAA ATT AGT CCA AAT AGT 
CCA AAT AAT GCT GTT ATG GCA CCT AAC AAA 
CTC ATT AGA GTG GGC AGA TGA TGT CGA GG‘3 
Primer used for PLB2 deletion  
Plb3/Nat F 5’ TAA GTA ATG ATA CGT CCA TTA TGT TCA AAA 
ATT ATT ATC AGT TAC ATA TTC GCA ACA GCT 
GAA GCT TCG TAC GC ‘3 
Primer used for PLB3 deletion  
Plb3/Nat R 5’ GCA AGA GAT ATT ATA CTG CTC CGG TAA ACA 
TCA ATA AAG TAA GCA TAA TCA TAG CGC ATA 
GGC CAC TAG TGG ATC TG ‘3 
Primer used for PLB3 deletion  
Nte1/ble F 5’ GAA TAG AAA GGC TTG GCT CTA GTT TTT GCA 
TGC GTT CAA TGA ATT GCA CTA CGA ACA ACG 
ACA ACC CTT AAT ATA ACT TC ‘3 
Primer used for NTE1 deletion  
Nte1/ble R 5’ CAA AAA ACG GTC ACC AAG GCG TTG GAA 
GAT AGA AAT CTA TCA AAT ACT ATT TCT TCT 
ATG ATC TGA TAT CAC CTA ATA AC ‘3 
Primer used for NTE1 deletion  
PLB1 XhoI 
Reverse 
5’ CAT TAG CTC GAG GGT TTT GTT TTA TTT 
TCT TTC CCG '3 
Primer used for PLB promoter 
insertion into pBH315 
PLB1 BglII 
Forward 
5’ CAT TAG AGA TCT CTT CAG CCT ATT ATT 
TAC GCA CCG '3 
Primer used for PLB promoter 
insertion into pBH315 
PLB2 XhoI 
Reverse 
5’ CAT TAG CTC GAG CTG CGT AAG AAG TGT 
TAC TTT AC '3 
Primer used for PLB promoter 
insertion into pBH315 
PLB2 BglII 
Forward 
5’ CAT TAG AGA TCT CGG GCA ATG CTT TGG 
TGA ATT ATT C '3 
Primer used for PLB promoter 
insertion into pBH315 
PLB3 XhoI 
Reverse 
5’ CAT TAG CTC GAG TAC TTA TAT TAT TAT 
GTG TGT AAT TTC C '3 
Primer used for PLB promoter 
insertion into pBH315 
PLB3 BglII 
Forward 
5’ CAT TAG AGA TCT ACT ACC GCT TGT GCG 
GAC CTG C '3 
Primer used for PLB promoter 
insertion into pBH315 
LGE1/Leu2 
reverse 
5’ CCC TAC TGC ATT AAT AAC AAT GAG TCC AGC 
TTT TCT TGG GTC AGT TGA ATA TTT AAT GCA 
GAA TCT TTT TAA GCA AGG AT 3’ 
Primer used for LGE1 deletion  
Lge1/Leu2 
forward 
5’ GTA TGA GCG GAT ACA CGG GAA ATA ATT 
ATA GCA GAT ACT CAT CCA CTC CTC CGA GAC 
AAA CAC ATA CCT AAT ATT ATT GC 3’ 
Primer used for LGE1 deletion  
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Actin Staining with Phalloidin-FITC. The protocol for actin staining was adapted from 
Reizman et al., Pringle et al., and the current protocols in molecular biology (122,123). Cells were 
grown in YPD media to log phase at an OD600 ~ 0.8. To 1 mL of culture 100 µL of 37% 
formaldehyde was added to fix the cells. The suspension was incubated at room temperature for 1 
hour followed by centrifugation at 8,000 rpm for ~5 mins to collect the pellet. Cells were washed 
three times with 1mL aliquots of phosphate buffered saline (PBS). The pellet was resuspended in 
1 mL of 0.2% Triton-X100/PBS solution and incubated at RT (25C) for 10 minutes. The cells 
were pelleted and washed three times with 1 mL aliquots of PBS followed by resuspension in 100 
µL of PBS. To 50 µL of the suspension, 8 µM FITC-phalloidin methanol stock solution was added 
followed by incubation on ice in the dark for 90 minutes.  Cells were washed five times with 1 mL 
aliquots of PBS.  Final pellet was resuspended in PBS.  An aliquot was placed onto a microscope 
slide and allowed to air dry in the dark. 10 µL of ProLong Gold was placed over the sample for 
preservation and for adherence of the cover glass (#1.5 thickness).  The slides were stored 
overnight in the dark to allow the Prolong gold to solidify.  All slides were stored at -20C until 
viewing by confocal microscopy.  
Microscopy. Brightfield and fluorescent microscopy were performed on a Nikon 
Microphot-SA microscope with attached camera. Confocal microscopy was performed on the 
Zeiss Axio Observer Z1 confocal microscope, and images were obtained with HCImage software 
(Zeiss). Scanning Electron Microscopy (SEM) was performed by Dr. Donna Stolz at the University 
of Pittsburgh. 
 Construction of the PLB-lacZ containing plasmids. Plasmids containing each of the PLB 
promoters were constructed previously in the lab (JPV 226, 228, and 230) but were non-functional 
so new constructs were made. The PLB promoters were amplified by PCR from the respective 
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plasmids using hybrid primers. The primers were engineered to contain BglII and XhoI restriction 
sites (Table 3.2). PCR products were purified from agarose gels using a gel extraction kit according 
to the manufacturer instructions (Qiagen). The PLB promoter products were cloned into the 
intermediate TOPO pCR2.1 vector using the TOPO TA Cloning Kit with One Shot TOP10 
electrocompetent cells (Invitrogen). The potential pCR2.1-PLB promoter plasmids were isolated 
from transformants and checked for the correct insertions by restriction digest with EcoRI. The 
constructed intermediate pCR2.1-PLB promoter vectors (JPV 325, 327, and 328) and the pBH315 
(JPV 161) were restriction digested with BglII and XhoI. The digested DNA was gel purified and 
extracted. The pBH315 backbone was treated with CIP followed by gel purification and extraction. 
Ligation of the pBH315 backbone with the PLB-promoter DNA was carried out with T4 Ligase at 
16ºC for 16 hours. Ligation products were transformed into E. coli competent cells. Plasmids 
isolated from transformants were checked for the correct PLB promoter insertion by restriction 
digest with BglII and XhoI as well as by BglII and SphI digestion.  
RNA Extraction and real time qRT-PCR gene expression analysis. Cultures were grown in 
YNB medium under the conditions specified in the text. RNA extraction and qRT-PCR was 
performed as described in Section 2.3.1. 
 β-galactosidase assays. Using cells grown in liquid media β-gal assays were performed as 
described in Chapter 2.3.1. β-gal activity assays from cells grown on plates were performed by 
plating the strains transformed with lacZ expression plasmids onto YNB – URA I+ plates 
containing X-GAL and incubated at desired temperature. Formation of a blue color in the cell 
patch indicated β-gal activity.  
PIS1 promoter replacement with the GAL1 promoter. The PIS1 promoter was replaced 
with the GAL promoter in the genome by amplifying DNA for insertion by PCR from the plasmid 
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pFA6a-KanMX6-PGAL1-3HA with hybrid primers named pFA6a-KanMX6-PGAL1-3HA F1 
(5'GTACCGATGAGATGAGATGAG…3') and pFA6a-KanMX6-PGAL1-3HA R1 
(5'ATTGGGAATATA….3'), each containing homology to the GAL promoter and region 
surrounding the PIS1 promoter. The PCR product was gel purified and transformed into JPV 13 
and JPV 203 and plated onto YT+Galactose+G418 plates.  
Sporulation and tetrad dissection. Sporulation media used included, KAc (0.05% glucose, 
1% potassium acetate, 0.1% yeast extract in DI water), and minimal media (10% potassium acetate 
and 0.05% zinc acetate). Sporulation media supplemented with amino acids and bases 
complementary to the strain auxotrophies were also used. Sporulation and tetrad dissection was 
carried out as published in Ausubel et. al. (99). Diploids to be sporulated were grown to an OD600 
= 3 in 5 mL of YPD medium, cells were harvested for 5 minutes at 1200 x g, washed once in water 
and resuspended in 1 mL of sporulation medium. Cells were sporulated at 30ºC for up to two 
weeks or until spores were microscopically visible. Cells were washed three times in sterile water 
and resuspended in 5 mL of sterile water. 30 µL of the cell suspension was diluted with 270 µL of 
sterile water and 3 µL of diluted glusulase was added to disrupt asci by vortex agitation.  
Suspension was incubated at room temperature until half of all tetrads had a disrupted ascus wall 
(2 - 6 minutes). Tetrad dissection was performed by placing treated spores in two parallel lines 
across the surface of the spore dissection plate (medium specified in text). Using the dissection 
needle, groups of four spores were separated into a line adjacent to the original position of the 
tetrad. After dissection, plates were incubated at 30ºC.  
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3.3 Results 
3.3.1  Cell morphology is altered upon loss of the Git1 transporter and in WT cells utilizing 
GroPIns as a sole phosphate source 
To begin understanding the role of Git1 in cellular morphology, in conjunction with its 
substrate, GroPIns, several phenotypic analyses were performed. Previous large scale 
morphological screens of the yeast deletion set classified the heterozygous git1∆/GIT1 diploid 
strain as football shaped (110). Here, microscopic examination of WT and the heterozygous 
git1/GIT1 diploid strains revealed minor differences in cell shape between the two strains grown 
in YPD, YNB I+ HiPi, and YNB I+ LoPi media (Figure 3-2). Each cell was classified as “football” 
shaped, defined as being pointed on both ends, or as “other”, based upon subjective visual 
examination and tallying. The percentage of football shaped cells in the git1∆/GIT1 strain was 
roughly the same in each of the media examined, suggesting phosphate concentration does not 
significantly affect cell shape.  
Transported into the cell by Git1, GroPCho or GroPIns can be supplied as the sole 
phosphate source for yeast cells (61). These metabolites are also found at physiologically relevant 
concentrations throughout different regions of the human body (51,124). We sought to determine 
if the presence of GroPIns in the medium facilitated any changes in the morphology of WT cells. 
Microscopic observations of WT cells grown in YNB and YPD medium, containing GroPIns in 
addition to KH2PO4 as an endogenous phosphate source, resulted in increased cellular aggregation 
(Figure 3-3). 
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Figure 3-2. WT and git1∆/GIT1 diploid strains display minor differences in cell shape.  
WT (JPV 381) and git1∆/GIT1 (JPV 201) were grown to log phase in YPD, YNB I+ HiPi, and YNB I+ 
LoPi media. A, An aliquot of each culture was examined under the light microscope. Strains were grown 
in duplicate and pictures of at least 5 frames per culture were obtained. Cells grown in YPD at 400X 
magnification are shown as a representative example. B, Images were examined and the percentages 
of football shaped cells was determined for each strain and condition. Cells in the budding stage were 
only considered when they were over half the size of the parent cell. All classifications were subjective 
based on my discretion. 
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Figure 3-3. WT cells display increased aggregation in the presence of GroPIns.  
WT cells (JPV 13) were grown to single colonies on YPD and I+ plates at 30ºC. A portion of an 
individual colony was resuspended in 15 µL of water, agitated by vortex mixing for 30 seconds, and 
sonication for 30 seconds. An aliquot of the suspension was viewed under the light microscope at 200X 
magnification. At least 3 colonies under each condition were observed. Pictures are representative of the 
entire data set.  
  
Over the course of my experiments, I observed that WT yeast cannot grow with GroPIns 
as the phosphate source when grown at an elevated temperature of 37ºC, prompting me to examine 
this phenomenon in more detail. WT strains in several genetic backgrounds (EG128, JPV 13; 
BY4741, JPV 203; ∑1278b, JPV 569) can grow on plates with GroPIns as a phosphate source at 
37ºC (Figure 3-4A), but were defective in growth in liquid media with GroPIns as the phosphate 
source (Figure 3-4 B and C). When WT cultures are started at an OD600 ≤ 0.02, after 60 hours of 
growth at 37ºC the culture in YNB I+ NoPi + 200 µM GroPIns media does not reach an OD600 > 
0.08, but in YNB I+ LoPi media the OD600 > 1.5 (data not shown). When WT cells were grown in 
YNB I+ NoPi + 200 µM GroPIns liquid media initially at 30ºC, and then shifted to 37ºC, growth 
did not stop, but the cultures reached stationary phase at a lower density (Figure 3-4B). 
Furthermore, the lower the cell density at the time of temperature shift, the greater the amount of 
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reduction in final density (data not shown). Preliminary studies to determine if a potential 96-well 
plate screen could be performed revealed WT could grow in YNB I+ NoPi + 200 µM GroPIns 
media at 37ºC in a 96-well plate without shaking, albeit minimally compared to 30ºC (Figure 
3-4C). To use as a screen in the future, tests would need to be completed in 96-well plates with 
shaking at 30ºC and 37ºC, to mimic traditional liquid growth in 5 mL cultures grown in a rotating 
wheel.  
 
Figure 3-4. WT cells have slowed growth when grown in media requiring utilization of 
GroPIns as a phosphate source at 37ºC. 
A, WT (JPV 203 and JPV 569) were grown in YNB I+ LoPi media at 30ºC and diluted to equal densities 
for plating to single colonies. Aliquots were spread onto YNB I+ LoPi and YNB I+ NoPi + GroPIns plates 
and incubated at 30ºC and 37ºC for 2 days.  B, WT (JPV 203) cultures were started at OD600 = 0.005 in 5mL 
cultures in listed media and grown at 30ºC in rotator wheel, and subsequently split after 12 hours (red line), 
for growth at 30ºC and 37ºC. C, WT (JPV 203) cultures were started at OD600 = 0.002 in 200 µL of media 
in a 96-well plate in the listed media and grown at 30ºC and 37ºC. Data are means ± S.E. of at least triplicate 
cultures.  
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3.3.2 Growth of the PLB mutants utilizing GroPIns as a phosphate source.  
The preliminary data suggesting WT cells display altered growth and aggregation in the 
presence of GroPIns prompted me to examine potential physiological or morphological alterations 
in cells lacking the B-type phospholipases, which produce GroPIns, when grown in the presence 
or absence of GroPIns in the medium. The plb123∆ (JPV 630) strain can grow with GroPIns as 
the sole phosphate source at 30⁰C, although slower than WT (Figure 3-5A). Microscopic exam of 
the cultures revealed the plb123∆ strain displays larger average cell size compared to WT (Figure 
3-5 B and C). Furthermore, abnormally large (XL) cells, with large vacuoles, were observed in 
plb123∆ cells when grown with 200 µM GroPIns as the phosphate source, and no XL cells were 
observed under the same condition in WT or in corresponding cultures containing 200 µM KH2PO4 
(LoPi) as the phosphate source. Cells were also examined in YNB I+ LoPi medium containing 
additional 200 µM GroPIns, but a notable increase in XL cells was not observed in this medium 
for WT or plb123∆ (data not shown).  This suggests that the forced utilization of GroPIns as a 
phosphate source in the absence of the PLBs results in the most extreme phenotype. Suspension 
of cells grown in corresponding media, but on agar plates, produced trends similar to those 
observed in the liquid media (data not shown). In media requiring utilization of 200 µM GroPIns 
as the phosphate source, XL cells were observed occasionally in the single and double PLB 
mutants examined, and subjectively appeared to be most prevalent in the plb2∆, plb12∆, and 
plb123∆ strains (Figure 3-6). However, since there was not an obvious change in morphology 
compared to WT a more complete quantitative analysis was not performed in the single or double 
PLB deletion strains.  
Preliminary scanning electron microscopy (SEM) images of WT and plb123∆ cells 
(Courtesy of Dr. Donna Stolz at the University of Pittsburgh) revealed large invaginations in the 
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surfaces of these XL cells (Appendix A 2). The cause of this observation is unknown, but suggests 
major cellular alterations when PI deacylation is disrupted, and GroPIns is used as a phosphate 
source. This result may indicate PLB mediated turnover is required for normal physiology when 
GroPIns is incorporated into cellular metabolism.  
 
 
Figure 3-5. GroPIns can be used as a phosphate source upon loss of the cell surface 
associated PLBs, but results in aberrant morphology.  
A, WT (JPV 13) and plb123∆ (JPV 480) were grown in YNB I+ LoPi media and inoculated into listed test 
media at starting OD600=0.005. B, Aliquots of culture were removed and examined microscopically. 
Quantitation of cell area from log phase cells growing in equivalent concentrations of KH2PO4 or GroPIns 
was performed using ImageJ software. Several fields from at least 3 separate cultures were analyzed. C, 
Phase contrast microscopy of representative fields at 400X magnification after 48 hours of growth.  
  53 
Figure 3-6. Cells lacking single deletions of 
the PLB genes display some instances of 
morphological abnormalities.   
WT (JPV 13), plb1∆ (JPV 477), plb2∆ (JPV 478), 
plb3∆ (JPV 479), plb12∆ (JPV 140) and plb123∆ (JPV 
480) were grown in in I+ LoPi media and inoculated 
into test media at OD600=0.005. Cultures were 
examined by phase contrast microscopy at 400X magnification 
after 38 hours of growth. Frames are representative of 
each condition.   
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Together the morphological abnormalities identified in the plb123∆ strain and in cells 
grown on GroPIns as a phosphate source could indicate potential alterations in the cytoskeleton 
cell wall, plasma membrane, and/or vacuolar morphology. Before pursuing other tests, including 
growth and drug susceptibility assay, another set of PLB mutants was constructed in two different 
strain backgrounds detailed in the next sections.  
3.3.3 Deletion of one or more PLB genes does not alter growth rate  
Preliminary experiments with PLB mutants in the EG123 background produced 
inconsistent results, prompting me to make all of the deletion strains in our standard laboratory 
strains. Deletion of each of the PLBs, PLB1, PLB2, and PLB3 were made singly and in 
combination in the BY4741 and ∑1278b backgrounds. Additionally, NTE1 was deleted singly and 
in the plb123∆ strain in BY4741. Growth of all the newly constructed PLB deletion strains (JPV 
617 – 630, Table 3.1) was monitored in several types of media including: YNB LoPi, YNB HiPi, 
and YNB NoPi + GroPIns, all with and without inositol. No major differences in growth between 
WT and plb123∆ in respective media were observed (Figure 3-7). As demonstrated in previous 
publications, and shown in Figure 3-7, growth on GroPIns results in a long lag phase. Microscopic 
examination of the plb123∆ strain when grown on GroPIns as the phosphate source revealed the 
presence of XL cells consistent with the observations in the EG128 background. Interestingly, WT 
cells in both the BY4742 and in the ∑1278b backgrounds also appeared to have more XL cells 
when grown on a medium requiring GroPIns utilization compared to low or high phosphate media, 
although this was a visual observation and not quantified.  
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Figure 3-7. Loss of PLB 1, 2, and 3 does not alter growth compared to WT.  
Indicated strains were pre-grown in YNB I- LoPi medium and inoculated at a low starting density into the 
desired medium. Optical density (A600) of the cultures was monitored over time.  
 
3.3.4 The plb123∆ strain has increased sensitivity to the actin destabilizer, Latrunculin A  
Actin cytoskeleton disruption can cause abnormalities in cell morphology. Furthermore, 
the yeast fitness database identified plb3∆ as having increased sensitivity to Latrunculin A (LatA), 
an actin destabilizing drug that inhibits actin polymerization. LatA inhibited growth of various 
combinations of the double PLB mutants, and most severely inhibited growth of the triple plb123∆ 
mutant, whereas Lat A did not affect growth of the single PLB deletion mutants (Figure 3-8). Cell 
viability of WT and plb123∆ strains after growth in the presence of LatA was similar based upon 
  56 
plating equal amounts of cells and counting individual colonies (data not shown).  Observation of 
growth sensitivity to LatA prompted us to microscopically examine the actin cytoskeleton. 
Preliminary observations revealed that in fixed cells stained with TRITC-phalloidin in the absence 
of LatA, the actin cytoskeleton of the plb123∆ cells appeared to be similarly organized to the WT 
cells, both strains exhibiting actin patches and cables, typical of yeast cells (Appendix A 3). In the 
presence of LatA, actin patches are visible in the WT, but interestingly, no defined organized actin 
structures are visible in plb123∆ (Appendix A 3). This microscopic observation was not pursued 
quantitatively and would require more replicate measures.  
 
Figure 3-8. Loss of multiple cell surface PLBs in the BY4741 background increases 
sensitivity to the actin destabilizer, Latrunculin A.  
The cells were grown from equal starting densities at 37C in YPD media with 1µM LatA (in DMSO) or 
with solvent. Inhibition by LatA for each strain was determined by calculating the percentage of growth in 
LatA containing media compared to growth in the control for the single (A), double (B), and triple (B) 
mutants after 25 hours of growth. Growth curves of WT and plb123∆ with and without presence of LatA 
(C). Chemical structure of Latrunculin A (D).  
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3.3.5 Phenotypic analysis of WT and strains bearing deletion of the PLB genes upon exposure 
to stressors targeting the plasma membrane and the cytoskeleton 
To continue our analysis of PLB function, growth was examined in the presence of several 
stressors shown in Table 3.3. In summary, no differences in visible growth sensitivity to the 
mentioned stressing agents were noted between WT and plb123∆ strains under the conditions 
examined (liquid and/or plate growth assays in BY4741 and ∑1278b backgrounds, data not 
shown). The strain bearing deletion of all four S. cerevisiae PLBs (plb123∆ nte1∆) was constructed 
in the BY4741 background and growth studies showed no alteration in sensitivity to calcofluor, 
NaCl, or SDS compared to WT (data not shown).  
Table 3.3 Chemical cell stressors evaluated and their targets  
Drug/Compound 
Name 
Targeted process/Molecular target 
SDS, NaCl, 
CdCl2, CuSO4 
Plasma membrane disturbing agents 
Calcofluor Cell wall destabilizer  
Benomyl Microtubule depolymerizing drug 
Nocodazole Interferes with microtubule polymerization 
Amphotericin B Ergosterol metabolism; Associates with ergosterol causing ion leakage 
through the membrane 
Terbinefine HCl Ergosterol metabolism; Inhibits the enzyme squalene monoxygenase 
preventing the conversion of squalene to lanosterol in the ergosterol 
biosynthetic pathway 
Ketoconazole Ergosterol metabolism; Inhibits enzyme that converts lanosterol to 
ergosterol 
Nystatin Ergosterol metabolism; Binds to ergostrol causing K+ ion leakage through 
the membrane 
 
3.3.6 Role of phosphate and growth phase in PLB expression  
In addition to identifying physiological processes associated with PLB activity, I wanted 
to examine how the PLB genes are regulated at the transcriptional level, and how that regulation 
impacts the broader GDTR pathway. I hypothesized that the PLB genes may be regulated by 
phosphate, as is the GroPIns transporter GIT1. Additionally, PLB transcript levels were compared 
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in log versus stationary phase cells, at 30ºC versus 37ºC, and in cells exposed to various stressors 
(SDS, NaCl, calcofluor, amphotericin B, LatA, choline, terbinefine, and nystatin).  
Plasmids containing each of the PLB promoters controlling the lacZ gene were constructed 
as described in Experimental Procedures (Chapter 3.2). The lacZ vectors and β-gal assays were 
used to obtain preliminary data for PLB expression (data not shown), however, real time qRT-
PCR was used as a more sensitive method to examine message levels under conditions of interest. 
Additionally, using the Yeast Tract database (yeastract.com), I identified potential transcription 
factors with binding sites in the promoters of the PLB genes that were likely involved in altered 
morphology and/or disrupted actin cytoskeleton. Strains bearing deletion of the genes encoding 
the transcription factors Msn2, Msn4, Crz1, Sfl1, Xbp1, Hac1, Sko1, and Yap1 were screened for 
changes in PLB gene expression. Noticeable differences in PLB promoter driven β–gal activity 
were observed in the msn2∆, msn4∆, and crz1∆ strains, but these were preliminary and not 
followed up at this stage. However, β–gal assays in WT strains transformed with the PLB-lacZ 
vectors suggested all three genes encoding the cell surface PLBs (PLB1-3), have greater expression 
at 37ºC compared to 30ºC. 
Since the Git1 transport activity is regulated by phosphate levels (102), I examined PLB 
gene regulation by phosphate levels. In agreement with the transport data, GIT1 transcript levels 
measured by qRT-PCR were found to be depressed in YNB HiPi medium compared to YNB LoPi 
medium (Figure 3-9B). Unlike GIT1, the PLB1-3 genes are not highly regulated by phosphate 
availability (Figure 3-9C). No difference in message abundance was noted in PLB1 or PLB2 in 
WT grown in HiPi versus LoPi medium, while PLB3 message was approximately twice as 
abundant in cells grown in HiPi compared to LoPi. Message abundance of PLB1-3 in WT cells 
gown in YNB + GroPIns media compared to YNB LoPi media was not significantly different 
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(Figure 3-9D). I also report that in WT cells PLB2 and PLB3 message levels decrease in stationary 
phase, while the PLB1 message increases in stationary phase compared to levels in log phase cells 
(Appendix A 4).  
 
Figure 3-9. Glycerophosphodiester transport via Git1, not production via Plb1-3 is 
regulated by phosphate availability.  
A – C, Relative message abundance of GIT1, PLB1, PLB2, and PLB3 in a WT strain grown in low Pi 
compared to high Pi containing medium (A and B) or low Pi compared to GroPIns containing medium (C). 
Total RNA was extracted and transcript levels were analyzed by real-time RT-PCR using the comparative 
∆∆CT method. Data were normalized to the amount of the endogenous control mRNA, SNR17, and 
expressed relative to the value in WT cells grown in high Pi medium. Values represent the means ± S.E. of 
at least 3 individual cultures each assayed in triplicate. Student’s t-test was performed to compare 
expression of each gene in media compared to YNB LoPi (A, p = 0.015; B, p = 0.028).   
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3.3.7 Lethality in the absence of PI synthase cannot be rescued by the presence of GroPIns 
in the medium 
A series of experiments were performed in an attempt to determine if a 
glycerophosphodiester (GPX) reacylation pathway exists in S. cerevisiae, and if so, does it require 
the PLBs.  GroPIns was chosen as the GPX substrate since GroPIns was shown to be the most 
abundant glycerophosphodiester accumulating in the media of S. cerevisiae, with GroPCho and 
glycerophosphoethanolamine present at much lower levels (125). We hypothesized that GroPIns 
enters cellular metabolism through reacylation to LysoPI and/or PI. Several approaches to 
determine if a reacylation synthesis pathway for PI exists in the cell will be briefly summarized 
here, however no evidence for reacylation of GroPIns to PI was obtained. The experimental goal 
in each of these approaches was to show that when the essential gene PIS1 is deleted or made 
nonfunctional, the cells can retain viability if the medium is supplemented with GroPIns, 
suggesting that GroPIns is reacylated to produce the essential PI (Figure 3-1 and Figure 3-10). 
 
Figure 3-10. Known PI synthesis through Pis1 activity and hypothetical PI synthesis by 
GroPIns acyltransferase activity.  
PI is synthesized from CDP-DAG and inositol through a condensation reaction catalyzed by PI Synthase 
(Pis1) and can be catabolized through the action of Plb3 to produce GroPIns. A PI synthesis pathway by 
GroPIns reacylation through GroPIns acyltransferase (GPI AT) activity is currently uncharacterized.  
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Using published methods described for chromosomal promoter replacement and PCR 
based gene deletion, the endogenous PIS1 promoter was replaced with the GAL1-inducible 
promoter (121,126). Transformants containing the GAL1 promoter were obtained, but while the 
transformants grew better on medium with galactose, cells continued to grow on glucose medium. 
In conclusion, the GAL1 promoter was too leaky to perform the depletion experiment. A few years 
later, the Lopes lab published work on a pis1∆ haploid strain containing a GAL-PIS1 plasmid 
(127). They kindly sent us this strain, but preliminary tests revealed that it still grows fairly well 
on medium containing glucose, as well as on galactose medium, corroborating my attempt. 
A diploid pis1∆/PIS1 (JPV 605) strain was transformed with the pYES2CT-HA-PIS1 
plasmid and transformants were sporulated in several types of sporulation media. Tetrads were 
dissected to isolate individual spores and the resulting individual colonies were tested to determine 
which were haploid by a mating assay, tested for PIS1 deletion by G418 resistance, and checked 
for presence of the PIS1 containing plasmid by growth on –URA plates. Only two of the spores 
screened met all of the requirements. These strains was propagated on galactose containing plates. 
Equal starting amounts of cells were grown in liquid and on plates in the following media: YNB 
I- LoPi, YNB I- LoPi + GroPIns + 5-FOA, and YNB I- LoPi + 5-FOA (some containing 5-FOA to 
induce loss of the plasmid and hence produce a pis1∆ strain). Growth occurred on all of these 
media indicating that even though the strain was confirmed to have PIS1 deleted and contains the 
PIS1 plasmid, something else was compensating for the deletion, or the cell had another copy of 
PIS1. Checking for PIS1 deletion by PCR revealed bands consistent with the presence of both a 
WT copy of PIS1 and a copy in which URA3 was inserted, suggesting that they are not truly 
haploid, that a recombination event occurred with PIS1 on the plasmid, or that mixed colonies 
were obtained. This question was not pursued further. 
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Direct deletion of PIS1 in a haploid strain in the presence of GroPIns was attempted. Since 
PIS1 is an essential gene this attempt would only be successful if GroPIns can be reacylated to 
rescue the PIS1 deletion. Homologous recombination by insertion of KanMX and transformation 
onto plates containing GroPIns resulted in transformants, but the insert was never in the correct 
location. As a control, PIS1 was successfully deleted in a diploid strain using the same methods 
used for the haploid.  Because selection for KanMX resulted in significant background growth, 
PIS1 was also directly deleted by homologous recombination by insertion of URA3. Many 
successful transformants appeared in the control diploid strains, and a few transformants appeared 
in the haploid strain.  Despite these strains being verified to be haploids through a mating assay, 
and PCR checking revealed several transformants contained the URA3 insert in the correct 
location, interestingly a band indicating the presence of a WT copy of PIS1 also appeared. The 
results suggest there was an extra copy of the chromosome, or this region was under pressure to 
duplicate.  
A pis1/PIS1 diploid was constructed in a diploid strain known to have a high sporulation 
efficiency (JPV 381). The deletion was made by insertion of URA3 and verified by PCR. The 
newly constructed diploid pis1∆/PIS1 (JPV 616) was efficiently sporulated in sporulation media 
(1% potassium acetate, 0.1% Bacto Yeast Extract, 0.05% dextrose). Tetrad analysis by pulling 
spores directly onto plates containing GroPIns produced maximum of two developing colonies per 
tetrad indicating that the pis1∆ haploid strain is unable to be rescued by the presence of GroPIns 
in the medium. Therefore, it is unlikely that GroPIns is able to be reacylated in order to rescue a 
pis1∆ mutant.  
In summary, I was unable to rescue a pis1∆ mutant through GroPIns supplementation. This 
could mean either that GroPIns cannot be reacylated, cannot be reacylated efficiently enough to 
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rescue the lethality, that genes responsible were not expressed under the conditions used here, or 
that Pis1 has another essential function besides synthesis of PI. To date, no enzyme has been 
characterized with acyltransferase activity to reacylate GroPIns, but recent work in the Patton Vogt 
lab in collaboration with the Stymne lab indicates GroPCho can be reacylated by a novel gene 
product in both yeast and plants.  
3.3.8 The functional Interaction between the PLBs and other genes, specifically Ypk1 and 
Lge1 
The described results concerning morphological and actin cytoskeletal abnormalities 
prompted me to examine the genetic interactions between Ypk1 – Plb1 and Lge1 – Plb3 because 
of their known involvement in actin dynamics and cell morphology, respectively. The Ypk1 – Plb1 
interaction became the primary focus for this dissertation and is discussed in Chapter 4.  A genome-
scale interaction study identified a negative genetic interaction between LGE1 and PLB3, in which 
the lge1∆ plb3∆ double mutant exhibited slower growth than either single mutant alone (128). 
Notably, the LGE1 mutant exhibits a large cell phenotype under optimal growth conditions (129). 
LGE1 is a verified ORF, predicted to be localized to the nucleus, but the function of the protein is 
currently unknown. Together with my data concerning the PLBs, I hypothesized this interaction 
impacted processes involved with maintaining proper cell morphology. Only preliminary data was 
collected examining the Plb3-Lge1 interaction. The lge1∆ plb3∆ strain was constructed to begin 
assessing the interaction between the two genes. Consistent with the published large scale genetic 
screen, the lge1∆ plb3∆ strain displayed slowed growth compared to the single deletion strains 
(Appendix A 5). No further studies were performed with the lge1∆ plb3∆ strain in this dissertation, 
but a follow-up of this interaction may elucidate a novel role for the PLBs, specifically Plb3, in 
maintaining optimal morphology.  
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3.4 Discussion 
Perturbation to the GDTR pathway by deletion of GIT1 or the PLB genes, or by forcing 
utilization of GroPIns as a sole phosphate source results in a variety of morphological changes in 
the cell. These morphological changes are known to be regulated by and/or affect a diverse range 
of processes. Since all of the players in the pathway have functional homologs in higher eukaryotes 
and because GroPIns is present in the human body, this has relevance for higher eukaryotes.  
Preliminary microscopic studies indicate the presence of GroPIns in the medium causes 
increased clumping in WT cells (Figure 3-3). Genetically, aggregation of cells generally occurs 
upon induction of the FLO genes, which are in part regulated by various environmental conditions 
including cations, pH, temperature, sugars, and ethanol (115). In some fungi aggregation can lead 
to formation of hyphae and biofilm structures, which contribute to pathogenesis. Possibly, GroPIns 
could be a signal promoting aggregation. Future studies may examine the expression of the FLO 
genes, or other genes implicated in flocculation. A sedimentation test would provide a quantitative 
assessment of differences in aggregation (113).  
Morphological changes in the cell can provide clues for elucidating the function of 
particular proteins. The football shaped cells observed upon loss of GIT1 are consistent with a 
published screen classifying the git1∆ mutant as football shaped (110). Altered cell shape can be 
due to a variety of factors involving the cell wall, plasma membrane, and cytoskeleton. Most 
interestingly, loss of the three cell surface PLBs resulted in XL cells, membrane invaginations, and 
actin cytoskeletal defects when forced to utilize GroPIns. My results suggest that the presence of 
GroPIns exacerbates disruptions to cell morphology in strains or conditions where morphology is 
already compromised, such as upon loss of the PLBs or upon heat stress (Figure 3-4 and Figure 
3-4).  
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To elucidate the underlying mechanism for the observed changes in cell size and 
morphology upon loss of the PLBs, I examined the effect of stressor known to perturb the cell 
wall, plasma membrane, and cytoskeleton. Increased sensitivity to LatA in plb123∆ yeast (Figure 
3-8) and actin staining (Appendix A 3) indicate loss of the PLBs results in a compromised actin 
cytoskeleton, providing a possible explanation for some of the observed morphological alterations. 
However, growth alone is not a complete measure of defects in plasma membrane and cell wall 
stability so these preliminary studies do not entirely rule out plasma membrane or cell wall defects 
in plb123∆ yeast cells. 
Membrane expansion and failure to divide can result in XL cells to develop (111). An 
experiment involving synchronization of cells and subsequent monitoring of division could also 
be employed. Since cultures did not produce uniformly XL cells, a series of measurements from 
mother and daughter cells would be useful to determine if there is a significant alteration in cell 
size in plb123∆ yeast. 
 There are a few descriptions in the literature describing cellular circumstances that produce 
large invaginations of the yeast cell membrane, however the cause of the large invaginations 
observed in plb123∆ cells is unknown. Published observations have demonstrated the presence of 
invaginations in cells including furrow like invaginations at the membrane compartment 
containing Can1 (MCC) domain and the sub-adjacent eisosomes (130-133), invaginations in 
regions termed PtdIns[4,5]P2 enriched structures (PES) (132), and invaginations in cells that are 
lacking two of the three genes encoding Sac1-containing phosphatases, INP51, INP52 and INP53 
(133,134). A recurring theme relating to cellular invaginations are the importance of 
phospholipids, particularly the phosphorylated phosphatidylinositols (PIPs), also essential 
regulators of the actin cytoskeleton (135,136). Interestingly, addition of glucose or ergosterol will 
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induce major changes in the PIPs (137,138). For example, addition of glucose causes rapid 
hydrolysis of the PIPs to produce the GroPIPs (59), an activity that has been suggested to be 
mediated by the PLBs. Therefore, it is tempting to speculate that these structures could be related 
to PtdIns[4,5]P2 levels and Sac1 function. Evaluation of these possibilities requires further 
experimentation. 
 Here, I show that the PLBs are transcriptionally regulated by temperature. Although 
preliminary experiments by β-gal accumulation assays did not indicate changes in transcription 
upon LatA treatment, it would be interesting to examine PLB message by the more sensitive qRT-
PCR method. Furthermore, using the β-gal assays I was unable to conclusively identify 
transcription factors strictly regulating the PLB genes, however further examination of the TFs of 
interest, Msn2/4 and Crz1, under various stress conditions will shed light on PLB gene regulation 
(Chapter 4.3.6). Regulation data compiled on SGD suggests several other transcription factors of 
interest that are shown to regulate PLB message levels under elevated temperature, various media, 
exposure to drug perturbations, or in different growth phases, indicating the combinatorial control 
regulating the PLB genes.   
 The PLBs have phospholipase, transacylase, and lysophospholipase activities (45,69). The 
ability of the PLBs to acylate GroPIns to PI has not been shown, and the studies described in this 
chapter suggest the cell does not have the capability to re-acylate GroPIns, or not sufficiently 
enough, to rescue growth in the absence of PI synthase under the conditions tested here.  However, 
the ability of yeast and plants cells to reacylate GroPCho has been shown in vitro (107,139), but 
the activity remained controversial without identification of the gene product. Recently, a paper 
submitted for publication from our lab in collaboration with the Stymne lab, in which I am a co-
author, reveals more evidence for GroPCho acyltransferase (GPC AT) activity in plants and in 
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yeast (submitted and in revision, Lager et al., 2014). This activity results in acylation of GroPCho 
to produce LysoPC, either by transferring an acyl group from an acyl-CoA or from LysoPC, 
followed by subsequent acylation to the full lipid, PC, by PLB or Ale1 transacylase activity. The 
GPC AT activity is not from PLB activity, but instead from an uncharacterized protein. Studies on 
this gene are currently underway in the Patton-Vogt lab in collaboration with the Stymne lab.  
 Pursuing other functional relationships with the PLB genes, including the Plb3-Lge1 
interaction, could provide more complete understanding of the physiological significance of the 
PLBs. Lge1 plays a role in ubiquitination of histone H2B in the nucleus, but minimal new 
information on Lge1 has been published (140). Moreover, hundreds of physical and genetic 
interactions with Lge1 have since been identified making the pursuit of the Lge1-Plb3 interaction 
less attractive (yeastgenome.org). Although, the interaction was initially interesting because of the 
large cell phenotype, which I thought could correspond to the XL plb123∆ cells we observed. 
However, other interactions such as a recently identified interaction between a vacuolar protein, 
Mon2, and PLB1, 2, and 3 (141) are of greater interest especially given the results that will be 
described in Chapter 4. Briefly, strains bearing deletion of one of the PLB genes displayed altered 
vacuolar fragmentation, an effect not observed in mutants with defective PLC or PLD pathways 
(141). 
In summary, loss of the cell surface associated PLBs and/or utilization of GroPIns causes 
alterations in the actin cytoskeleton and an increased cell size. Furthermore, PLB1-3 are regulated 
at the transcriptional level by temperature and growth phase in WT yeast. A more in depth 
characterization of the PLBs is essential in understanding of the GDTR pathway. Confirmation of 
and follow up of the observations presented in this chapter would provide more insight into the 
function and purpose of the PLBs in the GDTR pathway and in cellular physiology.   
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Chapter 4 Accelerated Plb1-mediated turnover of 
phosphatidylcholine upon loss of Ypk1 in S. 
cerevisiae 
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ABSTRACT  
Ypk1, the yeast homolog of the human serum- and glucocorticoid-induced kinase (Sgk1), 
affects diverse cellular activities, including sphingolipid homeostasis. We now report that Ypk1 
also impacts the turnover of the major phospholipid, phosphatidylcholine (PC). Pulse-chase 
radiolabeling reveals that a ypk1∆ mutant exhibits increased PC deacylation and 
glycerophosphocholine (GroPCho) production compared to WT. Deletion of PLB1, a gene 
encoding a B–type phospholipase that hydrolyzes PC, in a ypk1∆ mutant curtails the increased PC 
deacylation.  In contrast to previous data, we find that Plb1 resides in the ER and in the medium.  
Consistent with a link between Ypk1 and Plb1, the levels of both Plb1 protein and PLB1 message 
are elevated in a ypk1∆ strain compared to WT yeast.  Furthermore, deletion of PLB1 in a ypk1∆ 
mutant exacerbates phenotypes associated with loss of YPK1, including slowed growth and 
sensitivity to cell-wall perturbation, suggesting that increased Plb1 activity buffers against the loss 
of Ypk1. Since Plb1 lacks a consensus phosphorylation site for Ypk1, we probed other processes 
under the control of Ypk1 that might be linked to PC turnover. Inhibition of sphingolipid 
biosynthesis by the drug myriocin or through utilization of a lcb1-100 mutant results in increased 
PLB1 expression. Furthermore, we discovered that the increase in PLB1 expression observed upon 
inhibition of sphingolipid synthesis or loss of Ypk1 is under the control of the Crz1 transcription 
factor.  Taken together, these results suggest a functional interaction between Ypk1 and Plb1 in 
which altered sphingolipid metabolism upregulates PLB1 expression via Crz1. 
 
4.1 Introduction 
Ypk1, the yeast homolog of the human serum- and glucocorticoid- induced kinase (Sgk1), 
is a serine/threonine protein kinase known to affect multiple downstream processes, including lipid 
homeostasis (142-146), actin dynamics (147,148), cell wall integrity (147,148), endocytosis 
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(144,149), and lipid flippase activity (142). Ypk1 has a functionally redundant homolog, Ykr2. 
Either Ypk1 or Ykr2 is required for cell viability, but Ypk1 plays a more prominent role in several 
processes (147,150). For example, deletion of YPK1 results in a growth defect and increased 
sensitivity to several drugs, phenotypes that are not observed in the ykr2∆ mutant (147). Ypk1, a 
cytosolic protein, is recruited to the plasma membrane through its interaction with Slm1/2, proteins 
which contain a pleckstrin homology (PH) domain that mediates binding to PI[4,5]P2 (151,152).  
At the plasma membrane Ypk1 is first activated by target of rapamycin complex 2 (TORC2) 
(151,152) and then by Pkh1/2 phosphorylation (147). TORC2 has been shown to be activated by 
sphingolipid depletion (153) and elevated reactive oxygen species (ROS) (154). In turn, Pkh1 and 
Pkh2, homologs of the mammalian phosphoinositide-dependent protein kinase-1 (PDK1), 
preferentially phosphorylate and activate Ypk1 and Ykr2, respectively, although some crossover 
is observed (147). Pkh1 and Ypk1 are localized exclusively to the cytosol, while Pkh2 and Ykr2 
also enter the nucleus. Exogenous addition of the long chain base (LCB) phytosphingosine (PHS) 
activates Pkh1/Pkh2 in vitro as measured by an increase in PKC phosphorylation (155), while a 
more recent paper suggests that the ability of Pkh1/2 to activate Ypk1/2 is unaffected by LCBs, 
but instead requires the complex sphingolipid, mannosylinositol phosphorylceramide (MIPC) 
(142).  
The known targets of Ypk1 phosphorylation, Fpk1/2 (142), Orm1/2  (143), and Gpd1 (156) 
are all involved in some aspect of lipid metabolism. Ypk1 phosphorylates and thereby inactivates 
Fpk1 and Fpk2, which are upstream activators of the lipid flippase complexes, Lem3-Dnf1 and 
Lem3-Dnf2, respectively (142,157). Ypk1 phosphorylation of the endoplasmic reticulum (ER) 
transmembrane proteins, Orm1 and Orm2, renders them unable to bind to and inhibit serine 
palmitoyl transferase (SPT), the rate-limiting step in sphingolipid biosynthesis (13,143,158). 
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Finally, Ypk1 phosphorylates and inactivates Gpd1, glycerol-3-phosphate dehydrogenase, which 
reduces dihydroxyacetone phosphate (156). The product of this reaction, glycerol-3-phosphate, 
can be shuttled into multiple metabolic pathways, including phospholipid biosynthesis. A 
simplified schematic of the Ypk1 signaling pathway is shown in Figure 4-1. 
Figure 4-1. Simplified schematic of the Ypk1 signaling pathway and downstream events.  
Ypk1/Ypk2 are activated when phosphorylated by the kinases Pkh1 and TORC2. Ypk1/2 phosphorylate 
and negatively regulate the flippase activator proteins, Fpk1/2. Fpk1/2 can, in turn, phosphorylate and 
negatively regulate Ypk1. Ypk1 phosphorylates Orm1/2, negative regulators of the sphingolipid 
biosynthetic genes LCB1/2. Orm1/2 normally binds and inhibits serine palmitoyl transferase so when 
Orm1/2 are phosphorylated inhibition is relieved and sphingolipid synthesis can proceed. Ypk1 
phosphorylates Gpd1, glycerol-3-phosphate (G3P) dehydrogenase, turning off G3P production. Glycerol 3 
phosphate dehydrogenase reduces DHA to glycerol-3-phosphate. G3P can act as a precursor to 
phospholipids. Ypk1 phosphorylates and activates Lag1 and Lac1, components of the ceramide synthase 
(142,143,146,147,156,159) and unpublished results from the J. Thorner Lab).  
POTENTIAL EFFECTS OF YPK1 DELETION ON PHOSPHOLIPID HOMEOSTASIS: 
 
↑Flippase Activity  
= Less PE and PS in outer leaflet of PM 
 
↓SPT activity 
= Decreased basal levels of sphingolipids 
 
↓Ceramide Synthesis 
= Decreased complex sphingolipids and more sphingosine phosphates 
 
↑Glycerol-3-P  
= More flux into PC synthesis 
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Another finding linking Ypk1 to lipid metabolism is that overexpression of the B-type 
phospholipase, PLB1, rescues the lethality of the temperature sensitive ypk1tsykr2∆ mutant (1). 
The B-type phospholipases (PLB) catalyze the deacylation of glycerophospholipids to produce the 
glycerophosphodiesters and free fatty acids (Fig. 1D). In S. cerevisiae, four genes encode proteins 
with PLB activity, PLB1, PLB2, PLB3, and NTE1, which function in membrane remodeling in the 
cell. Based on in vivo studies, Plb1 primarily deacylates phosphatidylcholine (PC) to produce 
external glycerophosphocholine (GroPCho) (69).  Biochemical studies have suggested that Plb1 is 
plasma membrane-associated and secreted from the cell (43,45,69), whereas Nte1 is localized to 
the endoplasmic reticulum and is responsible for the production of internal GroPCho (103). The 
primary substrate for Plb2 appears to be exogenous phospholipids, and Plb3 acts on 
phosphatidylinositol (PI) to produce extracellular glycerophosphoinositol (GroPIns) (43,45).  
PC synthesis and catabolism are tightly regulated in yeast (9) and other eukaryotic cells 
(18), and disruptions to PC metabolism can result in aberrant physiological conditions. In 
mammalian cells increased choline uptake and incorporation into PC is a marker for proliferative 
growth (160), and conversely, inhibition of choline synthesis results in apoptosis (161). Aberrant 
PC levels and/or alterations in GroPCho have also been observed in patients with various cancers, 
such as colorectal (162) and prostate (163) cancer, and in Alzheimer’s disease (164,165).  What 
has remained unknown, however, is how protein kinases and members of the B-type 
phospholipases, which deacylate phospholipids to produce GroPCho, are coordinately regulated 
to ensure lipid homeostasis.  Here, we describe a novel role for Ypk1, the yeast homolog of Sgk1, 
in regulating Plb1 mediated PC turnover. 
4.2 Experimental Procedures 
Strains, plasmids, media, and growth conditions. The S. cerevisiae strains used in this study 
are shown in Table 1.  Strains were grown aerobically with shaking at 30ºC or 37ºC, as noted.  
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Turbidity was monitored by measuring the optical density at 600nm (A600) on a BioMate 3 Thermo 
Spectronic spectrophotometer. Empty vectors, YEp351 and pRS426, and vectors overexpressing 
each of the PLB genes, YEp351-PLB1, YEp351-PLB2, YEp351-PLB3, and pRS426-NTE1, were 
gifts from Susan Henry (YEp351 series) (45) and Chris McMaster (pRS426-NTE1) (166).  Media 
used for this study included rich yeast extract peptone dextrose (YPD) medium purchased from 
Fisher Scientific, or synthetic complete yeast nitrogen base (YNB) medium made as described 
previously, but containing 2% glucose and 75 µM inositol (93).  
Construction of strains. The S. cerevisiae WT strain BY4742 was purchased from Open 
Biosystems (Thermo Scientific, Huntsville, AL, USA). The deletion strains were constructed using 
standard homologous recombination techniques (121). Drug resistant markers, hphMX, KanMX, 
natMX, and ble were amplified from plasmids pAG32, pUG6, pAG25, and pUG66, respectively, 
using the primers listed in Table 2, and the resulting DNA fragments were inserted in place of the 
genes targeted for deletion. The plasmids were received from Euroscarf (167,168). For deletion of 
YPK1 in the crz1∆ strain, the URA3 cassette was amplified from plasmid pPMY-3xHA (169), and 
the resulting DNA fragment was used to disrupt YPK1.  
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Table 4.1 S. cerevisiae strains used in this study (Chapter 4) 
Strain Genotype Source 
JPV 399 WT, BY4742 BY4742; MATα his3∆1 leu2∆0 lys2∆0  ura3∆0 Research 
Genetics  
JPV 636 ypk1∆ BY4742; ypk1∆::KanMX Research 
Genetics  
JPV 668 plb1∆ BY4742; plb1∆::hph  This study 
JPV 766 ypk1∆plb1∆ BY4742; ypk1∆::KanMX plb1∆::hph  This study 
JPV 744 WT PLB1-I-3xHA BY4742; PLB1-I-3xHA This study 
JPV 745 ypk1∆ PLB1-I-3xHA BY4742; ypk1::KanMX PLB1-I-3xHA This study 
JPV 671 crz1∆ BY4742; crz1∆::KanMX Research 
Genetics  
JPV 782 crz1∆ypk1∆ BY4742; crz1∆::KanMX ypk1∆::URA3 This study 
JPV 680 plb123∆nte1∆ BY4742;  plb1∆::hph plb2∆::KanMX plb3∆::nat 
nte1∆::ble    
This study 
YPH 499  WT, YPH499 MATa ade2-101och his3∆200 leu2∆1 lys2-801am trp1∆1  
ura3-52  
(147) 
YES 3 ypk1∆ YPH499; ypk1-∆1::HIS3  (147) 
YES 1 ykr2∆ YPH499; ykr2-∆1::TRP1  (147) 
YPT 40 ypk1tsykr2∆ YPH499; ypk1-1ts::HIS3 ykr2-∆1::TRP1  (147) 
JPV 772 plb1∆ YPH499; plb1∆::hph   This study 
JPV 773 ypk1∆plb1∆ YPH499; ypk1-∆1::HIS3 plb1∆::hph   This study 
JPV 774 ypk1tsykr2∆plb1∆ YPH499; ypk1-1ts::HIS3 ykr2-∆1::TRP1 plb1∆::hph  This study 
YFR 276 ypk1tsykr2∆orm1∆ YPH499; ypk1-1ts::HIS3 ykr2-∆1::TRP1 orm1∆::hphNT1  (143) 
YFR 279 ypk1tsykr2∆orm2∆ YPH499; ypk1-1ts::HIS3 ykr2-∆1::TRP1 orm2∆::URA3 (143) 
YFR 283 ypk1tsykr2∆orm1∆orm2∆ YPH499; ypk1-1ts::HIS3 ykr2-∆1::TRP1 orm1∆::hphNT1 
orm2∆::URA3 
(143) 
RH 406 WT MATα leu2 trp1 ura3 bar1 (170)  
RH 3804 lcb1-100 MATα  leu2 trp1 ura3 bar1 lcb1-100ts (170)  
 
Table 4.2 Nucleotide sequences of primers used for gene deletions in this study (Chapter 4) 
Gene Name Primer Sequence 5' - 3' 
PLB1 Forward CAAAACCATGAAGTTGCAGAGTTTGTTGGTTTCTGCTGCAGTTTTGACTTCTC
TAACCAGCTGAAGCTTCGTACGC 
PLB1 Reverse AGAGCCTAAATTAGACCGAAGACGGCACTAATGACACTTAAGACACCA 
ATAAAAGGCATAGGCCACTAGTGGATCTG  
CRZ1 Forward CCATCACAGCAGTTTAGTACGATTATACACTCTGAACGCGAGTAAAACTAGG
TTGTATTTCAGCTGAAGCTTCGTACGC  
CRZ1 Reverse TACAAGGGAGTGATGCATCTTCTACCACTTTCAGTTTTAAAATGCCTACCAA
GAGCAGCATAGGCCACTAGTGGATCTG  
YPK1 Forward AGTTCCTCTCATATCAACAAACATTAATACAGTTCCTGAAAATGTATTCTTGG
AAGTCAAAGCGAACAAAAGCTGG 
YPK1 Reverse ATGTATTCACTAAGTCTATCTAATGCTTCTACCTTGCACCATTGAGCTACCTA
GCTGTTCCTGTAGGGCGAATTGGG 
PLB1-I-
3xHA 
Forward CTAACAGAGAACGTTAACGCTTGGTCACCAAATAACAGTTACGTC 
AGGGAACAAAAGCTGG 
PLB1-I-
3xHA 
Reverse TTCTCTGACTAAGTTAATATCATCATCACAGGTTACGTTCGCAGGCTGTAGG
GCGAATTGGG  
Bolded sequences are homologous to the template plasmids.  
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 [14C]-Choline labelling and preparation of external, internal, and membrane fractions. 
Cells were grown to uniform labeling in YNB medium containing 20 µM choline and 1 µCi/mL 
[14C]-Choline Chloride of negligible concentration (Perkin Elmer, NEC141VU250UC or 
American Radiolabelled Chemical, ARC 0208). Cells were harvested in log phase, washed free of 
excess label, and re-inoculated at OD600 = 0.2 into YNB medium containing 10 mM nonradioactive 
choline. At various time points, 1 mL aliquots of the chase cultures were removed and separated 
into external, internal, and membrane fractions (93,171).  In brief, cells were pelleted by 
centrifugation and the supernatant was removed and retained as the extracellular fraction. The cell 
pellet was resuspended in 0.5 mL of 5% trichloroacetic acid (TCA) followed by a 20 minute 
incubation on ice. Cells were pelleted again by centrifugation and the supernatant was removed as 
the intracellular (soluble) fraction. The pellet was then resuspended in 0.5 mL of 1 M Tris (pH = 
8), centrifuged, and the supernatant was added to the intracellular fraction. The final cell pellet 
was resuspended in 0.5 mL of 1 M Tris (pH = 8) and saved as the membrane fraction. Total counts 
(external + internal + membrane) recovered at each time point as well as the percentages of counts 
in each fraction were tracked by liquid scintillation counting (LSC). 
Analysis of choline-containing metabolites. The water soluble choline containing 
metabolites were separated by anion exchange chromatography (172). Internal and external 
samples were diluted 5-fold in deionized H2O, applied to a 250 µL Dowex 50Wx8 200 – 400 anion 
exchange column, and eluted as described previously (172). [14C]-GroPCho was eluted with a 1 
mL and 2 mL H2O wash. If present, [
14C]-choline phosphate was eluted with a subsequent 3 mL 
H2O wash. [
14C]-choline was eluted with 5 mL of HCl. Standards were used to verify the separation 
procedure, and label incorporated into each metabolite was quantified by LSC. To confirm results 
by independent methods, [14C]-choline containing metabolites from selected samples were 
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separated by TLC using previously published methods (173) and/or by HPLC with an in-line 
radioactive detector (65,66). For TLC, samples were dried down, resuspended in 1:1 
methanol:H2O, were spotted on Silica plates, and metabolites separated with a mobile phase of 
CH3OH:0.6% NaCl:NH4OH (50/50/5, v/v/v).  
Phospholipids from the membrane fraction were extracted as described previously (174). 
The membrane pellet was resuspended in 1 mL of ESOAK (95% ethanol: diethylether: H2O: 
pyridine: NH4OH, 15:5:15:1:0.036) and incubated at 60ºC for one hour. The suspension was 
centrifuged and the lipid containing supernatant was extracted with 2.5 mL of 
choloroform:methanol (2:1). Low speed centrifugation separated the layers and the bottom layer 
containing the glycerophospholipids was dried under N2 and the residue was resuspended in 
choloroform:methanol (2:1). Radiolabelled PC and LysoPC were resolved by TLC on Silica Gel 
60A (Whatman) plates in chloroform: ethanol: H2O: triethylamine (30/35/7/35, v/v/v/v) mobile 
phase (171,175).  
Analysis of PC synthesis rate. Strains were grown to log phase (OD600 = 0.5) in YNB 75 
µM inositol medium, harvested by centrifugation, and concentrated to equivalent densities in fresh 
YNB containing 75 µM inositol and 100 µM choline. To start the assay, 50 µL of 0.005 mCi/mL 
[C14]-choline chloride was added and cells were allowed to incubate for 30 minutes at 37°C. The 
cells were pelleted by centrifugation, washed with water, and suspended in 0.5 mL of 5% TCA for 
10 minutes. After pelleting, the supernatant was discarded and the membrane pellet was washed 
with water. Lipids were extracted from the remaining pellet as described above. Incorporation of 
[C14]-choline chloride into PC was quantified by LSC and verified by TLC.  
LC-MS analysis of extracellular choline and GroPCho. Cells were grown in YNB medium 
containing 75 μM inositol, 20 μM choline, and 2 mM KH2PO4 instead of 7 mM KH2PO4. The cells 
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were pelleted by centrifugation at 1,600 x g for 3 minutes and the supernatant containing the 
extracellular metabolites was filtered through 0.2 µM cellulose acetate filters. The method of 
analysis for these extracellular metabolites by mass spectrometry was described previously 
(104,176).  A 250 µL aliquot of supernatant was spiked with an internal standard (choline-d9) and 
water soluble lipid metabolites were extracted by addition of 2.25 mL of cholorform:methanol 
(2:1, v/v). The suspension was agitated with a Vortex mixer followed by centrifugation for 3 
minutes at 1,600 x g. The upper aqueous phase was dried under N2 and resuspended in 125 μL of 
acetonitrile:methanol (75:25, v/v) with 10 mM ammonium acetate, pH 4.5. After centrifugation at 
16,000 x g for 10 minutes, an aliquot of the supernatant was transferred to a LC vial and diluted 
20-fold in acetonitrile:methanol (75:25, v/v). A 10 µL volume was injected into the Agilent 1200 
series Rapid Resolution LC system coupled to an Agilent 6440 Triple Quadrupole Mass 
Spectrometer. Separations were performed on a Waters Xbridge HILIC (150×4.6 mm, 5 μm) 
column with an isocratic elution at a flow rate of 0.5 mL/min at room temperature. The mobile 
phase was acetonitrile/water (70:30 v/v) with 10 mM ammonium acetate.  Electrospray mass 
spectrometry (ESI-MS) was performed with the scan mode set to multiple reaction monitoring 
(MRM) targeting GroPCho (258.0 104.0), choline (104.1  60.1), and choline-d9 (113.1  
69.1) in fast switch ionization mode. The MS parameters were set as previously optimized: 10eV 
collision energy, 3.5 kV capillary voltage, 50 V fragmentor voltage, 200 ms dwell time, 300ºC 
drying gas temperature, and 325ºC sheath gas temperature. Sheath gas flow and drying gas flow 
rates were 10 and 8 L/min respectively. Each sample was run in duplicate. Data were acquired and 
analyzed using MassHunter Work Station software. The peak areas of the target metabolites were 
normalized to the internal standard and to the density of cells (OD600) from which metabolites were 
extracted.  
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RNA Extraction and real time qRT-PCR gene expression analysis. Cultures were grown in 
YNB medium containing 75 µM inositol under the conditions specified in the text. RNA was 
extracted using a hot phenol-chloroform extraction (99). A 7 µg sample of RNA was DNase treated 
with 2 units of DNase at 37ºC for 30 minutes using the TURBO DNA-free™ Kit (Applied 
Biosystems) per the manufacturer’s specifications. Message abundance was quantified by 
quantitative reverse transcriptase PCR (qRT-PCR) using the Verso™ SYBR® Green 1-Step QRT-
PCR ROX Kit (Thermo Scientific) on the Applied Biosystems StepOnePlus Real Time PCR 
System. The primers used are shown in Table 4.3. Standard curves for each primer pair were 
optimized to determine acceptable primer concentrations (70-100 nM) and template concentrations 
(15-25 ng/25 µL reaction). Reverse transcription was carried out at 50C for 15 minutes followed 
by 95C for 15 minutes for RT inactivation and polymerase activation. Amplification parameters 
were 40 cycles at 95C 15s, 54.5C 30s, and 72C 40s. Primer specificity was verified by melt 
curve analysis and visualization of amplicons by gel electrophoresis. Primer sets did not produce 
amplicons when RNA from the respective deletion strains was used as template. No template 
control (NTC) and minus reverse transcriptase (-RT) reactions were performed to verify the 
absence of genomic DNA contamination in the RNA samples and/or the reagents. RNA from at 
least three independent cultures of all strains was analyzed in triplicate reactions per primer set. 
Data were normalized to the endogenous control gene, SNR17, and analyzed using the comparative 
∆∆CT approach (100,101).  
Table 4.3 Nucleotide sequences of primers used for qRT-PCR 
Gene Name Primer Sequence 5' - 3' 
SNR17 Forward TTG ACT CTT CAA AAG AGC CAC TGA  
SNR17 Reverse CGG TTT CTC ACT CTG GGG TAC 
PLB1 Forward GCA TAC ACC AAG GAG GCT TTG  
PLB1 Reverse GAG TGG ATA GCA AGG AAG TGT CAC 
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Construction of the chromosomal PLB1-I-3xHA allele.  The plasmid pPMY-3xHA (169), 
kindly provided by Nancy Hollingsworth (Stony Brook University), was used as the template to 
amplify a 3xHA-URA3 module for insertion into the genome between amino acids 30 and 31 of 
Plb1. Because Plb1 is predicted to be GPI anchored to the plasma membrane, insertion at this point 
would avoid cleavage of the HA tag from either end since both the N-terminal localization signal 
and C-terminal GPI anchor attachment site are cleaved during processing and GPI anchor 
attachment. Insertion did not interfere with the predicted catalytic site for Plb1. The primers used 
to amplify the 3xHA-URA3 module are listed in Table 4.2. The PCR product was transformed into 
WT and ypk1∆ strains and transformants were selected on YNB plates lacking uracil.  To verify 
integration at the correct location DNA was extracted and used as template with two sets of 
primers. Verified transformants were grown in YPD liquid medium to allow for recombination 
and loss of the URA3 marker. Cells that had lost the URA3 marker were selected on YNB plates 
containing 5-FOA. DNA was extracted from the 5-FOA resistant colonies and used as a template 
for PCR. Strains producing the expected amplicon size, indicating insertion of the 3xHA and loss 
of the URA3, were named JPV 767 (WT + PLB1-I-3xHA) and JPV 745 (ypk1∆+ PLB1-I-3xHA). 
These strains therefore contain DNA encoding an internal 3xHA tag between nucleotides 90 and 
91 of PLB1 in their genomic DNA. The function of Plb1 containing the 3xHA tag was verified by 
observing the expected Plb1 activity in PC turnover/GroPCho production experiments.  
Protein extraction and sucrose gradient separation. For total protein extraction from cell 
lysates, cultures were grown in YNB+75 µM inositol medium to log phase (OD600 ≈ 0.7). Cells 
were collected by centrifugation of a 125 mL culture and the supernatant was removed for 
evaluation of secreted protein. The supernatant was concentrated 100-fold using an Amicon Ultra 
30K centrifugal filter (Millipore). The cell pellet was resuspended in 200 µL SUME protein lysis 
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buffer (1% SDS, 8 M urea, 10 mM MOPS, 10 mM EDTA, 1 mM AEBSF, 1X Yeast/Fungal 
Protease Arrest™ G-biosciences 786-333), and lysed with glass beads by eight 1-minute alternate 
cycles of agitation on a Vortex mixer and incubation on ice. Centrifugation at 2000 x g for 5 
minutes removed unbroken cells and debris. Protein concentration in the concentrated supernatant 
and the cell lysate was determined by Bradford assay kit (Thermo Fisher).  
Sucrose gradient separation was performed as described (177,178). A 100 mL culture was 
grown to log phase and 2 mL of 0.5 M NaN3 was added at time of harvest. The cells were collected 
by centrifugation and broken by glass bead lysis in a 10mM Tris-HCl, pH 7.5, 1mM EDTA, 10% 
sucrose solution. Cell lysates were cleared of debris by low speed centrifugation and the resulting 
lysate was layered onto an 11 mL gradient of 30-70% sucrose in the lysis buffer. The gradient was 
centrifuged at 100,000 x g in a Beckman SW41 rotor for 18 hours at 4ºC. One mL fractions were 
collected from the top of the gradient by pipetting. Proteins of interest were analyzed by SDS-
PAGE and Western blot analysis.  
Western blot analysis. Total protein extracts were analyzed by SDS-PAGE and Western 
blotting. Equal amount of protein was loaded onto NuPAGE Bis-Tris gels (Invitrogen, IM-8042) 
and transferred to a nitrocellulose membrane using the XCell Blot Module (Invitrogen). 
Membranes were incubated in blocking buffer (phosphate buffered saline (PBS) containing 5% 
casein in 0.1M NaOH, 5% BSA, phenol red, and NaN3) for 30 minutes at room temperature. 
Primary antibody against HA-Plb1 (monoclonal antibody HA-11, Covance catalog number MMS-
101P) was added to the solution at a 1:10,000 dilution and incubated overnight at 4ºC.  Primary 
antibody was removed and the membrane was washed in PBS. The membrane was incubated in 
blocking buffer, without NaN3, containing a 1:125,000 dilution of secondary antibody (HRP-
labeled affinity–purified antibody to mouse IgG (H+L), KPL catalog number 074-1806) for 1 hour 
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at room temperature. The membrane was washed in PBS and incubated with SuperSignal West 
Femto extended duration substrate reagent (Peirce, #34095) before exposure on either a Kodak 
440CF Image Station or exposure to Kodak Biomax MR Film for visualization.   
Sucrose gradient fractions were analyzed by SDS-PAGE and Western blot analysis as 
described for total protein extracts, but equal volumes of each fraction were run on the SDS-PAGE 
gel instead of equal amounts of protein. Membranes were probed with primary antibodies against 
HA-Plb1, Sec61 (1:1,000), and Pma1 (1:4,000).  Anti-Pma1 was provided by Dr. Carolyn 
Slayman, Yale University, and anti-Sec61 was obtained as described (179). The blots were then 
incubated with the appropriate secondary antibody, HRP-conjugated anti-rabbit or HRP-
conjugated anti-mouse. For quantification of Western blots, densitometry was carried out using 
the Kodak 1D software.  
Statistical Analysis. GraphPad Prism was used for statistical analysis by Student’s t – test or 
ANOVA as indicated.  
4.3 Results 
4.3.1 Plb1 mediated extracellular GroPCho production increases upon loss of YPK1.  
Plb1 deacylates phosphatidylcholine to produce free fatty acids and extracellular 
glycerophosphocholine (GroPCho) (69) (Figure 4-2 C).  To better define the link between Ypk1 
and Plb1 activity, turnover of phosphatidylcholine (PC) and the concomitant production of the 
GroPCho were examined. Cells grown to uniform labeling with C14-choline chloride were washed 
free of label and re-inoculated into fresh medium containing 10 mM choline at 37°C. The chase 
was performed at elevated temperature to maximize turnover, since the Ypk1 pathway is activated 
by heat stress (11,142) and because PLB1 expression is upregulated by elevated temperature (see  
Figure 4-5a). These experiments were performed in both the BY4742 and YPH499 backgrounds 
because of slight differences in phenotypes observed in ypk1∆plb1∆ double mutants constructed 
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in the two backgrounds, as described below.  At the indicated times, cells were harvested, the 
percentages of the total radioactivity in the extracellular, intracellular, and membrane fractions 
were determined, and the metabolites produced were identified. Radioactivity in the extracellular 
fraction, which is used to monitor in vivo Plb1 activity, consisted of C14-GroPCho and free C14-
choline. As shown in Figure 4-2, deletion of YPK1 resulted in increased production of extracellular 
GroPCho that is ameliorated by deletion of PLB1. This held true for both strain backgrounds, 
although the magnitude of the change varied from nearly 3-fold for YPH499 to roughly 5-fold for 
BY4742. The rest of the counts at each time point were in either the membrane or the intracellular 
fraction (Table 4.4).  
Examination of the intracellular fractions revealed there is a decrease in internal GroPCho 
production in both the ypk1∆ and the ypk1∆plb1∆ strains (Table 4.4). Internal GroPCho production 
occurs primarily through Nte1 mediated turnover (103), suggesting that there may be a trade-off 
between Nte1 and Plb1 activity upon loss of Ypk1. Loss of Ypk1 also appears to cause increased 
extracellular choline. The phospholipase D (PLD) that hydrolyzes PC into free choline and 
phosphatidic acid (180), Spo14, could be responsible for the increase. Although quantitative 
differences in the levels of choline metabolites were observed as a function of strain background, 
the general trends were consistent. Also, deletion of YKR2, the paralog of YPK1, did not affect 
GroPCho production (Figure 4-2 B).  
To confirm the results obtained through radiolabeling, and to obtain a more complete 
picture of the extracellular choline metabolites produced, we performed tandem mass spectrometry 
(LC-MS/MS). Through radiolabeling, we were able to monitor the turnover of Kennedy pathway-
derived PC synthesized during the labeling period. Through MS, we could monitor all GroPCho 
produced during the experiment through both the PE methylation pathway and through the 
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Kennedy pathway (9). Importantly, the MS data confirmed that GroPCho production rose upon 
deletion of YPK1, and that Plb1 plays a major role in mediating the increase (Figure 4-2 C). Using 
MS, we also detected a decrease in extracellular GroPCho production by plb1∆ yeast as compared 
to WT cells that was not apparent through pulse-chase radiolabelling. As indicated by both the MS 
data and the radiolabeling data, Plb1 cannot be the only phospholipase responsible for extracellular 
GroPCho production, as strains lacking Plb1 still produce GroPCho.  In fact, a strain in which all 
of the known PLBs are deleted, plb123∆ nte1∆ exhibits greatly reduced, but not completely 
eliminated GroPCho production (Figure 4-2 C), suggesting that one or more deacylating 
phospholipases have yet to be identified. 
4.3.2 Turnover of another glycerophospholipid, phosphatidylinositol, is unaffected by 
deletion of YPK1.  
In a WT strain, GroPIns produced through the Plb3-mediated deacylation of PI is the major 
phospholipid metabolite found in growth medium (45). To monitor this metabolite, WT and ypk1∆ 
cells grown to uniform labeling with [H3]-inositol were chased with non-radiolabelled inositol, 
similar to the conditions used in the C14choline labeling experiments above. However, we observed 
no significant difference between WT and ypk1∆ strains in the rate of PI turnover or in the 
percentage of water soluble inositol-containing counts found in extracellular (WT 31% ± 1 and 
ypk1 25% ± 2) or intracellular (WT 22% ± 1 and ypk1 26% ± 3) fractions following a 5-hour 
chase.  
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Figure 4-2. Plb1-mediated extracellular GroPCho production is increased upon deletion of 
YPK1.  
A and B, Strains in the BY4742 (A) and YPH499 (B) backgrounds were pre-grown at 30⁰C in YNB medium 
containing 0.2 Ci/mL [14C]-Choline chloride, followed by a chase at 37⁰C in YNB medium containing 10 
mM choline. Extracellular, intracellular, and membrane fractions were isolated, and [14C]-choline-
containing metabolites from extracellular fractions were separated by anion exchange column 
chromatography. Values are the means ± S.E. of triplicate cultures and are representative of multiple 
experiments. One-way ANOVA was performed indicating a significant difference between GroPCho 
produced in the ypk1∆ strain compared to GroPCho produced by each of the other strains listed (A, p ≤ 
0.011; B, p ≤ 0.015). C, Cells grown to log phase were harvested and the extracellular medium analyzed 
for GroPCho by LC-MS. Relative abundance is normalized to OD600 and to the internal standard. Values 
are the means ± S.E. of at least two independent cultures.  D, Plb1 mediated deacylation of PC to GroPCho. 
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Table 4.4 Cell Associated Counts from Figure 4.1 
A. Cell Associated Counts in BY4742 (% of total counts) 
Strain 
Time, 
hours 
Internal 
Choline 
Internal 
GroPCho 
Membrane 
PC 
Total  
Counts 
WT                   
0 2 ± 0 34 ± 1 58 ± 3 94 
4 2 ± 0 81  ± 1 10 ± 0 93 
plb1∆ 
0 1  ± 0 38 ± 1 61 ± 3 99 
4 1  ± 0 76  ± 1 15 ± 1 92 
ypk1∆ 
0 1  ± 0 31 ± 1 66 ± 3 98 
4 1  ± 0 50 ± 4 18 ± 2 69 
ypk1∆ plb1∆ 
0 1 ± 0 35 ± 3 57 ± 4 92 
4 1 ± 0 55  ± 3 24 ± 1 80 
 
B. Cell Associated Counts in YPH499 (% of total counts) 
Strain 
Time, 
hours 
Internal 
Choline 
Internal 
GroPCho 
Membrane 
PC 
Total  
Counts 
WT                   
0 0 ± 0.2 7 ± 1 90 ± 1 97 
4 2 ± 0.4 14 ± 2 62 ± 2 82 
plb1∆ 
0 2 ± 1 13 ± 1 82 ± 1 97 
4 1 ± 0.1 9 ± 4 63 ± 1 82 
ypk1∆ 
0 2 ± 1 11 ± 1 84 ± 1 97 
4 2 ± 0.2 10 ± 2 53 ± 7 69 
ypk1∆ plb1∆ 
0 3 ± 1 15 ± 2 80 ± 3 98 
4 3 ± 0.5 8 ± 2 68 ± 3 70 
* Values for the internal and membrane metabolites are derived  
from the experiments described in Figs. 1A and 1B. 
 
4.3.3 PC Synthesis via the Kennedy pathway is unaffected by loss of YPK1.  
Since an increased rate of PC deacylation and GroPCho production was observed upon loss 
of Ypk1, we next tested if the rate of PC synthesis was affected. The logic underlying this 
experiment was that Cki1 (choline kinase) and Pct1 (cholinephosphate cytidylyltransferase), both 
of which are involved in PC synthesis by the Kennedy pathway, contain potential consensus Ypk1 
phosphorylation sites [R-x-R-x-x-S/T-ϕ where ϕ is a preference for hydrophobic amino acids 
(150)]. To detect changes in synthesis rate via the Kennedy pathway, we measured the 
incorporation of [C14]-choline into PC following a 30 minute pulse, but no difference was found 
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between WT and ypk1∆ yeast (Figure 4-3). This result also suggests that choline uptake was not 
significantly affected by loss of Ypk1. 
 
Figure 4-3. Synthesis of PC is not altered upon loss of Ypk1.  
WT and ypk1∆ strains in the BY4742 background were grown to log phase, harvested, and resuspended to 
equal densities in YNB medium. [C14]-choline was added and the amount of incorporation into PC after 30 
minutes was determined. Values are the means ± S.E. of three independent cultures assayed in duplicate. 
Similar results were observed in the YPH499 background (data not shown). 
 
In contrast, the Plb1 sequence lacks the Ypk1 consensus phosphorylation site. Furthermore, 
Plb1 was shown to have a low likelihood value for phosphorylation by Ypk1 in a large-scale 
peptide screen for kinase activity (181). Similarly, the Plb1 sequence does not contain the Fpk1 
phosphoacceptor site, RxSLD(x)15-21RxSLxD (142). Thus, direct regulation of Plb1 through 
phosphorylation by Ypk1 or its downstream kinase, Fpk1, is unlikely. In addition, a strain bearing 
deletion in FPK1 did not significantly alter GroPCho production. The percentages of total [C14]-
choline label incorporated into external GroPCho in the fpk1 and WT strains following an eight 
hour chase, were 8 ± 1% and 5 ± 1%, respectively. Together, these data strongly suggest that Fpk1 
is not involved in the regulation of Plb1 by Ypk1. 
4.3.4 The secreted and cell associated forms of Plb1 increase in a ypk1∆ strain.   
Plb1 activity has been reported in plasma membrane fractions, in the periplasm, and in the culture 
supernatant (45,69). However, localization data were absent in large-scale analyses using fluorescent tags 
fused to the C-termini of yeast ORFs expressed under control of their endogenous promoters (71-75), and 
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in a study utilizing C-terminal fusions to an epitope tag with the target genes expressed under control of the 
GAL promoter (76). In addition, a localization screen of proteins involved in lipid metabolism in which 
Plb1 was C-terminally tagged and expressed under the control of the TEF promoter, demonstrated ER and 
vesicle localization, but plasma membrane localization was not apparent; the medium/secreted fraction was 
not analyzed in this study (77). Complicating the question of Plb1 localization is that it has a predicted GPI-
anchor, which should lead to plasma membrane residence (78,182).  During processing, GPI-anchored 
proteins are cleaved just after the anchor attachment site, which removes the C-terminus (22). Therefore, if 
Plb1 were GPI-anchored, C-terminal tagging—as used in several of the studies cited above—would be 
unable to detect the final processed protein.  
To establish the localization of Plb1, and to have a reliable epitope-tagged Plb1 for Western 
analysis, we constructed a WT and ypk1∆ strain in which HA was inserted into the genomic copy 
of PLB1 near the N-terminal end, after the signal sequence, but before the catalytic site. This PLB1-
I-3xHA construct was judged functional by confirming that ypk1∆ containing PLB1-I-3xHA 
displayed elevated GroPCho production indistinguishable from the ypk1∆ strain (see 
“Experimental Procedures”; data not shown). Consistent with increased GroPCho production, 
ypk1∆ containing the PLB1-I-3xHA allele displayed greater Plb1 abundance in total cell lysates 
and in the medium as compared to the WT strain ( Figure 4-4 A and B). To examine intracellular 
localization, we performed sucrose gradient fractionation using lysates from WT strains that 
contained the integrated, functional PLB1-I-3xHA gene. Interestingly, we found Plb1 associated 
with the ER (as indicated by co-migration with Sec61), as expected for a protein trafficking 
through the secretory pathway, but the protein was absent from plasma membrane fractions, as 
indicated by the migration of Pma1 (Figure 4-4C). These results, which are consistent with fluorescence 
microscopy of C-terminally tagged Plb1 under the control of the TEF promoter (77), lead us to conclude 
that the protein is not plasma membrane associated, and that if it is GPI-anchored, it is efficiently released 
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from the plasma membranes under the conditions used here. We suspect that the cell surface-associated 
Plb1 activity that releases GroPCho into the medium is due to its periplasmic localization.  
 
 Figure 4-4. Plb1 protein abundance and localization.  
A, WT and ypk1∆ yeast containing the PLB1-I-3xHA allele were grown in YNB medium at 30⁰C to log 
phase. The supernatant was concentrated 100-fold, and total protein was extracted from the cells. Western 
blot was performed on both fractions using an anti-HA-Plb1 primary antibody and HRP-conjugated anti-
mouse secondary. GAPDH was used as a loading control for the lysate fractions. B, Amount of Plb1 protein 
was quantified by densitometry of western blots and normalized to the culture density (OD600) and sample 
volume. Values represent the fraction of total Plb1 protein in the WT strain. C, WT yeast containing PLB1-
I-3xHA were grown in YNB medium, lysed, and subjected to sucrose gradient centrifugation. The gradient 
was fractionated and the migration of Plb1 and the indicated marker proteins, Pma1 (plasma membrane) 
and Sec61 (ER), were determined by SDS-PAGE and Western blot analysis. Fraction number 1 on the left 
represents the top of the gradient. 
 
Although Plb1 is predicted to be 72 kDa, the species found in the lysate migrates at about 
145 kDa. While the 145 kDa band is the most abundant band in the medium, a less abundant, 
diffuse band around 260 kDa is also present.  Plb1 is known to be N-glycosylated (183,184), and 
multiple glycosylated forms of secreted phospholipase B have been detected previously 
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(69,185,186). Upon treatment with Endo Hf, the protein migrates as one band at approximately 72 
kDa (data not shown).   
4.3.5 Compromised sphingolipid synthesis upregulates PLB1 expression and increases PC 
turnover.  
Consistent with the observed increases in PC deacylation and Plb1 abundance (Figure 4-2 
and Figure 4-4), PLB1 transcript levels also increased upon loss of YPK1 at both 30°C and after a 
37°C temperature shift (Figure 4-5 A). In both WT and ypk1∆ yeast, a shift to 37°C increased PLB1 
message levels. The ypk1∆ strain in the YPH499 background displayed a similar trend (data not 
shown).  
The major role for Ypk1 described in the literature is the regulation of sphingolipid 
homeostasis (143). If the mechanism by which loss of Ypk1 upregulates Plb1 expression involves 
compromised sphingolipid synthesis, we would expect reduction of sphingolipid synthesis by 
other means to have a similar effect on Plb1 expression. Indeed, PLB1 expression was elevated in 
a WT strain treated with either myriocin or aureobasidin (Figure 4-5 B and C), which inhibit SPT 
and inositolphosphoceramide (IPC) synthase, respectively (187,188) (Figure 4-5 D). We also 
monitored PC turnover in WT cells treated with myriocin, and saw the expected increase in 
external GroPCho production (Figure 4-5E). Similar trends were observed in a YPH499 strain 
background.  Sphingolipid synthesis can also be diminished genetically through the use of the 
lcb1-100 strain, which harbors temperature-sensitive SPT activity (170). As anticipated, the lcb1-
100 strain shifted to the restrictive temperature also exhibited increased PLB1 expression as 
compared to WT (Figure 4-5F).  
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Figure 4-5. PLB1 message levels are elevated by heat stress and upon disruption of 
sphingolipid homeostasis.  
A, Strains in the BY4742 background were grown to early log phase in YNB medium at 30°C. Cultures 
were split and incubated at 30⁰C or 37⁰C, as indicated, for 3 hours. B, Cells were grown in YNB medium 
at 30°C to an OD600 ≈ 0.7, myriocin (dissolved in methanol) was added to a final concentration of 1 µg/mL, 
and cultures were incubated for 2 hours at 30°C. C, Cells were grown in YNB medium at 30°C to an OD600 
≈ 0.4, aureobasidin (dissolved in methanol) was added to a final concentration of 1 µg/mL and the cells 
were incubated for 3 hours at 30°C.  A-C, At harvest, total RNA was extracted and PLB1 transcript levels 
were analyzed by real-time qRT-PCR using the comparative CT method. Data were normalized to the 
amount of the endogenous control mRNA, SNR17, and expressed relative to the value in WT control cells. 
Values represent the means ± S.E. of at least 3 independent cultures assayed in triplicate. D, Simplified 
schematic of sphingolipid synthesis in S. cerevisiae including targets of inhibiting drugs. E, WT cells in the 
BY4742 background were pre-grown at 30⁰C in YNB medium containing 0.2 Ci/mL [14C]-Choline 
C.A. B.
D.
F.
E.
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chloride, followed by a chase at 30⁰C in YNB medium containing 10 mM choline and 1 g/mL myriocin 
in methanol or an equivalent volume of methanol. Extracellular, intracellular, and membrane fractions were 
isolated, and [14C]-choline containing metabolites from extracellular fractions after 3 hours were separated 
by anion exchange chromatography. Values are the means ± S.E. of at least duplicate cultures and are 
representative of multiple experiments. Similar trends were observed in the YPH499 background (data not 
shown). F, The lcb1-100 and WT strains were grown in YNB medium at room temperature (25°C) to an 
OD600 ≈ 0.4, then shifted to the restrictive temperature, 37°C, for 90 minutes. RNA was extracted and 
analyzed as in A-C. Student’s t-test was performed for statistical analysis (B, p = 0.05; C, p = 0.008; F, p 
= 0.0006). 
 
4.3.6 Crz1 mediates PLB1 upregulation either when sphingolipid biosynthesis is 
compromised or when Ypk1 is absent.  
A recent microarray study showed that many of the up/down regulated genes — including 
PLB1 — identified in a ypk1∆ykr2∆ strain bearing an analogue inactivated allele of YPK1 (YPK1as) 
contain binding sites for the Crz1 transcription factor (151,152).  Thus, we examined the role of 
Crz1 in mediating PLB1 expression in response to altered sphingolipid biosynthesis or when YPK1 
is deleted. A ypk1∆ mutant exhibited increased PLB1 message levels as compared to WT yeast, 
while PLB1 message levels were unchanged in a ypk1∆crz1∆double mutant (Figure 4-6 A). In 
addition, upregulation of PLB1 expression in response to myriocin treatment (Figure 4-5 B) 
observed in a WT strain did not occur in the crz1 strain (Figure 4-6 B). This data indicates that 
Crz1 is required for the upregulation of PLB1 expression that occurs upon loss of Ypk1.  
4.3.7 Ameliorating disrupted sphingolipid synthesis by deletion of ORM1 and ORM2 in a 
ypk1∆ strain partially rescues PLB1 expression to WT levels.  
A primary mechanism by which Ypk1 regulates sphingolipid synthesis is through 
phosphorylation of Orm1 and Orm2 (13,189). Orm1 and Orm2 are ER transmembrane proteins 
that regulate sphingolipid biosynthesis by binding to and inhibiting SPT (13,158). Upon 
phosphorylation by Ypk1, the interaction between Orm1/2 and SPT is lessened, and sphingolipid 
biosynthesis is upregulated. Thus, if Ypk1 regulates Plb1 via an Orm1/2 dependent effect on 
sphingolipid synthesis, we would expect PLB1 expression to mirror WT levels in a 
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ypk1tsykr2∆orm1∆orm2∆ strain grown at the restrictive temperature. In fact, we found that deletion 
of ORM1/2 only partially reduced PLB1 expression compared to the ypk1tsykr2∆ strain (Figure 
4-7). These results suggest that Ypk1 regulates sphingolipid synthesis via a mechanism that is 
partially independent of Orm1/2 phosphorylation.  
           
Figure 4-6. Crz1 mediates PLB1 upregulation either when sphingolipid biosynthesis is 
compromised or when Ypk1 is absent.  
A, Strains (BY4742) were grown in YNB medium at 30°C to an OD600 ≈ 0.7 (log phase). An aliquot was 
diluted to an OD600 ≈ 0.2 and grown for 3 hours at 37°C. B, WT and crz1 strains were grown in YNB 
medium at 30°C to an OD600 ≈ 0.7, myriocin (dissolved in methanol) was added to a final concentration of 
1ug/mL, and incubated for 3.5 hours at 30°C. A and B, RNA was extracted and PLB1 message levels were 
analyzed by qRT-PCR using the comparative CT method. Data were normalized to the amount of the 
endogenous control mRNA, SNR17, and expressed relative to the value in WT cells grown at 30ºC (A) and 
WT cells grown with vehicle, methanol (B). Values represent the means ± S.E. of 3 independent cultures 
assayed in triplicate. Student’s t-test was performed for statistical analysis, p ≤ 0.0001. 
 
 
Figure 4-7. Deletion of ORM1 and ORM2 in a ypk1 strain partially reduces PLB1 
expression.  Cells were grown in YNB medium at 30ºC to early log phase followed by a shift to 35ºC 
for 1.5 hours. Total RNA was extracted and PLB1 transcript levels were analyzed by real time qRT-PCR 
using the comparative ∆∆CT method. Data were normalized to the amount of the endogenous control 
mRNA, SNR17, and expressed relative to the value in WT cells. Values represent the means ± S.E. of 3 
independent cultures assayed in triplicate. Student’s t-test was performed for statistical analysis, p ≤ 0.04. 
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4.3.8 Overexpression of only PLB1 rescues ypk1tsykr2∆ lethality at the restrictive 
temperature.   
Plb1 was previously identified as a multicopy suppressor of lethality in the ypk1tsykr2∆ 
strain at the restrictive temperature of 37°C (147). To determine if rescue was PLB1-specific or 
could be conferred by other PLB-encoding genes, growth was monitored in the ypk1tsykr2∆ strain 
overexpressing PLB1, PLB2, PLB3, or NTE1.  The genes were expressed from their endogenous 
promoters on multicopy plasmids (see “Experimental Procedures”). Even though there was a 200-
300-fold increase in PLB1, PLB2, and PLB3 message levels and a 50-fold increase in NTE1 
message levels, only overexpression of PLB1 rescued ypk1tsykr2∆ lethality at the restrictive 
temperature (Figure 4-8).  
 
Figure 4-8. Overexpression of only PLB1 rescues the lethality of the ypk1tsykr2 strain at 
restrictive temperature.  
A. WT and ypk1tsykr2 strains (YPH499) harboring the indicated plasmids were pre-grown in selective 
medium, harvested, and resuspended to equivalent densities. Cells from 5-fold serial dilutions of each 
culture were spotted onto selective medium and grown for 3 days at the permissive (30⁰C) and restrictive 
(35⁰C) temperatures.  
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4.3.9 Deletion of both PLB1 and YPK1 leads to synthetic interactions.  
Based on the data presented in Figure 4-8, PLB1 and YPK1 appear to genetically interact.  
To confirm this hypothesis, we examined specific phenotypes in strains lacking both genes.  As 
shown in Figure 4-9A, a negative genetic interaction was observed between YPK1 and PLB1 when 
growth was monitored, although the severity of the defect varied somewhat depending upon the 
genetic background employed. On solid YNB medium, ypk1∆plb1∆ isolates constructed in both 
the BY4742 or YPH499 backgrounds displayed a growth defect as compared to ypk1∆ at 30ºC and 
35ºC (Figure 4-9 A). The ypk1∆plb1∆ strain constructed in the YPH499 background also exhibited 
a growth defect on YPD plates (Figure 4-9B).  
 The Ypk1 pathway influences several downstream events, including cell wall integrity 
(147,148). Therefore, we examined the effect of the cell wall perturbing agent, calcofluor white, 
on growth. A ypk1∆plb1∆ mutant exhibited increased sensitivity to calcofluor white as compared 
to ypk1∆ (Figure 4-9B). This result was most striking in the YPH499 background, where no growth 
was observed in the ypk1∆plb1∆ strain in the presence of calcofluor white when present at a final 
concentration of 8.5 µg/ml. These findings, together with the fact that PLB1 is a multicopy 
suppressor of the lethality of the ypk1tsykr2∆ strain, indicate that increased PC turnover via Plb1 
activity increases the fitness of yeast when Ypk1 is absent.  More generally, these findings suggest 
that sphingolipid synthesis is coordinated with PC turnover to maintain optimal lipid homeostasis. 
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Figure 4-9. The slowed growth phenotype and sensitivity to the cell wall perturbing agent, 
calcofluor white, in a ypk1 strain is exacerbated by deletion of PLB1.  
A, Strains in the BY4742 and YPH499 backgrounds were pre-grown in YNB medium, harvested, and 
resuspended to equivalent densities. Cells from 5-fold serial dilutions were spotted onto YNB plates and 
incubated for 48 (BY4742) or 32 hours (YPH499). C and D, WT and deletion strains were pre-grown in 
YNB medium, harvested, and resuspended to equivalent densities. 5-fold (BY4742) or 10-fold (YPH499) 
dilutions were spotted onto YPD and YPD + 8.5g/mL calcofluor white plates and incubated at 30⁰C for 
32 or 48 hours, respectively. Data displayed is representative of multiple experiments. 
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4.4 Discussion 
PC is the most abundant glycerophospholipid in eukaryotic membranes and its synthesis 
and catabolism are highly regulated. In yeast, the known routes of PC catabolism occur through 
the action of the phospholipase D encoded by PLD1/SPO14 (180), the ER localized PLB encoded 
by NTE1 (103), and PLB1 (69). Here we show that Plb1 activity (Figure 4-2) and expression 
(Figure 4-5, Figure 4-6) were modulated by the serine/threonine kinase Ypk1. Furthermore, we 
show that regulation occurs via a mechanism in which the cell can detect compromised 
sphingolipid biosynthesis (Figure 4-6). Blockage of SPT activity through use of an lcb1-100 
mutant or by treatment with myriocin also results in increased PLB1 expression. Treatment of cells 
with aureobasidin A, which blocks downstream steps in the sphingolipid biosynthetic pathway, 
led to a similar effect, indicating that the formation of the complex sphingolipid, IPC, at a 
minimum, is required to regulate PLB1 (Figure 4-6).   
Plb1 has been widely accepted as a secreted and plasma membrane-associated protein 
based on cellular fractionation studies and its role in the production of extracellular GroPCho (69). 
Our results, utilizing a Plb1 construct with an internal HA tag to account for a potential GPI anchor, 
indicate that Plb1 is secreted (Figure 4-5A) and fractionates with the ER marker, Sec61, but not 
with the plasma membrane marker, Pma1 (Figure 4-5C). As a secreted and glycosylated protein, 
it is not unexpected to find Plb1 at the ER. However, our data along with that of others suggest the 
intriguing possibility that Plb1 may be active intracellularly as well as at the cell surface, since it 
has been shown to metabolize excess intracellular lysophospholipids (190) and to be involved in 
PC acyl chain  remodeling (191).  The secreted/periplasmic form of Plb1 is most likely responsible 
for the production of extracellular GroPCho. Notably, extracellular GroPCho is not a dead-end 
metabolite, but can be recycled into PC synthesis following its uptake via glycerophosphodiester 
transporters that have been identified in both S. cerevisiae (61) and C. albicans (104,106). 
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Ypk1 regulates sphingolipid synthesis by phosphorylating Orm1/2 (143). Phosphorylated 
Orm1/2 cannot bind to SPT, resulting in upregulated sphingolipid synthesis. However, our results 
show that the increase in PLB1 expression observed in a ypk1∆ strain is not entirely mediated by 
Orm1/2, since PLB1 transcript levels are not depressed to WT levels in the 
ypk1tsykr2∆orm1∆orm2∆ strain (Figure 4-8). This result suggests that Ypk1 may affect 
sphingolipid synthesis via a mechanism that goes beyond regulation of Orm1/2 activity. 
Alternately, deletion of Orm1/2 may have additional consequences that impinge upon Plb1 
expression and phospholipid metabolism. For example, an orm1∆orm2∆ strain is an inositol 
auxotroph, indicative of disrupted regulation of phospholipid metabolism (158). Furthermore, 
auxotrophy can be reversed by growth in the presence of myriocin, indicating a connection 
between sphingolipid and phospholipid metabolism upon loss of Orm1/2 (158).  These data 
suggest a complicated relationship between Orm1/2 and its role in regulating sphingolipid and 
phospholipid metabolism.  
Phosphorylation of the lipid flippase activator, Fpk1, by Ypk1 downregulates the Dnf1 and 
Dnf2 flippases (142).  In addition, Fpk1 has been linked to elevated levels of ROS that are 
produced upon loss of Ypk1 (154). Our results do not indicate a connection between Plb1 activity 
and Fpk1, as a fpk1∆ strain does not display increased PC turnover and Plb1 does not have a Fpk1/2 
phosphoacceptor site. We also discovered that the calcineurin dependent responsive element 
(CDRE) transcription factor, Crz1, is a key regulator of the increased PLB1 expression observed 
upon disruption of sphingolipid biosynthesis. Interestingly, Crz1 is not responsible for increased 
PLB1 transcription observed upon heat stress (Figure 4-7A), suggesting multiple levels of PLB1 
regulation, depending on the applied stress. Consistent with our findings, a ypk1∆ykr2∆ strain 
bearing a YPK1as allele displays increased expression of several genes, many that have Crz1 
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binding sites in their promoters, including PLB1 (151). Based on these and other data, a model 
was proposed in which the TORC2 and calcineurin pathways act antagonistically to maintain the 
optimal cell growth and survival (151). When Ypk1 is recruited to the plasma membrane by 
Slm1/2, there is a shift toward downregulation of the calcineurin pathway and upregulation of 
TORC2 signaling. Therefore, in a ypk1∆ strain, activation of the calcineurin pathway would 
predominate, activating the downstream transcription factor, Crz1, which in turn activates various 
CDRE genes, including PLB1 (Figure 4-10). Interestingly, treatment of cells with myriocin results 
in TORC2-dependent phosphorylation of Ypk1 in a manner that requires the Ypk1 recruiting 
proteins, Slm1/2, to translocate from eisosomes to membrane compartments containing TOR 
(152,153). Since Slm1 relocalization was suggested to be a result of an altered sphingolipid 
environment, and an increase in ROS (154), it is tempting to speculate that alterations in the 
eisosome lipid environment due to Plb1-mediated PC turnover may also contribute to Slm1 
relocalization.  
Our phenotypic analysis of the ypk1∆plb1∆ double mutant suggests that upregulated Plb1 
activity upon loss of Ypk1 is a functionally important compensatory mechanism, since slowed 
growth and sensitivity to calcofluor white are exacerbated upon deletion of PLB1 in the ypk1∆ 
strain (Figure 4-9). Two lines of evidence indicate Plb1 activity, as opposed to activity of the other 
PLBs, mediates this phenomenon: i) only overexpression of PLB1 rescues growth of the 
ypk1tsykr2∆ strain at restrictive temperature (Figure 4-8), and ii) turnover of PI, the primary 
substrate of Plb3, is not altered in the ypk1∆ strain.   
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Figure 4-10. Model of PLB1 transcriptional activation upon loss of Ypk1 or upon 
disruption to sphingolipid biosynthesis by the presence of myriocin.  
The left panel displays events occurring in a WT cell where the TORC2/Ypk1 signaling pathway 
predominates resulting in a basal level of PLB1 trnscription and basal level of Plb1-mediated PC turnover. 
The right panel displays event occurring upon loss of YPK1 where the Calcinuerin signaling pathway 
predominates causing Crz1 dephosphorylation and resultant elevation of PLB1 trnscript levels and elevation 
of Plb1-mediated PC turnover. The right panel (gray) also displays elevation of Crz1 activated PLB1 
transcription in the presence of myriocin. The dotted line indicates movement TORC2, Target or 
rapamyacin complex 2; SPT, serine palmitoyl transferase. 
 
In summary, our results indicate that Ypk1, in addition to regulating sphingolipid synthesis 
and plasma membrane flippase activity, also regulates the turnover of the major phospholipid, PC. 
Future studies will focus on the mechanism by which altered sphingolipid biosynthesis, as 
engendered by loss of Ypk1, activates the myriad of genes under the control of Crz1, such as Plb1. 
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Chapter 5 Summary and Future 
Directions 
 
5.1 Summary of results 
My dissertation work has resulted in novel contributions to our understanding of the B-
type phospholipases in S. cerevisiae. First, Ira1 and Ira2 were implicated in regulation of both the 
production of extracellular GroPIns and its transport into the cell.  However, I was unable to 
implicate the Ras/cAMP pathway in this regulation suggesting that other undefined functions of 
Ira1/2 might be involved. Second, examination of various aspects of the GDTR pathway revealed 
loss of the cell surface associated PLBs, Plb1-3, and/or utilization of GroPIns as a phosphate source 
results in abnormal actin cytoskeleton and an increased cell size. Regarding the reutilization aspect 
of the GDTR pathway, I was unable to determine if reacylation of GroPIns can occur in the cell. 
Third, I identified a novel interaction between Ypk1 and Plb1 demonstrating that in addition to 
regulating sphingolipid synthesis and plasma membrane flippase activity, Ypk1 also regulates the 
Plb1-mediated turnover of the major phospholipid, PC.  
Additionally, my work has suggested many new avenues that could be pursued in order to 
better understand the relationship between phospholipid turnover via phospholipases of the B-
type, sphingolipid metabolism, and the Ypk1 kinase. Here, I discuss what I feel are the most 
pressing open questions and future directions that could be pursued.  
5.2 How does alteration in sphingolipid biosynthesis result in activation of Crz1? 
I have documented a novel role for Ypk1 in regulation of Plb1-mediated PC turnover. This 
data adds to the published findings indicating that Ypk1 contributes to the maintenance of both 
sphingolipid and phospholipid homeostasis. Ypk1 does not appear to regulate Plb1 by direct kinase 
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activity, but instead Plb1 activity is elevated in ypk1∆ yeast due to the disruption of sphingolipid 
metabolism (Figure 4-5, Figure 4-6).  This disruption causes transcriptional upregulation of PLB1 
in a Crz1-dependent manner.  
To identify genes involved in Crz1-mediated gene regulation, a screen of selected deletion 
mutants bearing a plasmid (CDRE plasmid) containing a promoter region with binding sites for 
the transcription factor Crz1 linked to the lacZ gene could be utilized. This plasmid has been 
constructed by other researchers and is available (11). Transcriptional induction could be 
monitored by measuring β-galactosidase activity upon treatment of the cells with myriocin or 
another drug disrupting sphingolipid metabolism. Mutants to be tested would include those that 
have a link to calcium metabolism, since Crz1 is a calcineurin/calcium-activated transcription 
factor. For example, strains lacking the plasma membrane calcium channel complex, Mid1/Cch1, 
and the vacuole cation channel Yvc1, both of which allow calcium into the cytoplasm, are prime 
candidates to be tested (192).  
5.3 Are other genes in phospholipid synthesis affected by disrupted sphingolipid synthesis? 
Since Ypk1 appears to be a major regulator of lipid homeostasis, additional genes 
transcriptionally regulated by loss of Ypk1 and/or disruptions to sphingolipid biosynthesis could 
be identified. Genes of interest may include genes containing potential Crz1 binding sites in their 
promoters or genes involved in some aspect of lipid metabolism that I believe are linked to Ypk1 
function. Several genes of interest involved in lipid metabolism that also have Crz1 binding sites 
in their promoter regions include: ORM2, SCS2, CHO2, NTE1, INO1, OPI3, and LAC1 
(YEASTRACT), while other genes of interest involved in lipid metabolism include SPO14 and 
GDE1. Specifically, measuring message levels by qRT-PCR of the selected genes could be 
performed in two sets of samples: i) in a wild type strain as compared to a ypk1∆ mutant and ii) in 
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wild type cells either treated or not treated with the sphingolipid synthesis inhibiting drug, 
myriocin.  
5.4 Does Plb1 play a role in Slm1 relocalization from eisosomes to MCT domains leading to 
TORC2 and Ypk1 activation? 
As discussed in Chapter 4, the antagonism between the TORC2 (promotes cell growth) and 
the calcineurin (promotes cell survival) pathways suggests a potential explanation for the increase 
in Plb1-mediated turnover upon loss of Ypk1 (151,152,193), with cell survival and Crz1 activation 
predominating in the absence of Ypk1. The Slm proteins must be translocated from eisosomes to 
the plasma membrane MCT in order for Ypk1 to be recruited to the plasma membrane for 
activation by TORC2 (153). Recent literature suggests that elevated levels of ROS are the essential 
signal for Slm1 relocalization to the MCT (154), and others have demonstrated that depletion of 
sphingolipids, hypo-osmotic stress, and mechanical membrane stress all cause Slm1 relocalization 
from eisosomes to MCT patches (152). While it has been suggested that sphingolipid levels may 
be important for Slm1 movement, it would be interesting to see if Plb1 and PC levels also play a 
role. For these experiments localization of fluorescently tagged Slm proteins could be compared 
in a WT and plb1∆ strains with and without myriocin treatment. Ypk1 phosphorylation by TORC2 
could also be monitored in these strains. If Slm protein localization is altered in plb1∆ cells, ROS 
levels could be compared in WT, ypk1∆, plb1∆, and ypk1∆plb1∆ strains since ROS is the proposed 
essential mediator of Slm protein relocalization. Fluorescently tagged Slm constructs are available 
from other labs (153), and published procedures exist for measuring Ypk1 phosphorylation (153) 
and ROS abundance (154). Further understanding of how lipids regulate the Slm proteins and the 
resultant Ypk1 activation by TORC2 is of interest because both TORC2 and ROS are elevated in 
cancer cells (154).  
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5.5 Is the plasma membrane lipid composition altered in YPK1/PLB1 deficient cells? 
Evaluation of the plasma membrane phospholipid composition in the YPK1/PLB1 mutants 
should be completed to better understand if phospholipid composition itself, in addition to 
sphingolipids, may influence Ypk1 signaling and/or cellular processes. Lipid composition 
specifically in the plasma membrane, ER, and vacuole fractions of WT, ypk1∆, plb1∆, and 
ypk1∆plb1∆ strains could be compared. Each membrane fraction can be isolated by published 
techniques and lipids – phospholipids, sphingolipids, neutral lipids, and sterols – can be extracted 
and their abundances quantified. Particular lipid composition has been found to be essential for 
some plasma membrane enzymes (194,195). Turnover events, through the action of the B-type 
phospholipases and other enzymes continually causes alterations to the plasma membrane lipid 
composition and is equally important. While my data indicates that PC turnover is altered in the 
ypk1∆and ypk1∆plb1∆ strains, turnover of the other major glycerophospholipids, 
phosphatidylinositol (PI), phosphatidylserine (PS), and phosphatidylethanolamine (PE) and the 
concomitant production of their metabolites, GroPIns, GroPSer, and GroPEtn could be thoroughly 
analyzed. Furthermore, more rigorous evaluation of methylation pathway synthesized PC turnover 
is also warranted.  
5.6 Is the functionality of model plasma membrane proteins, 1,3-β-glucan synthase, Git1, 
Pma1, and Can1, altered in YPK1/PLB1 deficient cells? 
Disrupted lipid regulation occurring upon YPK1 deletion may in turn abolish the proper 
lipid environment required for activity of essential plasma membrane enzymes. Phospholipase 
activity has been shown to alter plasma membrane enzyme function including lysophospholipase 
overexpression dependent inhibition of amiloride-sensitive epithelial sodium channel (ENaC) 
activity in mammalian cells (196), or PLA2 activity and lysophospholipid inhibition of the 1,3-β-
glucan synthase in yeast (197). My preliminary experiments have identified several potential 
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enzymes whose activities are altered upon deletion of PLB1 and YPK1, including 1,3-β-glucan 
synthase (Appendix A 17), Git1 (plasma membrane GPI transporter protein) (Appendix A 19), and 
Pma1 (plasma membrane ATPase) (Appendix A 20), and an enzyme whose activity is not altered, 
Can1 (arginine transporter) (Appendix A 21).  
Additional enzymes of interest, particularly spanning localization in different membrane 
compartments could be identified and analyzed for altered function. Upon verification that enzyme 
activity is indeed altered, the level of control causing the alterations in enzyme activity could be 
determined:  transcription (mRNA levels), post-transcriptional (protein levels), activity, and/or 
localization. These protein activities could be expected to be involved in phenotypes reported in 
this dissertation. Furthermore, if these proteins or others are verified to have altered activity upon 
loss of YPK1 and/or PLB1, future studies could evaluate the requirement for specific lipid 
environments for their optimal functionality by employing synthetic liposomes.  
5.7 Do the B-type phospholipases play a role in deacylation of the phosphorylated 
phosphoinositides in vivo? 
The roles of the PIPs have been extensively studied in yeast and higher eukaryotes 
demonstrating their key regulatory role in fundamental eukaryotic cell processes such as 
endo/exocytois, membrane trafficking, cell division, actin organization, and in the localization of 
proteins that bind to lipids, such as those with PH domains (31). PIP catabolism mostly occurs 
through the action of PLCs, but it can also occur by the action of PLA2 and/or PLB enzymes with 
concomitant production of the GroPIPs, lysophospholipids, and free fatty acids, with the GroPIPs 
being the least studied metabolite (51).  Glucose addition to stationary phase S. cerevisiae cultures 
was shown to result in release of GroPIns, GroPI[4]P, and GroPI[4,5]P2 into the extracellular 
medium (59). It is known that deacylation reactions are one method of PIP turnover in yeast (45). 
In addition, the literature suggests that both PIPs and their deacylation products, the GroPIPs, play 
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a role in actin cytoskeleton function. Thus, the potential role of the PLBs in this process is obvious 
considering my work showing that strains with PLB1-3 deleted have an increased sensitivity to the 
actin destabilizer, Lat A, as well as have an abnormal actin organization in the presence of 
Latrunculin A. Examination of PLB activity on the PIPs is also warranted for their potential role 
in the Ypk1-Plb1 signaling interaction as the Slm proteins have PH domains that are required for 
Ypk1 recruitment to the plasma membrane. Thus, I propose that determining if the PLBs are active 
against the PIPs in vivo is warranted.   
Although reproducible detection of the GroPIPs has proven difficult since they are 
physiologically present at low concentrations, new techniques and dyes specific to PIPs may aid 
in future PIP/GroPIP analyses. HPLC or LC/MS analysis of GroPIns and the GroPIPs would need 
to be employed. Fusion of known PIP binding domains to specific flares tagged with GFP have 
been constructed to use in detection of PtdIns[4,5]P2 and PtdIns[4]P (198,199) and Annexin V 
conjugated to Alexa Fluor 488 is available for specific binding to PS (200). Complete analysis of 
the PIPs and GroPIPs in the YPK1 and PLB1-3 mutant strains would require development and 
optimization of additional techniques to monitor these metabolites at their physiologically relevant 
concentrations in vivo.   
5.8 Final conclusions about the importance of PLBs  
The experiments completed thus far provide novel insights into the roles and regulation of 
the B-type phospholipases, and how regulation of lipid metabolism and turnover can affect many 
cellular processes. Long-term goals could include further elucidating the mechanism by which 
Ypk1 regulates Plb1, and developing an understanding of how this regulation impacts global 
cellular processes such as, cell wall integrity, actin dynamics, eisosome assembly, endocytosis, 
and general cell health. The outcomes of the studies would further our understanding of how lipid 
metabolism is integrated with other important aspects of cellular physiology in a eukaryotic cell.  
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Appendix A 
 
Preliminary data from exploratory experiments pertaining to or referenced in Chapter 3 are 
found in Appendices A 2 - A 5. Appendices A 6 - A 16 contain data collected as part of the project 
described in Chapter 4, but were not included with the submitted manuscript. No narrative will be 
included with those figures. Additional preliminary experiments performed by me that were not 
pursued further, or that will be continued by other members of the lab are included in Appendices 
A 17 - A 21 and are referred to in Chapter 5 for discussion purposes.  
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A 1. Genes with predicted or observed phospholipase activity in S. cerevisiae. 
(Gene descriptions from SGD, yeastgenome.org) 
       
 
GeneID GENE Aliases Description from Saccharomyces Genome Database
853007 CLD1 YGR110W
Mitochondrial cardiolipin-specific phospholipase; functions upstream of Taz1p to generate 
monolyso-cardiolipin; transcription increases upon genotoxic stress; involved in restricting Ty1 
transposition; has homology to mammalian CGI-58
856001 FMP30 YPL103C
Protein with a role in maintaining mitochondrial morphology; also involved in maintaining normal 
cardiolipin levels; mitochondrial inner membrane protein; proposed to be involved in N-
acylethanolamine metabolism; related to mammalian N-acylPE-specific phospholipase D
856739 ISC1 YER019W
Inositol phosphosphingolipid phospholipase C; mitochondrial membrane localized; hydrolyzes 
complex sphingolipids to produce ceramide; activates genes required for non-fermentable carbon 
source metabolism during the diauxic shift; activated by phosphatidylserine, cardiolipin, and 
phosphatidylglycerol; mediates Na+ and Li+ halotolerance  
854251 LPX1 YOR084W
Peroxisomal matrix-localized lipase; required for normal peroxisome morphology; contains a 
peroxisomal targeting signal type 1 (PTS1) and a lipase motif; peroxisomal import requires the 
PTS1 receptor, Pex5p and self-interaction; transcriptionally activated by Yrm1p along with genes 
involved in multidrug resistance; oleic acid inducible
854943 NTE1 YML059C
Serine esterase, phospholipase B; homolog of human neuropathy target esterase (NTE); Nte1p-
mediated phosphatidylcholine turnover influences transcription factor Opi1p localization, 
affecting transcriptional regulation of phospholipid biosynthesis genes  
850411 PER1
YCR044C, 
COS16
Protein of the endoplasmic reticulum; required for GPI-phospholipase A2 activity that remodels 
the GPI anchor as a prerequisite for association of GPI-anchored proteins with lipid rafts; 
functionally complemented by human ortholog PERLD1  
855895 PGC1 YPL206C
Phosphatidyl Glycerol phospholipase C; regulates the phosphatidylglycerol (PG) content via a 
phospholipase C-type degradation mechanism; contains glycerophosphodiester 
phosphodiesterase motifs  
855020 PLB1 YMR008C
Phospholipase B (lysophospholipase) involved in lipid metabolism; required for efficient acyl 
chain remodeling of newly synthesized phosphatidylethanolamine-derived phosphatidylcholine; 
required for deacylation of phosphatidylcholine and phosphatidylethanolamine but not 
phosphatidylinositol; PLB1 has a paralog, PLB3, that arose from the whole genome duplication 
855018 PLB2 YMR006C
Phospholipase B (lysophospholipase) involved in lipid metabolism; displays transacylase activity 
in vitro; overproduction confers resistance to lysophosphatidylcholine
854151 PLB3 YOL011W
Phospholipase B (lysophospholipase) involved in lipid metabolism; hydrolyzes 
phosphatidylinositol and phosphatidylserine and displays transacylase activity in vitro; PLB3 
has a paralog, PLB1, that arose from the whole genome duplication 
855860 PLC1 YPL268W
Phospholipase C; hydrolyzes phosphatidylinositol 4,5-biphosphate (PIP2) to generate the 
signaling molecules inositol 1,4,5-triphosphate (IP3) and 1,2-diacylglycerol (DAG); involved in 
regulating many cellular processes; Plc1p and inositol polyphosphates are required for acetyl-
CoA homeostasis which regulates global histone acetylation
855720 SPO1 YNL012W
Meiosis-specific prospore protein; required for meiotic spindle pole body duplication and 
separation; required to produce bending force necessary for proper prospore membrane assembly 
during sporulation; has similarity to phospholipase B
853902 SPO14
YKR031C, 
PLD1
Phospholipase D; catalyzes the hydrolysis of phosphatidylcholine, producing choline and 
phosphatidic acid; involved in Sec14p-independent secretion; required for meiosis and spore 
formation; differently regulated in secretion and meiosis; participates in transcription initiation 
and/or early elongation of specific genes; interacts with "foot domain" of RNA polymerase II; 
deletion results in abnormal CTD-Ser5 phosphorylation of RNA polymerase II at specific 
promoter regions  
853964 TGL4
YKR089C, 
STC1
Multifunctional lipase/hydrolase/phospholipase; triacylglycerol lipase, steryl ester hydrolase, 
and Ca2+-independent phospholipase A2; catalyzes acyl-CoA dependent acylation of LPA to 
PA; required with Tgl3p for timely bud formation; phosphorylated and activated by Cdc28p; 
TGL4 has a paralog, TGL5, that arose from the whole genome duplication  
853309 YJL132W YJL132W
Putative protein of unknown function; localizes to the membrane fraction; possible Zap1p-
regulated target gene induced by zinc deficiency; YJL132W is a non-essential gene; contains 
domain for Zinc dependent phospholipase C
850809 YLR118C
YLR118C, 
APT1
Acyl-protein thioesterase responsible for depalmitoylation of Gpa1p; green fluorescent protein 
(GFP)-fusion protein localizes to both the cytoplasm and nucleus and is induced in response to 
the DNA-damaging agent MMS ; contains conserved domain for Abhydrolase 2, 
Phospholipase/Carboxylesterase
854187 YOR022C YOR022C
Putative carboxylic ester hydrolase; similar to bovine phospholipase A1; the authentic, non-
tagged protein is detected in highly purified mitochondria in high-throughput studies
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A 2. Loss of the cell surface associated PLBs results in invaginations of the cell membrane 
when grown in media containing GroPIns as the sole phosphate source. 
A, WT (JPV 13) and plb123∆ (JPV 480) were grown on YNB I+ LoPi and YNB I+ NoPi +200 µM GroPIns 
agar plates. A sample of the cells from each condition were analyzed by SEM. B, Magnified image of 
plb123∆ in GroPIns media Arrows point to cells displaying large invaginations. Photos courtesy of Dr. 
Donna Stolz, University of Pittsburgh. 
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A 3. Exposure to LatA alters distribution of actin patches and cables upon loss of PLB1-3.  
Cells grown as described in Fig. 3-14. TRITC-phalloidin staining of the actin cytoskeleton in the absence 
(A) and presence (B) of Latrunculin A (LatA). Visualized by the Zeiss Axio Observer Z1 confocal 
microscope, 100x 1.4NA objective. Images obtained with HCImage software.  
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A 4. Alterations in PLB message levels in log phase compared to stationary phase.  
Total RNA was extracted from harvested cells followed by DNase treatment. Transcript levels were 
analyzed by real-time RT-PCR using the comparative ∆∆CT method. Data were normalized to the amount 
of the endogenous control mRNA, SNR17, and expressed relative to the value in WT cells in log phase. 
Values represent the mean ± S.E. of at least 3 individual cultures each assayed in triplicate. 
 
 
A 5. Deletion of LGE1 and PLB3 results in slowed growth and decreased colony size.  
WT (JPV 399), plb3∆, lge1∆ (JPV 637), and lge1∆plb3∆  patched to single colonies on YPD plates at 30ºC 
(A) and growth curve in YPD media at 30ºC (B). In the lower panels (A), two independent isolates are 
streaked from single colonies.   
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A 6. Protein Architecture upon construction of the PLB1-I-3HA allele. 
(Supplement to Experimental Procedures, HA-allele). The HA tag was inserted into the PLB1 gene without 
interference with the localization signal, the GPI signal, and the catalytic site.  
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A 7. Plb1 mediated external glycerophosphocholine production is increased upon deletion 
of YPK1 at multiple time points in the BY4742 background.  
(Supplement to Fig. 4.1A and Table 4.1A). Separation of metabolites from external, internal, and membrane 
fractions is shown for multiple time points, after 0, 2, 4, and 13 hours of chase. Values are the means ± S.E. 
of at least triplicate cultures. 
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A 8. Plb1 mediated external glycerophosphocholine production is increased upon deletion 
of YPK1 at multiple time points in the YPH499 background. 
(Supplement to Fig. 4.1B and Table 4.1B). Separation of metabolites from external, internal, and membrane 
fractions is shown for multiple time points, after 0, 4, and 8.5 hours of chase. Values are the means ± S.E. 
of at least triplicate cultures.  
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A 9. Kennedy pathway synthesis of phosphatidylcholine is not altered upon loss of Ypk1.  
(Supplement to Fig. 4.3). Strains in the YPH499 background were grown to log phase in YNB 75 µM 
inositol media. [C14]-choline was added to equivalent amounts of cells in YNB media and the amount of 
incorporation into PC after 30 minutes was determined. Lipids were extracted and [C14]-choline 
incorporation was measured by LSC (A) and verified to be incorporated into PC by TLC (B). A non-
radioactively labeled standard for PC was visualized by staining the TLC plate with Thioflavin S solution. 
Values are the means ± S.E. of three independent cultures assayed in duplicate.  
 
 
 
A 10. Deletion of the flippase activators, Fpk1 or Fpk2, or deletion of LSP1 or PIL1, 
involved in eisosome formation do not alter extracellular GroPCho production. 
(Supplement to Chapter 4). Strains in the BY4742 background bearing the indicated gene deletions were 
pre-grown at 30⁰C in YNB media containing 0.2µCi/mL [14C]-Choline chloride, followed by a chase in 
YNB media containing 10 mM choline at 37⁰C. Extracellular, intracellular, and membrane fractions were 
separated from harvested cells at the listed time points. Separation of [14C]-choline containing metabolites 
from extracellular and intracellular fractions was performed using anion exchange column chromatography, 
but no differences from WT were observed, except in the ypk1∆ strain as previously discussed. Data shown 
is the mean ± S.E. of at least duplicate cultures. 
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A 11. Overexpression of the plasma membrane flippase, DNF1, does not result in altered 
extracellular GroPCho production. 
Supplement to Chapter 4. WT (BY4742) was transformed with pRS423 (JVE 338) and pRS423-DNF1 
(JVE 339) and pre-grown at 30⁰C in YNB media lacking uracil containing 0.2µCi/mL [14C]-Choline 
chloride, followed by a chase in YNB media containing 10mM choline at 37⁰C. Extracellular, intracellular, 
and membrane fractions were separated from harvested cells at the listed time points. Separation of [14C]-
choline containing metabolites from extracellular and intracellular fractions was performed using anion 
exchange column chromatography. Data shown is the mean ± S.E. of triplicate transformants. 
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A 12. Secreted and cell-surface associated Plb1 protein abundance in log and stationary 
phase is elevated in a ypk1∆ mutant.  
(Supplement to Figure 4-4). A, WT + PLB1-I-3xHA and ypk1∆ + PLB1-I-3xHA were grown in YNB media 
at 30⁰C to log and stationary phase. Supernatant was concentrated 100-fold, while total protein was 
extracted from the cells. Western blot was performed on all fractions using an anti-HA-Plb1 primary 
antibody and HRP-conjugated anti-mouse secondary. Note there is less protein in the stationary phase 
samples than the log phase samples.  
 
 
 
 
 
A 13. Regulation of PLB1, PLB2, and PLB3 message levels upon loss of Ypk1 or upon loss 
of transcription factors, Crz1, Msn2, and Msn4.  
Strains in the BY4742 background were grown to early log phase in YNB media at 30°C. Total RNA was 
extracted and PLB transcript levels were analyzed by qRT-PCR using the comparative ∆∆CT method. Data 
were normalized to the amount of the endogenous control mRNA, SNR17, and expressed relative to the 
value in WT cells. Values represent the mean ± S.E. of three cultures assayed in triplicate. Results of interest 
from this experiment include upregulation of PLB3 in ypk1 cells compared to WT, however a concurrent 
increase in Plb3-mediated GroPIns production was not observed (Chapter 4). Msn2 and Msn4 did not 
appear to regulate PLB1 or PLB3 under the growth conditions tested, but may be involved in depressing 
PLB2 message. Crz1 appears to have regulate PLB1 and possibly PLB3 message levels.  
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A 14. Compromised sphingolipid synthesis by the presence of myriocin results in increased 
extracellular GroPCho production.   
(Supplemental to Fig. 5E.) Separation of metabolites from external, internal, and membrane fractions is 
shown for multiple time points, after 0, 3, and 6 hours of chase. Values are the means ± S.E. of at least 
triplicate cultures.  
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A 15. Overexpression of the PLB genes on a multicopy plasmid elevates corresponding PLB 
message levels.  
(Supplemental to Figure 4-8). A, WT cells transformed with the PLB overexpression plasmids, YEp351-
PLB1, YEp351-PLB2, YEp351-PLB3, and pRS426-NTE1, were grown to log phase in selective media at 
30°C. Total RNA was extracted and PLB1, PLB2, PLB3, and NTE1 transcript levels were analyzed by real-
time qRT-PCR using the comparative ∆∆CT method. Message levels were normalized to the endogenous 
control, SNR17, and expressed relative to the message in corresponding WT + empty vector. Values 
represent the mean ± S.E. of at least 3 individual transformants assayed in triplicate. 2-way ANOVA 
showed no statistical difference between values for PLB1, PLB2, or PLB3, but expression of NTE1 was 
significantly different.  
 
 
 
 
 
A 16. The slowed growth phenotype and sensitivity to the cell wall perturbing agent, 
calcofluor white, for a ypk1∆ strain is exacerbated by deletion of PLB1.  
(Supplemental to Figure 4-9). Strains in the YPH499 (A and B) and BY4742 (C and D) backgrounds were 
grown in YNB media containing 75 µM inositol at 30⁰C and 37⁰C. Data represent the mean and standard 
error of at least three replicates. E, Cells from 10-fold serial dilutions of strains in the YPH499 background 
were spotted onto YPD, YPD + 0.5 M NaCl, and YPD + 8.5 µg/mL calcofluor white plates and incubated 
at both 30⁰C and 35⁰C for 3 days. None of the strains were able to grow on YPD + 8.5 µg/mL calcofluor 
white plates at 35⁰C. Data displayed is representative of multiple experiments. 
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A 17. 1,3-β glucan synthase activity is depressed upon deletion of PLB1 and YPK1.  
Plasma membrane isolated from WT (JPV 399), plb1 (JPV 668), ypk1 (JPV 636), and ypk1plb1 (JPV 
669) grown in YNB I+ media to log phase (OD600 ≈ 0.7) at 30C, harvested, washed with 1 mM EDTA, and 
assayed for 1,3-β-glucan synthase activity according to published procedures (201-203).  Acid washed glass 
beads (2 mL) and 8 mL of cold Breaking Solution (0.5 M NaCl, 1 mM EDTA, 1 mM PMSF) were added 
to cell pellet on ice. Vortex and incubations on ice were done alternately for 1-2 minutes and repeated 10 
times. Cell lysate was transferred to a fresh tube and beads were washed with an aliquot of breaking buffer 
and added to the lysate. Centrifuging 5 minutes at 1500 x g at 4⁰C cleared unbroken cell and debris. 
Supernatant (membrane fraction) was transferred to ultracentrifuge tubes and breaking solution was added 
up to top of tube. Membranes were pelleted at 100,000 x g for 30 minutes at 4⁰C. Pellet was resuspended 
in 1mL of membrane buffer (50 mM Tris-HCl pH = 7.5, 1 mM EDTA, 1 mM β-mercaptoethanol, 33% 
glycerol) and homogenized on ice with the Dounce homogenizer. Protein concentration was determined by 
Bradford assay. 20µg of protein was assayed for 1 hour at 30°C in a reaction containing 2 µL of 0.1 M 
UDP-glucose, 1.25 µL of UDP-[14C]-glucose (0.02 µCi/mL), 3 µL of 10% BSA, 2 µL of 0.5 M KF, 3 µL 
of 10mM EDTA,  4µL of 1mM GTP, and water up to 40µL. The reaction was stopped by addition of 1mL 
10% TCA and filtered through glass fiber (GF/C, Whatman 1822-025). Filters were washed with three 1 
mL aliquots of 10% TCA followed by two 1 mL washes with 95% ethanol. Incorporation of [C14]-UDP-
glucose into cells was quantified by liquid scintillation counting. Data represent mean ± S.E. of four 
independent cultures. The ypk1plb1 1,3-β-glucan synthase activity is from multiple colonies of only one 
deletion isolate.  
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A 18. Altered expression of the catalytic subunit of 1,3-β glucan synthase, Fks2.  
WT (JPV 399), plb1 (JPV 668), ypk1 (JPV 636), and ypk1plb1 (JPV 669) transformed with pFKS2-
lacZ (JVE 336) were grown to log phase (OD600 ≈ 0.8) in YNB –URA media at 30ºC and 37ºC. Harvested 
cells were assayed for β-gal activity as described in Experimental Procedures (Chapter 2.3.1). Data 
represent the mean ± S.E. of four independent transformants.  
 
 
 
A 19. Activity of the plasma membrane protein, Git1, is depressed upon loss of Ypk1 
and/or Plb1. 
WT (JPV 399), plb1 (JPV 668), ypk1 (JPV 636), and ypk1plb1 (JPV 669) grown in YNB I- 200µM 
KH2PO4 media were harvested and assayed for their ability to transport [H3]-GroPIns in a 6 minute assay 
at 30ºC as described in Materials and Methods (Chapter 2). Data represent the mean ± S.E. of three 
independent cultures assayed in duplicate. 
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A 20. Pma1 activity is not lost by deletion of PLB1 and/or YPK1.  
WT (JPV 399), plb1 (JPV 668), ypk1 (JPV 636), and ypk1plb1 (JPV 669) cells grown in YNB I+ 
media to log phase at 30ºC were harvested and membranes isolated as described in Galan et al.(204). 
Sodium azide was added to culture, cells were pelleted and washed, and resuspended in lysis buffer (0.1 M 
Tris-HCl pH = 7.5, 0.15 M NaCl, 5 mM EDTA, protease inhibitor mix) to a concentration of 50 ODU/0.2 
mL. Chilled glass beads were added to meniscus of suspension and vigorously agitated with a vortex 
between incubations on ice. Lysate was removed to a fresh tube and beads were washed with aliquot of 
lysis buffer that was added to cell lysate. Centrifugation at 3,000 rpm (should have been slower because 
likely lost Pma1 at this speed) removed unbroken cells and debris. Supernatant was removed as the PM 
enriched fraction and centrifuged for 45 minutes at 12,000 rpm x g. Pellet containing membranes was 
resuspended in 10X diluted lysis buffer. Protein concentration was measure by Bradford assay. 40 µg of 
protein was assayed for ATPase activity as described in Koland et al.(205). Protein sample was added to 1 
mL of ATPase assay buffer (50 mM MES, 5 mM MgCl2, 5 mM NaN3, pH = 6 with Tris) with and without 
100 µM orthovanadate and pre-incubated for 5 minutes at 30ºC. To start assay 20 µL of 0.1 M ATP (sodium 
salt) was added and incubated for 10 minutes at 30ºC. The reaction was stopped with 2mL of stop solution 
(2% sulfuric acid, 0.5% ammonium molybdate, 0.5% SDS). The product corresponding to ATPase activity, 
phosphomolybdate, was reduced by addition of 20 uL of 10% ascorbic acid. The reaction sat for 5minutes 
at RT before absorbance was read at 750 nm. Blanks containing no enzyme and no ATP were run to subtract 
out background. Data trends are representative multiple experiments.  
 
 
 
A 21. Sensitivity to canavanine is not altered upon YPK1 and/or PLB1 deletion.  
Indicates Can1 arginine transport is not compromised in these strains. WT (JPV 399), plb1 (JPV 668), 
ypk1 (JPV 636), ypk1plb1 (JPV 669), WT (JPV 523), ypk1 (JPV 768), ypk1tsykr2 (JPV 771) and 
can1 cells were grown in YNB media, diluted to OD600 = 1.0 in water. Four 10-fold serial dilutions were 
performed and 5 µL of each dilution was spotted onto YNB – arginine plates ± 7.5 µg/mL canavanine. 
Plates were incubated at 30ºC and 37ºC for 48 hours.  
- Arginine - Arginine + Canavanine
plb1∆ WT
ypk1∆plb1∆ ypk1∆
can1∆ WT
